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Abstract
Transient receptor potential canonical (TRPC) channels are a family of non-selective cation
channels which have a wide range of physiological functions. In this thesis we used genetic
approaches to investigate functional roles of TRPC3, TRPC6
We used the Cre/loxP system to delete TRPC3 exclusively from nociceptive neurons, using
Nav1.8Cre, and from all dorsal root ganglion (DRG) neurons, using Advillin Cre.
Inflammatory pain behavior was attenuated in both TRPC3 conditional null animals but acute
mechanical, cold and thermal pain behavior was not affected. Microarray analysis identified a
number of dysregulated pathways in the nociceptors of the TRPC3 conditional null mice,
providing insights into inflammatory pain pathways.
Given the similarity between TRPC channels we used a TRPC3/TRPC6 global double
knockout to further investigate TRPC function. The TRPC3/TRPC6 double knockout mice
were found to have attenuated mechanosensation specific to light touch, with no deficits in
noxious mechanosensation, due to a reduction of rapidly adapting mechanically activated
current in the small-medium DRG neurons. The TRPC3/TRPC6 double knockouts had no
deficits in acute thermal or cold pain, or in neuropathic pain. The TRPC3/TRPC6 double
knockouts were also behaviourally deaf, confirmed by auditory brainstem recordings. This
work indicates a role for TRPC3 and TRPC6 in mechanosensation in sensory neurons and
outer hair cells.
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11 Introduction
1.1 Pain and nociception
Pain is defined by the International Association for the Study of Pain as “An unpleasant
sensory and emotional experience associated with actual or potential tissue damage, or
described in terms of such damage” (www.iasp-pain.org). Nociception is the process by
which tissue-damaging stimuli activate ion channels within sensory neurons. Nociception is
exclusively the presence of electrical activity within the relevant sensory neurons; it does not
necessarily result in a conscious pain sensation, similarly pain may be experienced without
nociception. Nociception is essential for survival, to avoid situations which could cause tissue
damage and protect injuries, but pain can outlast the original injury developing into chronic
pain.
The British Pain Society defines chronic pain as continuous, long-term, persistent pain
extending beyond the time that would be expected for healing. Chronic pain is a major
clinical problem; of nearly 50,000 people across 16 European countries 19% suffer chronic
pain, of which 36% have inadequate pain control from medication (Gfk NOP British Pain
Society Survey, 2005). Many existing analgesics are inadequately effective, as well as having
side effects and abuse liabilities; efficacy is limited to making pain more manageable rather
than controlling it. Over the past 20 years research for new analgesics has been limited to
drugs acting on well-established targets such as cyclooxygenase inhibitors, local anesthetics
and opioids. New targets are needed to avoid the side-effects and limitations of current
analgesics.
21.2 Nociception and DRG primary afferent neurons
The primary afferent neurons of the somatosensory nervous system convey sensory
information from their terminals in peripheral and visceral tissues to the spinal cord. The cell
bodies of the primary afferent neurons are contained within the dorsal root ganglion (DRG).
There are multiple subtypes of sensory neuron in the DRG which are broadly classified into
three groups according to anatomical and functional features, Aβ-fibres, Aδ-fibres and C-
fibres, which are further classified into nociceptive and non-nociceptive neurons.
Figure 1.1 The primary sensory neurons and their terminations within the spinal cord.
Primary afferent fibres terminate in laminae I – V of the dorsal horn, synapsing with interneurons,
nociceptive specific (NS) neurons and wide dynamic range (WDR) neurons. The laminae of the dorsal
hornwhere sensory neurons terminate are labeled. Peptidergic and non-peptidergic C- fibres terminate in
lamina II,  Aδ-fibres terminare in lamina I and Aβ-fibres terminate in lamina V. The different classes of 
primary afferent neurons are discussed further in 1.2 (Nociception and DRG primary afferent neurons)
31.2.1 Non- nociceptors
1.2.1.1 Aβ-fibres 
Aβ-fibres have nerve endings in the skin which are closely associated with Merkel cells and 
hair shafts which create highly touch-sensitive areas (see Figure 1.2). The Aβ-fibres terminate 
in laminas III and IV of the spinal cord and have a fast conduction velocity of 10-30m.sec-1.
Conduction velocity is determined by the diameter and degree of myelination of the neuron,
hence the large diameter and thick myelination of Aβ-fibres underlies their fast conduction 
velocity. The majority of Aβ-fibres respond to innocuous stimuli such as light touch, 
although a small proportion of Aβ-fibres have been shown to transduce noxious stimuli 
(Lawson, 2002). They are unimodal and show adaptation in their response to a repeated
stimulus, which therefore classifies them as non-nociceptive neurons.
Figure 1.2 Innervation of the skin by somatosensory neurons.
Adapted from (Lumpkin and Caterina, 2007) .
The skin is innervated by Aβ-fibres, Aδ-fibres and C-fibres. Aβ-fibres innervate Merkel cells and hair 
shafts, Aδ-fibres terminate in the dermis and C-fibres in different epidermal layers.  Transduction of the 
sensory stimulus, and hence the proteins and ion channels required, occur at the terminals of the sensory
neurons, in the skin.
41.2.2 Nociceptors
The further two subtypes of sensory neuron are known as nociceptors because they respond
to noxious stimuli. A noxious stimulus must be converted into an electrical signal by primary
afferent neurons before it is transmitted to higher centres to be perceived as pain. Nociceptors
respond to three types of noxious stimuli, mechanical, thermal and chemical which activate
the free ending terminals which are mostly found in the skin (MacIver and Tanelian, 1993).
1.2.2.1 Aδ-fibres 
Aδ-fibres are medium diameter, lightly myelinated neurons with a conduction velocity of 1.2-
10m.sec-1. Aδ-fibres terminate in laminas I and V of the spinal cord and respond to noxious 
mechanical, thermal and chemical stimuli. Their response to certain stimuli divides the Aδ-
fibres into two further categories; Type I fibres are responsive to heat, mechanical and
chemical stimuli with a fast conduction velocity and increase their response as the stimulus
increases. Type II fibres respond only to thermal and chemical stimuli with a reduced
conduction velocity and an adapting response to increased stimulus (Wall et al., 2005).
1.2.2.2 C-fibres
C-fibres are small and unmyelinated, giving them the slowest conduction velocity of the
primary afferent neurons at <1.2m.sec-1. C-fibres terminate in laminae I and II of the spinal
cord. Most C-fibres, like Aδ-fibres, are polymodal nociceptors responding to noxious 
mechanical, thermal and chemical stimuli. There is in addition a small subset of C-fibres
which transduce only innocuous thermal information (Hunt and Mantyh, 2001).
1.2.3 Silent nociceptors
Nociceptors are classically defined as primary afferent neurons which respond to excessive
mechanical or thermal stimuli outside the normal physiological range (Bessou and Perl,
1969;Burgess and Perl, 1967;Van and Gybels, 1972). There is also a sub-population of
nociceptors which are typically unresponsive to noxious stimuli (Meyer et al., 1991), the so
called “silent” nocieptors (McMahon and Koltzenburg, 1990b). In an experimental model of
arthritis initially unresponsive (silent) fibres gained mechanical sensitivity and new receptive
5fields were found in the injured area (Schaible and Schmidt, 1988) showing that during
ongoing pain states the silent nociceptors can be recruited to enhance the total nociceptive
input and contribute to pain and hyperalgesia (McMahon and Koltzenburg, 1990a).
1.2.4 Gene expression in nociceptors
Nociceptors develop from the neural crest stem cells. Initially they all express the nerve
growth factor (NGF) tyrosine kinase receptor TrkA and are dependent on NGF for survival
(Crowley et al., 1994), but during postnatal development TrkA is down-regulated in
approximately 50% of nociceptors. These neurons now begin to express the tyrosine kinase
receptor Ret, a component of the glial cell line-derived neurotrophic factor (GDNF) receptor
(Molliver et al., 1997;Molliver and Snider, 1997). GDNF-sensitive C-fibres express cell
surface glycoconjugates that bind the lectin IB4 and do not synthesise neuropeptides such as
calcitonin gene-related peptide (CGRP). The NGF-sensitive C-fibres are peptidergic,
synthesising CGRP and also substance P, and do not bind IB4.
The expression pattern of sensory channels and receptors within the peptidergic and non-
peptidergic neurons is complex and regulated through a number of pathways. Runx1, a
transcription factor, is required to activate expression of a large fraction of channels and
receptors including the transient receptor potential channels TRPA1, TRPV1 and the
adenosine triphosphate (ATP) gated channel P2X3 (Chen et al., 2006). Runx1 dependent
genes can be further divided into i) Ret-dependent, ii) Ret-independent and TrkA- dependent,
iii) Ret-independent and TrkA-independent pathways.
The differential expression patterns produce functional differences between the two types of
nociceptor. Non-peptidergic nociceptors are more responsive to capsaicin, protons and ATP
activation (Dirajlal et al., 2003;Burgard et al., 1999) whereas peptidergic nociceptors have
larger heat currents and have more tetrodotoxin (TTX) resistant current (Stucky and Lewin,
1999); TTX is a toxin originating from puffer fish that blocks a subpopulation of voltage-
gated sodium channels.
61.2.5 Identification
The different subsets of sensory neurons may be identified using microscopy and
immunohistochemistry. Aβ-fibres can be easily identified within the DRG as they are larger 
and have distinctive thick myelination. C-fibres and Aδ-fibres are not so easily distinguished 
on size alone but staining with Nissl causes C-fibres to appear as small and dark cells,
whereas A-fibres are larger and lighter. Proteins unique to each cell type are also used for
immunochemical identification, peripherin is unique to C-fibres and the neurofilament
NF200 is unique to A-fibres.
1.2.6 Central projections
The spinal cord has 10 laminae identified by Rexed in 1952 (Rexed, 1952). The 5 most
superficial laminae are involved in sensory transduction. Non-peptidergic nociceptors
synapse in lamina I and outer lamina II (IIo), whereas peptidergic nociceptors synapse in
inner lamina II (IIi). The distinct projection patterns of the two types of nociceptors may play
a role in the differing mechanisms of inflammatory and neuropathic chronic pain states
(Snider and McMahon, 1998).
1.3 Nociception
1.3.1 Mechanical
Aβ -fibres respond to innocuous mechanical stimuli such as light touch, whereas C-fibres and 
a subset of Aδ-fibres respond to noxious mechanical stimuli only. Noxious 
mechanotransduction does not require any specialized organs, instead the mechanically
sensitive nociceptors terminate as free nerve endings in visceral organs or the skin, and
tellingly, cultured DRG neurons retain their mechanosensitive properties (Drew et al., 2002).
Ion channels from several families have been suggested as the mechanosensor for noxious
stimuli, including the TRP and epithelial sodium channel (ENaC) families. In culture, many
nociceptors display a slowly inactivating current in response to mechanical stimulation (Drew
et al., 2004) that is consistent with the slowly adapting nature of primary afferent nociceptors
(Lewin and Moshourab, 2004). This mechanically activated current is blocked by gadolinium
(Kimitsuki et al., 1996), FMI-43 (Drew and Wood, 2007) and by Ruthenium red (Caterina et
al., 1997).
7Members of the TRP family have been investigated as putative mechanosensors. TRP
channels share a number of characteristics with the mechanically-activated currents in DRG
neurons. Both are inhibited by gadolinium and ruthenium red, sensitive to extracellular Ca2+,
and have non-selective cation permeability (Watanabe et al., 2002;Drew et al., 2002).
TRPA1 is present in the inner ear and in small C-fibre nociceptors (Corey et al.,
2004;Kobayashi et al., 2005). TRPA1 localises to the sensory endings and stereocilia (Nagata
et al., 2005) making it a good candidate for a mechanosensory channel. Corey et al showed
that siRNA targeted to TRPA1 is able to decrease transduction currents (Corey et al., 2004)
but this is likely an off target effect since TRPA1-/- mice show no decrease in hair cell
transduction and have normal hearing (Bautista et al., 2006;Kwan et al., 2006). TRPV4 is
expressed in hair cells and Merkel cells (Liedtke et al., 2000) and was originally cloned and
implicated in mechanosensation due to its homology to the Caenorhabditis elegans
mechanosensor OSM-9. Indeed, TRPV4 transcripts are able to reverse the loss of nose touch
sensation in OSM-9 mutated C. elegans (Liedtke et al., 2003). TRPV4-/- mice exhibit a
reduced response to pressure on the tail but no change to von Frey withdrawal thresholds
(Suzuki et al., 2003). Although there is some evidence that TRPV4 may be mechanically
gated it does not appear to be the only mechanosensor since mechanical sensation is not
abolished in TRPV4-/- mice, and moreover TRPV4 appears to be present in only 11% of DRG
neurons (Suzuki et al., 2003).
MEC-4, MEC-6 and MEC-10 are members of the DEG/ENaC family and are required for
light touch sensation in C. elegans (Chalfie and Sulston, 1981). Acid sensing ion channels
(ASIC) also belong to this family, and as such, ASIC2 (Garcia-Anoveros et al., 2001;Price et
al., 2000) and ASIC3 (Price et al., 2001) are found in mammalian mechanosensory nerve
endings. Location and homology to other mechanically sensitive channels has led to ASICs
being implicated in mechanosensation, yet both ASIC3-/- and ASIC2-/- DRG neurons have
normal mechanically activated currents in culture (Drew et al., 2004). Behaviourally, ASIC3-
/- mice have normal acute mechanical withdrawal thresholds assessed by von Frey hairs
(Chen et al., 2002;Price et al., 2001). ASICs do not therefore appear to be involved in
mechanotransduction in nociceptors but may have other roles in mechanosensation. An in
8vitro skin nerve preparation of ASIC2 -/- mice showed reduced mechanical sensitivity in low-
threshold fibres (Price et al., 2000) suggesting ASIC2 may be involved in light touch
sensation. ASIC3-/- mice have reduced responses to high-intensity mechanical and thermal
stimuli (Chen et al., 2002), suggesting that ASIC3 could modulate high intensity pain
regardless of the modality.
A number of accessory proteins that are essential for mechanotransduction have been
identified. MEC-2 is a stomatin-related protein that is required for touch sensation in C.
elegans but is not itself the mechanically sensitive channel. MEC-2 regulates MEC-4 and
MEC-10 and is essential for their mechanical activity (Goodman et al., 2002). Stomatin-Like-
Protein 3 (SLP3), a mammalian homologue of MEC-2, appears to have a similar function in
mice and as such. SLP3 mutants lose mechanical sensitivity in 35% of their skin
mechanoreceptors (Wetzel et al., 2007).
1.3.2 Thermal
1.3.2.1 Heat
There are two types of noxious heat responses that can be classified by their response
thresholds. A subset of both C-and Aδ-fibres respond to a moderate threshold of ~43°C, the 
approximate temperature at which innocuous warmth becomes noxious heat. A smaller
percentage of Aδ-fibres are high-threshold, responding to temperatures above 52°C. 
Responsiveness to capsaicin is a pharmacological trait of the moderate threshold heat
sensitive neurons and this was exploited to be used as part of a cDNA screening assay to
identify VR1, later re-termed TRPV1, as a thermosensor (Caterina et al., 1997) . TRPV1 is
predominately expressed in trigeminal and dorsal root ganglia, within small – medium
diameter neurons and can be activated by capsaicin and temperatures of ~ 45°C (Caterina et
al., 1997). TRPV1-/- mice have deficient heat responses in culture and also behaviourally
(Caterina et al., 2000). Interestingly the behavioural differences occur with high-threshold
noxious heat of >50°C and not at the moderate noxious threshold of ~45°C previously
predicted.
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insensitive to capsaicin but responds to high threshold noxious heat with a threshold of ~52°C
(Caterina et al., 1999). This receptor was originally named VRL1 but later re-termed TRPV2.
TRPV2 is found mainly in medium-large diameter neurons within the DRG (Caterina et al.,
1999), which are IB4 negative and therefore not C-fibres. These properties are consistent
with the high thermal threshold Type I Aδ-fibres that Wall and Melzack described (Wall et
al., 2005).
Other members of the TRPV family are also implicated in thermosensation. TRPV3 is
expressed in keratinocytes and is activated at temperatures above 33°C (Peier et al.,
2002b;Xu et al., 2002;Guler et al., 2002). TRPV3-/- mice do not have the preference for warm
temperatures (30°C – 38°C) that is shown by wildtype mice (Moqrich et al., 2005). Impaired
thermosensation in this temperature range suggests a role for TRPV3 in sensing innocuous
warmth. TRPV4 is also activated by warm temperatures in the range of 27°C – 34°C (Guler
et al., 2002).
1.3.2.2 Cold
Noxious cold activates Aδ fibres and a subset of C fibres (Simone and Kajander, 1997). 
Application of menthol to the skin causes a cooling sensation because these cold-sensitive
fibres are sensitised or directly activated by menthol (Hensel and Zotterman, 1951). A
number of different mechanisms have been proposed for cold transduction including direct
activation of a non-selective cation channel, inhibition of background potassium conductance
and inhibition of Na-K-ATPase.
Around 7% of cultured DRG neurons respond to cooling (Reid and Flonta, 2001b). These
cold-responsive neurons possess a mixed-cation current that is potentiated by menthol,
sensitive to extracellular Ca2+ and insensitive to amiloride (Reid and Flonta, 2001b). The
identity of channels conferring cold sensitivity in DRG neurons were discovered by McKemy
et al. using expression cloning and Ca2+ imaging (McKemy et al., 2002). A cDNA library
was constructed and transfected into HEK293 cells and subsequently calcium imaging was
used to look at which cells responded to menthol and cold. A single cDNA was identified and
termed CMR1, and this was found to be an orthologue to the TRPM8 channel in humans.
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TRPM8 is found in small diameter neurons in the DRG, which agrees with previous data that
the majority of noxious cold sensitive neurons are C-fibres (Leem et al., 1993a;Leem et al.,
1993b). TRPM8-/- mice have impaired cold sensation, having no strong preference for a
warmer environment as opposed to an aversive cooler environment (Dhaka et al., 2007). It
has also been observed that nociceptive responses to cold are reduced, although not abolished
in TRPM8-/- mice (Dhaka et al., 2007) suggesting that TRPM8 may also have a role in
noxious cold.
TRPM8 was also identified as a cold sensor in DRG by Peier et al using a bioinformatic
approach (Peier et al., 2002a). The same group additionally identified another cold-sensitive
TRP-like channel that is found in nociceptors, ANTKM1 (later termed TRPA1) (Story et al.,
2003). TRPA1 is mainly expressed in sensory neurons that are activated by capsaicin and are
insensitive to menthol (Story et al., 2003), indicating that TRPM8 and TRPA1 exist in two
distinct populations of cold-sensitive neurons. Jordt et al found that TRPA1 can also be
activated by mustard oil, however this study disputed the cold sensitivity of the channel
(Jordt et al., 2004). Two behavioural studies using TRPA1-/- mice have failed to resolve this
contention, with one group reporting no difference in cold sensitivity (Bautista et al., 2006)
and the other showing a small reduction in noxious cold responsiveness (Kwan et al., 2006).
It has been suggested that the reported cold sensitivity of TRPA1 is actually an indirect effect
of the increased intracellular Ca2+ concentration upon cooling (Babes et al., 2006;Zurborg et
al., 2007), however, Karashima et al have shown Ca2+ independent gating of TRPA1 by cold.
This study also reported reduced behavioural responses to noxious cold in TRPA1-/- mice
(Karashima et al., 2009).
From the current evidence it is suggested that TRPM8 is mainly involved in sensing
innocuous cold and TRPA1 in noxious cold sensation. TRPM8 is activated at temperatures
below 23°C which is in the cool, but not unpleasant, temperature range whereas TRPA1 is
activated at around 17°C which is considered noxious cold. Furthermore, TRPV1, a marker
for nociceptors, is co-expressed in 97% of TRPA1 neurons but in only 50% of TRPM8
neurons (Story et al., 2003). In support of a potential role in noxious cold sensation TRPA1
11
has been found to be upregulated in inflammation and is thought to contribute to cold
hyperalgesia (Obata et al., 2005).
To further complicate the issue there are furthermore a number of cold sensitive peripheral
neurons which express neither TRPM8 nor TRPA1 (Babes et al., 2006;Munns et al., 2007).
Inhibition of potassium channels may also be involved in cold sensitivity, causing
depolarization and activation of cold sensitive neurons (Reid and Flonta, 2001a;Viana et al.,
2002). Using 4-AP to block voltage-gated potassium channels that may be acting as an
‘excitability brake’ can induce cold sensitivity in previously unresponsive DRG neurons
(Munns et al., 2007) providing a TRP-independent mechanism of cold transduction.
1.3.3 Inflammatory pain
Inflammation is a reaction to injury or irritation that is characterized by redness, pain and
swelling. The tissue damage and inflammation causes the release of a large number of
molecules both within the periphery and also centrally where they activate and sensitise
peripheral neurons and central pain circuits. These pain mediators are responsible for the
initiation and maintenance of thermal and mechanical hyperalgesia that accompanies, and
sometimes outlasts, inflammation.
1.3.3.1 ATP
Levels of ATP and ATP gated receptors, P2X receptors, are increased after inflammation (Xu
and Huang, 2002). Of the P2X receptors P2X3 is exclusively expressed in nociceptors (Chen
et al., 1995) where its homomeric form is the main type of ATP gated receptor (Souslova et
al., 2000) . P2X3-/- mice have reduced formalin induced pain behaviour in both the acute and
inflammatory phases (Souslova et al., 2000) suggesting a role of these receptors in
inflammatory pain that has been confirmed by pharmacological block (Tsuda et al.,
1999;Zhong et al., 2001).
1.3.3.2 Protons
Inflammation also causes a drop in pH, and the excess protons that result can activate a
number of channels including ASICs. ASIC1b and ASIC3 subunits are almost exclusively
expressed on peripheral sensory neurons (Waldmann et al., 1997) and are up regulated in
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inflammatory conditions (Duan et al., 2007). ASIC antagonists reduce complete Freund’s
adjuvant (CFA) induced thermal and mechanical hyperalgesia, further supporting a role of
these channels in inflammatory pain (Dube et al., 2005). However, results from transgenic
animal studies have produced conflicting results, with ASIC3-/- mice exhibiting increased,
decreased or no change in hyperalgesia following inflammation (Price et al., 2001;Sluka et
al., 2003;Staniland and McMahon, 2008). Low pH is also able to sensitise TRPV1 channels
by shifting the temperature response curve such that TRPV1 is activated at physiological
body temperature (Tominaga et al., 1998). The pharmacological properties of the proton
“activated” current cannot fully account for proton-evoked pain responses. Thus whilst
ASICs and TRPV1 may play an important role in proton-evoked pain, this role is likely to be
modulatory and/or not exclusive.
1.3.3.3 Bradykinin
Bradykinin (BK), a peptide that is released during inflammation, directly activates
nociceptors via two G-protein coupled receptors (GPCRs) coupled to PLC, B1 and B2 (Inoue
and Ueda, 2000). The B2 receptor is activated by BK itself whereas B1 is activated by
des(arg)BG a major metabolite of BK. Activation of these receptors produces Inositol
triphosphate (IP3) and diacylglycerol (DAG), leading to stimulation of protein kinase C
(PKC) which phosphorylates cation channels, ultimately resulting in depolarization. B2
receptors are constitutively expressed in a wide range of tissues including sensory neurons,
whereas B1 receptor expression increases following inflammation and tissue damage (Regoli
and Barabe, 1980). The B1 and B2 receptor have different roles in inflammatory pain, B2
receptors are necessary for the development of thermal hyperalgesia following carrageenan-
induced inflammation (a model of acute inflammatory pain) but has no effect on
chronic/persistent forms of hyperalgesia (Boyce et al., 1996). Conversely, B1-/- mice have
attenuated hyperalgesia in CFA, confirmed by pharmacological techniques (Fox et al.,
2003;Pesquero et al., 2000).
1.3.3.4 Neurotrophins
A number of neurotrophins are released during inflammation including NGF (Donnerer et al.,
1992;Woolf et al., 1994). Administration of exogeonous NGF produces hyperalgesia further
supporting a role in inflammatory pain (Lewin et al., 1993;Lewin et al., 1994). NGF acts
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through TrkA receptors, activating intracellular signalling cascades including MAPK
pathways. NGF is able to sensitise peripheral neurons and induce changes that lead to central
sensitisation (Lewin et al., 1993). NGF increases expression of substance P , CGRP and also
TRPV1 causing thermal hyperalgesia (Bevan and Winter, 1995). Brain dervived
neurotrophic factor, BDNF, is also upregulated in inflammatory pain states in an NGF
dependent manner, however it’s role in inflammatory pain is unclear.
1.3.3.5 Histamine
Histamine is released following the degranulation of mast cells during inflammation and can
act as a neurotransmitter. H1, H2 and H3 receptors are activated by histamine and are
expressed throughout the central nervous system (CNS). Knockout of H1 or H2 leads to
higher pain thresholds in both basal and inflammatory states (Mobarakeh et al.,
2000;Mobarakeh et al., 2006). Antagonists of H1 receptors have also been shown to decrease
inflammatory pain (Olsen et al., 2002). H3 activation, however, attenuates both nociceptive
behaviours and oedma in inflammatory pain (Cannon et al., 2007), conflicting with the
actions of histamine on H1 and H2 receptors. It has been found that H3 is not activated
during inflammatory pain models including the formalin test (Cannon et al., 2007) which
may explain these results.
1.3.3.6 Serotonin
Serotonin, also known as 5-HT, activates many different receptor subtypes including the
5HT3 receptor which is expressed along C and A- delta fibres. Injection of exogenous
serotonin causes pain that can be attenuated by 5HT3 receptor antagonists, suggesting a
possible role in nociception (Suzuki et al., 2004). 5-HT3R-/- mice show reduced pain
behaviours in some inflammatory pain models but not others (Zeitz et al., 2002). The 5HT3R
may therefore contribute to nociceptive processing in a modulatory role.
1.3.3.7 Substance P
Substance P is present in a sub-population of small sensory neurons and its release is
increased in inflammation, sensitising sensory neurons (Lembeck et al., 1981). Mice deficient
in the substance P receptor, NK1, show reduced mechanical hyperalgesia and oedema during
inflammation (Kidd et al., 2003).
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1.3.3.8 CGRP
CGRP is expressed in DRG neurons (Gibson et al., 1984), and in a significant proportion it
co-localises with substance P. Up-regulation of CGRP is characteristic of inflammatory
diseases and has been shown in a number of inflammatory pain models (Smith et al.,
1992;Hanesch et al., 1993). The number of CGRP positive neurons increases during
inflammation, indicating not only increased CGRP synthesis but also activation of CGRP
synthesis in neurons that would not normally produce this peptide (Hanesch et al., 1993).
1.3.3.9 Prostglandins
Prostaglandins (PG) are synthesised from arachidonic acid, which is released upon tissue
damage and inflammation, by COX- 1 and COX- 2. Inhibition of these enzymes is the
dominant mechanism of analgesic action by non-steroidal anti-inflammatory drugs
(NSAIDs). The prostaglandin receptors EP1 – 4 are G protein coupled receptors, acting
through Gs to activate protein kinase A (PKA). Prostaglandins are able to sensitise peripheral
neurons through sensitisation of TRPV1 (Moriyama et al., 2005) and voltage-gated sodium-
channels (VGSC). Prostaglandins also have central actions in the spinal cord, seen when PG
are intrathecally administered (Uda et al., 1990), the mechanisms of this central sensitisation
are unclear.
1.3.3.10 Cytokines
Cytokines are released by immune cells and glial cells but also directly by sensory neurons
during inflammation . The cytokine cascade initiated by the early generation of TNFα and IL-
1β leads to production of further downstream cytokines and other mediators such as NO, 
ATP and the complement pathway. TNFα and IL1-β are able to produce pain in vivo in both 
animals and man (Sommer and Kress, 2004) acting directly on the peripheral terminals of
nociceptors (Rueff and Mendell, 1996). Antisera not only to TNFα and IL1-β, but also to 
NGF, are able to block this hyperalgesia, suggesting a large proportion of their actions are
mediated through NGF (Safieh-Garabedian et al., 1995;Woolf et al., 1997). The long-term
changes in behaviour induced by cytokines require alterations in gene transcription and
protein expression but TNFα and other upstream cytokines also produce very rapid changes 
in neuronal excitability which arise from direct effects on ion channel properties. For
example, TNFα produces hyperalgesia by acting through TNFR1 (Sommer et al., 1998) to 
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activate a number of pathways, including p38 MAPK , leading to phosphorylation of TTX-
resistant sodium channels and TRPV1 (Jin and Gereau, IV, 2006) which enhances the
excitability of the peripheral nociceptors.
1.3.4 Neuropathic pain
Neuropathic pain is pain caused by disease, damage or dysfunction in the nervous system,
usually in the periphery. Sufferers may experience spontaneous pain as well as hyperalgesia,
increased sensitivity to a noxious stimulus, and allodynia, pain produced by a normally
innocuous stimulus. Neuropathic pain leads to change in gene expression and neuron
excitability in the spinal cord and peripheral nerves.
Nerve damage causes injured and uninjured primary afferents to fire ectopically resulting in
an afferent barrage of inputs into the spinal cord (Chul Han et al., 2000). This afferent
barrage is the likely cause of spontaneous pain experiences and also the trigger for central
changes in the spinal cord and the brain. The first event triggering the peripheral changes may
include the loss of trophic support in the form of GDNF, NGF and other similar molecules.
Trophic factors are usually taken up by sensory endings and retrogradely transported to the
cell soma but this process is lost when nerve damage occurs. Growth factors are vital for
neuronal development and are also thought to be neuroprotective (Huang and Reichardt,
2001). Administration of GDNF to the cell soma is able to reverse neuropathic pain and
reduce related ectopic discharges in animal models of neuropathic pain (Boucher et al., 2000)
highlighting it’s importance in normal neuronal function. The block of axonal trafficking also
causes an accumulation of voltage gated sodium channels, which determine excitability, the
excess channels are then able to insert in erroneous sites such as neuromas and areas of
demyelination leading to hyperexcitability (Kretschmer T, 2002). Degeneration of nerves can
occur at the injury site leading to release of cell contents including inflammatory mediators
and other signalling molecules which can act not only on the injured afferent but also on
adjacent non-injured neurons.
Novel signals, loss of trophic support and other changes result in alterations in neuron gene
expression profiles (Costigan et al., 2002). Genes involved in apoptosis, neurodegeneration
and neuroinflammation are found to be up regulated in injured DRG cells, consistent with
16
increased apoptosis and cell death in the spinal cord and DRG after injury (Himes and
Tessler, 1989).
A number of genes which are able to directly or indirectly alter excitability are also
differentially regulated in injured DRGs and spinal cord. VGSCs are important in
determining the excitability of a neuron and a number of VGSCs are found to have altered
expression after nerve injury; Nav1.8 is found to be down-regulated and Nav1.3 upregulated
as pain hypersensitivity in neuropathic pain develops (Black et al., 1999;Dib-Hajj et al.,
1996). Nav1.3 shows faster recovery following inactivation which may facilitate repetitive
firing at lower thresholds when it is expressed de novo in injured DRG neurons, leading to
ectopic and spontaneous firing. In vivo treatment with antisense to Nav1.8 mRNA
substantially reduced neuropathic pain (Lai et al., 2002), however, knockout of Nav1.8 had
no effect on neuropathic pain, nor complete deletion of Nav1.8 expressing neurons casting
doubt on the involvement (Kerr et al., 2001;Abrahamsen et al., 2008).
The α2δ1 subunit of voltage gated calcium channels, which is important for function and 
expression of the channel, is upregulated in neuropathic pain models (Luo et al., 2001). This
upregulation is correlated with development and maintenance of allodynia (Li et al., 2004).
The α2δ1 subunit is also the binding site for gabapentin (Gee et al., 1996). Gabapentin and
analogues such as Pregabalin have analgesic properties in both the clinic and also animal
models of neuropathic pain (Tanabe et al., 2009;Tolle et al., 2008;Field et al., 2006) which
further supports α2δ1 contribution to neuropathic allodynia . 
Nerve injury will also result in an inflammatory reaction, either in response to the infection or
autoimmune disorder causing the neuropathy or to the cellular debris resulting from cell
death associated with neuropathy. The release of proinflammatory mediators plays a criticial
role in the development and maintenance of neuopathic pain (Bennett, 1999;Schafers et al.,
2003;Cui et al., 2000). Bradykinin is a potent inflammatory mediator which acts through the
B1 or B2 receptors to increase intracellular Ca2+. In nerve-injured mice B1 receptor
expression increases and there is also a phenotypic switch of the cells responsible for BK
signalling. In naive mice BK signalling occurs through non-myelinated fibres whereas after
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nerve injury B1 receptors are laregely found on myelinated neurons and satellite cells (Rashid
et al., 2004).
1.3.5 Central Processing
Noxious stimuli are transmitted from primary afferent nociceptors to the brain via the dorsal
horn of the spinal cord. The dorsal horn is divided into 6 laminae, labelled I – VI from
outermost inwards. Most nociceptive Aδ-and C-fibres terminate in the superficial lamina I 
and lamina II whereas Aβ-fibres innervate the deeper laminae III-VI (Todd, 2002). The 
nociceptors can be further divided on the basis of their peptidergic content and site of
termination with peptidergic C-fibres terminating in lamina I and outer lamina II, non-
peptidergic C-fibres terminating in inner laminae II and finally Aδ-fibres terminating mainly 
in lamina I. The dorsal horn itself has a number of different neuronal cell types that the
primary afferent fibres can synapse with; nociceptive-specific (NS) cells for example are
mostly found superficially and synapse exclusively with Aδ- and C-fibres. NS cells respond 
only to high threshold stimuli. Proprioceptive cells receive input from Aβ cells only, and 
respond to touch. Wide dynamic range (WDR) neurones receive input from all three types of
sensory fibre and hence respond to stimuli ranging from light touch to noxious pressure, heat
and chemicals. Excitatory and inhibitory interneurons within the spinal cord can also act to
increase or decrease the responses of NS and WDR cells.
Peripheral sensory neurons communicate with spinal neurons using a variety of
neurotransmitters. Glutamate is the major excitatory neurotransmitter found throughout the
nervous system and activates post-synaptic NMDA, AMPA and mGLuR receptors in the
spinal cord. Other neurotransmitters include BDNF, which is released by Aδ-fibres and some 
C-fibres, substance P and CGRP, which are also released by C-fibres.
Output from the dorsal horn is transferred to higher centres of the brain by spinal projection
neurones along several ascending pathways including the spinothalamic and
spinoparabrachial. The spinobrachial pathway projects from the superficial lamina of the
dorsal horn to the parabrachial area and periaqueductal grey whereas the spinothalamic tract
originates in the deeper laminae and project predominantly to the thalamus.
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Higher centres such as the rostroventral medulla (RVM) can modulate dorsal horn activity
through descending inhibition and descending facilitation. Descending pathways from the
RVM are predominantly facilitatory and act via the release of 5-HT onto 5-HT3 receptors in
the spinal cord. Depletion of spinal 5-HT attenuates the behavioural hypersensitivity
normally seen after nerve ligation (Rahman et al., 2006). Descending inhibition involves the
release of norepinephrine (NE) in the spinal cord from brainstem nuclei. The NE acts mainly
on α2-adrenoceptors in the spinal cord and inhibits transmitter release from primary afferent
terminals which suppresses the firing of the projection neurons in the dorsal horn (Fleetwood-
Walker et al., 1985). Descending modulatory pathways, be they inhibitory or facilitatory, can
undergo plastic changes in chronic pain states. Studies after peripheral inflammation have
shown an increase in descending noradrenergic inhibition (Stanfa and Dickenson, 1994)
together with enhanced efficacy of α2-adrenoceptor agonists (Mansikka and Pertovaara,
1995)
Nociceptor activity can induice plastic changes in the dorsal horn which plays an important
role in inflammatory hyperalgesia and neuropathic pain. Repetitive firing of C fibres
amplifies the dorsal horn response, a phenomenom known as wind-up which is dependent on
the removal of the Mg2+ block from the pore of the NMDA receptor. NMDA receptor
activation causes a large influx of Ca2+ ions into the neuron which initiates intracellular
signalling cascades that activate various effectors. nNOS, CaMKI/II and ERK are a few of
these effectors and can promote long-term potentiation (LTP) which is an abrupt and
sustained increase in the efficiency of synaptic transmission and results in elevated
responsiveness and activity of dorsal horn neurons, termed central sensitisation. LTP induces
long lasting changes which, unlike wind-up, persist after the duration of the stimulus.
1.3.6 Voltage-gated sodium channels
Voltage-gated sodium channels (VGSC or Nav) are transmembrane proteins that allow the
rapid influx of sodium ions that underlie the depolarizing upstroke of action potentials
(Catterall, 2000). VGSCs typically open rapidly in response to membrane depolarizations and
also have a fast-inactivation caused by a cytoplasmic loop blocking the pore of the channel
(West et al., 1992). The functional unit of the VGSC is a 220-260kD α subunit which forms 
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the transmembrane helices, including the pore and voltage sensor. The α subunit alone is 
sufficient for functional sodium currents, however auxillary β subunits associated with and 
modulate the current and/or stabilization and localization of the α subunit (Isom, 2001). 
VGSCs can be divided into two groups based on their sensitivity to tetrodotoxin (TTX). Nav
1.1, 1.2, 1.3, 1.6 and 1.7 are TTX sensitive and Nav1.5, Nav 1.8 and Nav1.9 are TTX resistant.
Nine α subunits have been cloned in mammals (Nav1.1 – Nav1.9) and 4 auxillary β subunits. 
Nav 1.7, 1.8 and 1.9 are expressed in sensory neurons where they play a role in nociception.
Nav 1.7, a TTX-S channel, is expressed at high levels in rodent and human DRG and
sympathetic ganglia, especially in C-fibres. Several pain conditions have been linked to
Nav1.7 in humans which are reviewed in (Raouf et al., 2010). A mutation in the SCN9A
leading to a non-functional channel causes congenital insensitivity to pain, both thermal and
mechanical (Cox et al., 2006).Conversely, a gain of function mutation results in primary
erythermalgia, a pain disorder characterised by severe burning pain of extremities (Yang et
al., 2004). In a nociceptor-specific knock-out of Nav 1.7 the mice were found to have reduced
mechanical and thermal pain in both acute and inflammatory conditions (Nassar et al., 2004).
Nav1.8, a TTX-R channel, is expressed almost exclusively in the subpopulation of small-
diameter sensory neurons important in nociception (Akopian et al., 1996) and is important in
acute and inflammatory pain function shown by studies with Nav1.8 null mice (Akopian et
al., 1999). The role of Nav1.8 in neuropathic pain states remains controversial. Studies with
Nav1.8-null mice have concluded there is no role in neuropathic pain (Akopian et al., 1999)
but small interfering RNAs which knock-down Nav1.8 are able to reverse the mechanical
allodynia resulting from CCI in rats (Dong et al., 2007).
Nav1.9, another neuronal TTX-R channel, is also expressed in small-diameter DRG neurons
(Tate et al., 1998). Nav1.9, like Nav1.7 and Nav1.8, appears to have a role in inflammatory
pain shown by Nav1.9 null mice (Priest et al., 2005) but no role in neuropathic pain (Amaya
et al., 2006).
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The role of a fourth neuronal Nav channel in nociception has been proposed. Nav1.3 is a
TTX-S channel that is expressed in developing neurons but is down-regulated in mature
neurons (Beckh et al., 1989). Following axotomy or inflammation Nav1.3 mRNA and protein
are significantly up-regulated suggesting that this change of expression may contribute to
altered neuron excitability. However, Nav1.3 null mice exhibit normal pain behaviours in
acute, inflammatory and neuropathic pain conditions (Nassar et al., 2006).
1.4 TRP Channels
The transient receptor potential (TRP) channels are the second largest family of cation
channels in mammals. TRP channels are expressed and function in a great variety of
multicellular organisms, including worms, Drosophila, zebrafish, mice and humans. The
discovery of this family of channels came from the study of Drosophila photoreceptors. A
mutant fly had a transient receptor potential in the light-induced current and lacked a Ca2+
entry mechanism, the gene responsible for the phenotype was a channel protein, the TRP
channel (Montell and Rubin, 1989;Harteneck et al., 2000). TRP channels are identified by
sequence homology as their functions are disparate and often unknown. The TRP superfamily
is broadly divided into groups 1 and 2, making 7 subfamilies of TRP channels in total. The
composition of the TRP superfamily in worms, flies, mice and humans is shown in Table 1.1.
Worms Flies Mice Humans
TRPC 3 3 7 61*
TRPV 5 2 6 6
TRPM 4 1 8 8
TRPA 2 4 1 1
TRPN 1 1 0 0
TRPP 1 1 3 3
TRPML 1 1 3 3
Total 17 13 28 27
Table 1.1 Composition of TRP superfamily in worms, flies, mice and humans
(*, TRPC2 is present but a pseudogene in humans)
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The evolutionary tree for TRP channels is shown in Figure 1.3, sequence identity can be as
low as 20% but all TRP channels form cation-permeable channels with six-transmembrane
domains and polymodal activation properties. The TRPs include several notable sequence
elements and domains, the largest region of sequence homology spans the 6 transmembrane
segments, including the pore loop situated between the 5th and 6th transmembrane segments.
TRPC, TRPM and TRPN channels also contain a 23-25 amino acid TRP domain at the C-
terminal end with two highly conserved portions – TRP box 1 and TRP box 2 (Figure 1.3).
1.4.1 Structure of TRP channels
The structure of TRP channels has been elucidated using hydrophobicity analysis (Phillips et
al., 1992) and epitope immunocytochemistry (Vannier et al., 1998). The channel has a
tetrameric structure with each of the four subunits contributing to the channel functionality.
The consensus structure of each subunit consists of six transmembrane domains, similar to
that of voltage gated Ca2+ channels (VGCC), illustrated in Figure 1.4. Like a VGCC,
Figure 1.3 The TRP domain and evolutionary tree of mammalian TRP channels
The evolutionary distance is shown by the branch length is point accepted mutations (PAM) units, which is
the mean number of substitutions per 100 residues.(Venkatachalam and Montell, 2007)
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transmembrane domains 5 and 6 of the TRP channel is connected by a large loop which
contains a motif essential to channel function, this is the proposed pore of the channel (Voets
and Nilius, 2003). The N and C termini of the protein are intracellular and contain domains
that are important for membrane trafficking and binding of modulators such as calmodulin
(Tang et al., 2001).
1.4.2 Transient Receptor Potential Canonical Channels
The TRPC family contains seven proteins that can be divided in to four subsets based on
amino acid sequence similarity. The mammalian TRPCs include three to four ankyrin repeats
at the N terminus. TRPC1 and TRPC2 form two individual groups, TRPC 3, 6 and 7 together
forms a third group and the fourth and final group consists of TRPC4 and 5. Humans express
only six TRPC proteins as TRPC2 is a pseudogene, in mice and rats TRPC2 has been linked
to pheromone sensing (Hofmann et al., 2002).
Figure 1.4 Structure of TRP channels
(Clapham et al., 2001;Clapham, 2003)
23
1.4.3 Properties of TRPC channels
Although some of the TRPC proteins, such as TRPC1, are ubiquitously expressed throughout
all tissues all TRPC receptors are expressed at some level in the nervous system and some,
for example TRPC3, are highly enriched in neurons. All TRPC channels are nonselective
cation channels although there are differences in the permeabilities of Ca2+ relative to Na+
and other cations, summarised in Table 1.2.
Gene
Name
Selectivity
PCa:PNa
Proposed mode of
activation
Expression Function
TRPC1 Non-selective SOC Heart, brain, testis, ovaries Ca2+ homeostasis,
EPSC in purkinje cells
TRPC2 2.7 SOC, DAG VNO, testis Pheromone response,
acrosome reaction
TRPC3 1.6 SOC, DAG,
exocytosis
Brain, DRG, smooth muscle IBDNF, EPSC in
purkinje cells,
TRPC4 7 (>1003) SOC Brain, endothelia, adrenal
gland, retina, testis
Vasorelaxation,
neurotransmitter
release
TRPC5 9.5 SOC Brain Neurite extension
TRPC6 5 DAG Lung, brain, DRG, smooth
muscle
Myogenic response,
TRPC7 1.9 SOC, DAG Eye, heart, lung Ca2+ signalling in
keratinocytes
Table 1.2 Mammalian TRPC channel properties.
Adapted from (Montell, 2005).
SOC, store-operated channel, VNO, Vomeronasal organ, EPSC, excitatory postsynaptic potential.
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TRPC channels are commonly activated through phospholipase C (PLC) dependent
pathways, although the mechanisms thorough which stimulation of PLC leads to the
activation of the different members of the TRPC family are not yet fully understood. It has
been suggested that release of Ca2+ from internal stores, DAG production or an exocytotic
mechanism may be responsible.
TRPC channels show a moderate selectivity for Ca2+ relative to Na+ , thus their activation
may be able to modulate a host of secondary cascades and intracellular signalling in non-
excitable cells, leading to cell depolarization. Under certain conditions, TRPC1, TRPC4 and
TRPC5 can be activated by the emptying of intraceullular calcium stores mediated by IP3,
whilst TRPC3, TRPC6 and TRPC7 are instead activated by DAG (Hofmann et al., 1999).
1.4.4 Modulation of TRPC channels
The tetrameric structure of TRPC channels lends itself to multimerization hence ion channel
properties become a function of their composition. Co-expression of TRPC channels and
FRET analysis have shown that heteromeric channels form between two groups of TRPC
channels, TRPC1, -4, -5 and TRPC -3, -6, -7 (Hofmann et al., 2002;Goel et al., 2002).
However an interacting protein, STIM1, is able to promote cross-group
heteromultimerizations (Yuan et al., 2007). The same studies showed that TRPC2 does not
interact with any other TRPC channels. Novel combinations of TRPC subunits have been
found in embryonic brain involving more than two types of TRPC subunit (Strubing et al.,
2003). Multimerization is not restricted to the TRPC subunits, TRPC1 is able to form a
heteromeric channel with another member of the TRP family, TRPP2 (Zhang et al., 2009).
The formation of many different channel types could be utilized to alter channel permeability
and selectivity within different cell types depending on the composition of subunits present.
The role of TRPC channels within calcium signalling necessitates the interactions with Ca2+
signalling complexes that are assembled in plasma membrane microdomains. Homer proteins
are scaffolds that bind Ca2+ signalling proteins and play a central role in Ca2+ signalling.
TRPC channels have a Homer binding motif PPXF in their C terminus which mediates
formation of a TRPC channel – Homer – IP3R complex. The formation of this complex has
been shown to regulate TRPC1 gating (Yuan et al., 2003) and also translocation of TRPC
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channels to the membrane (Kim et al., 2006). Caveolin is also a scaffold protein that aids
translocation of TRPC channels. TRPC1 is able to bind to caveolin at both the N and C
terminus aiding the transport of TRPC1 to the plasma membrane (Brazer et al., 2003).
In addition to this scaffolding role, protein- protein interactions of the TRPC family can also
directly regulate channel activity, and particularly the Src kinase family have been implicated
in the regulation of TRPC3 and TRPC6. Fyn, a Src kinase, interacts with TRPC6 and
modulates TRPC6 activity via tyrosine phosphrylation (Hisatsune et al., 2004) and Src
kinase is obligatory for the activation of TRPC3 by muscarinic receptors (Vazquez et al.,
2004).
Another general regulatory mechanism of TRPC channels is exocytotic insertion and retrieval
of the channels from the plasma membrane. TRPC3 interacts with the SNARE proteins
VAMP2 and SNAP which aid the translocation of TRPC3 to the plasma membrane (Singh et
al., 2004). TRPC5 is translocated to the plasma membrane via a different mechanism,
involving PI3K, Rac1 and PIP5K (Bezzerides et al., 2004). TRPC6 is also reportedly
regulated by exocytosis (Cayouette et al., 2004), which may be linked to MxA a member of
the dynamin family (Lussier et al., 2005).
Calmodulin is important in TRP channel regulation in Drosophila where it negatively
regulates TRP and TRPL channels. Calmodulin binds to the C-terminus of all TRPC channels
(Tang et al., 2001) and has been shown to regulate activation and inactivation of TRPC4 and
TRPC1 respectively (Tang et al., 2001;Singh et al., 2002). Calmodulin is also able to interact
with TRPC channels in coordination with other proteins such as Enkutin and PI3K.
1.4.5 The TRPC3/6/7 subfamily
The TRPC3/6/7 group of the TRPC family share 70-80% homology. Although TRPC3 is the
most thoroughly characterised amongst the group of TRPC channels, initial studies into
TRPC6 and TRPC7 showed very similar results suggesting that the group shares activation
and functional properties.
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All three members of the TRPC3/6/7 group are expressed to varying degrees in the CNS.
TRPC3 is the most highly expressed and is found in distinct regions of the brain, namely
purkinje cells (Huang et al., 2007;Otsuka et al., 1998) but also in non-neuronal cells,
oligodendrocytes (Fusco et al., 2004). TRPC6 is expressed in interneurons in the brain
(Huang et al., 2007) and also purkinje cells (Kunert-Keil et al., 2006), but has higher levels
of expression in peripheral tissues including lung, kidney and muscle (Riccio et al., 2002b).
TRPC7 has lower levels of expression than TRPC3 or TRPC6 but is found in the brain and
other tissues including keratinocytes (Riccio et al., 2002b). All TRPC channels are found
within the DRG; TRPC3 is particularly highly expressed and is found exclusively in
nonpeptidergic small diameter neurons (Elg et al., 2007).
Co immunopreceiptation studies have shown that TRPC channels can form homomeric
channels, as well as strictly defined heteromeric channels within the group but not between
groups, both in vitro and in vivo (Hofmann et al., 2002). However, novel subunit
compositions have recently been found, for example together TRPC1/TRPC3 function as
heteromeric channels in hippocampal cells (Wu et al., 2004) and TRPC1/3/7 complexes in
HEK cells (Zagranichnaya et al., 2005). Immunohistochemistry studies have shown that
TRPC3 co-localises with TRPC1, 4 and 5 rather than with TRPC6/7 in certain regions of the
brain, suggesting that more heteromeric conformations may exist (Chung et al., 2006).
The activation mechanisms of TRPC3, 6 and 7 channels have been investigated using various
experimental approaches leading to conflicting results. Venkatachalam showed TRPC3 as a
SOC when expressed in DT40 cells (Venkatachalam et al., 2001), whereas the majority of
other studies showed TRPC3 as a receptor activated channel when expressed in HEK293
cells. Variations in activation mechanisms in different cell lines (Trebak et al., 2002) were
ultimately linked to expression levels rather than a different cell environment (Vazquez et al.,
2003). A possibility for this difference could be that TRPC3 acts as a SOC only when
interacting with other proteins that are in limited supply. TRPC3 is known to form
heteromeric channels within the TRPC3/6/7 group and other interactions may well exist.
When TRPC3 is over-expressed, more homomeric channels could form that may have
different activation properties.
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TRPC6 activation has always been less controversial. When originally cloned, Boulay
showed TRPC6 acts as a receptor activated, but not store-operated, cation channel (Boulay et
al., 1997) and subsequent studies that showed insensitivity to depletion of internal stores have
confirmed this (Hofmann et al., 1999).
TRPC7 was originally shown to be receptor activated in a similar way to TRPC3 and 6 when
expressed in HEK293 cells (Okada et al., 1999) but Riccico showed that TRPC7 behaved as
a SOC (Riccio et al., 2002a). Confusingly, both of these studies were performed in the same
HEK293 cell line which would in all probability have similar expression levels.
Investigations by Lievremont et al showed that the mode of expression, transient or stable,
was producing these conflicting results (Lievremont et al., 2004).
The high homology shared between TRPC3, 6 and 7 is a likely reason why the three channels
share many common biophysical properties, including within activation mechanisms. There
are, however, striking difference between the constitutive activities of the channels. In
HEK293 cells, TRPC3 and TRPC7 show significant constitutive activity (Okada et al.,
1999;Zhou et al., 2008a), whereas constitutive activity of TRPC6 is negligible (Hofmann et
al., 1999).
Whether acting as receptor activated or SOCs the precise molecular mechanisms of activation
and regulation of TRPC3/6/7 are not completely understood. Three main hypotheses have
been proposed; conformational coupling with the IP3 receptor, a second messenger system,
and an exocytosis-like mechanism.
All seven channels of the TRPC family can be activated downstream of PLC; PLC cleaves
PIP2 into two molecules, IP3 and DAG. IP3 induces the emptying of intracellular stores by
activating the IP3 receptor on the endoplasmic reticulum. Some TRPC channels can be
activated as a consequence of this depletion by interacting with the IP3 receptor (Adebiyi et
al., 2010;Yuan et al., 2003)
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TRPC channels can also be activated by a PLC dependent mechanism that does not require
store depletion. In the case of TRPC3/6/7 this receptor operated mode appears to involve
activation by DAG. Direct activation of TRPC3/6/7 channels by OAG, a DAG analogue, has
been shown in excised patches(Hofmann et al., 1999;Okada et al., 1999). Subsequent studies
have not been able to replicate this direct activation of TRPC3/6/7 (Lemonnier et al., 2008).
An explanation may be that although activation was shown in excised patches, it is not direct,
and other required factors are retained in the patch, but the retention can vary depending on
the experimental set-up. This is supported by Smyth et al who showed that newly
translocated TRPC3 channels lose the ability to be activated by OAG, suggesting other
coupling factors are required that may be in limited supply (Smyth et al., 2006).
It has also been suggested that TRPC channels may be activated by an exocytosis
mechanism. TRPC6 levels at the plasma membrane are increased following activation of a
PLC pathway and also directly by OAG. Store depletion is also able to increase TRPC6
levels at the membrane but in this case TRPC6 activation levels do not increase (Cayouette et
al., 2004). In contrast, TRPC3 is not externalized following PLC stimulation or OAG.
TRPC3 is shown to be inserted into the membrane following activation by Epidermal growth
factor, EGF, but there is no activation (Smyth et al., 2006). Excoytosis mediated activation
for TRPC channels appears to depend not only on the specific channel but also the signalling
cascade which leads to the exocytosis.
TRPC7 has lower expression in the brain, and unlike TRPC3 and TRPC6 it is not found in
smooth muscle cells. TRPC7 is expressed in keratinocytes where it acts as a receptor-
operated channel mediating calcium influx signals that lead to differentiation and
proliferation (Beck et al., 2006).
1.4.5.1 Functions of TRPC3 and TRPC6
TRPC channels are able to form homo and heteromeric complexes which has made it difficult
to unambiguously assign specific functions to one or the other TRPCs, especially within a
subfamily with shared biophysical characteristics; in many cases it is likely that the functions
of TRPCs overlap. In excitable cells, that are kept in a hyperpolarized state, the cation entry
through TRPC channels would lead to membrane depolarization, activation of voltage gated
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sodium and calcium channels. In both excitable and non-excitable cells the activation of
TRPCs results in increases in intracellular Ca2+ concentration ([Ca2+]i) leading to a range of
[Ca2+]i responses which play pivotal roles in cellular and tissue functions. The complex set of
molecular responses elicited from TRPC activation and the widespread distribution indicates
their varying functional roles, some of which are outlined below. For a more detailed review
see (Abramowitz and Birnbaumer, 2009).
Focal segmental glomerulosclerois
Focal segmental glomerulosclerosis (FSGS) is a cause of nephritc syndrome and kidney
failure. A gain of function mutation in TRPC6 is responsible for a subset of forms of FSGS
(Winn et al., 2005). Overexpression of TRPC6 specifically in mouse podocytes (cells which
respond to glomerular pressure), is sufficient to reproduce glomerular disease consistent with
the human phenotype (Krall 2010). In podocytes, TRPC6 interacts with podocin (Huber et
al., 2006), a homologue of which contributes to mechanosensation in C. elegans which is
proposed to alter the local lipid environment enabling TRPC6 to respond directly to the
deformation of the plasma membrane (Huang et al., 1995).
Myogenic response
The vasculature is exposed to frequently changing mechanical forces. Vascular smooth
muscle cells respond to pressure causing constriction of arteries and arterioles which is
known as the myogenic response. One proposed model for the myogenic response is the
centralized model involving membrane ion channels which open in response to mechanical
force. TRPC3 and TRPC6 are highly expressed in vascular smooth muscle (Dietrich et al.,
2005). Antisense TRPC6 decreased and TRPC6 protein expression greatly increased smooth
muscle depolarization in response to mechanically induced stretching in ex vivo arteries
(Welsh et al., 2002). However, TRPC6-/- mice showed enhanced agonist-induced contractility
in response to stretching of arterial segments (Dietrich et al., 2005). It was found that TRPC3
mRNA expression was increased in the TRPC6-/- mice which may be able to account for this
unusual result as TRPC3 has constitutive activity (Zhou et al., 2008a). This theory is
supported by the ability of TRPC3-specific small interference RNA to abolish the increased
basal activity. These results implicate both TRPC3 and TRPC6 in the myogenic response.
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Motor coordination
Within the brain TRPC3 is expressed highly in the cerebellum, particularly in Purkinje cells,
and is required for synaptic transmission (Hartmann et al., 2008). In TRPC3-/- mice, the slow
EPSP following mGLuR1 activation is absent and as a result the mice lack motor
coordination (Hartmann et al., 2008). It has also been suggested that TRPC3, in coordination
with Na+ channels, are able to regulate basal neuronal activity of GABA neurons, since an
antibody to TRPC3 decreases spontaneous firing and hyperpolarizes the cells (Zhou et al.,
2008a). In contrast, TRPC6 is involved in excitatory synapses where TRPC6 expression is
enriched and contributes to spatial learning and memory tasks (Zhou et al., 2008b).
Neuronal growth and development
Within the CNS, TRPC3 co-localises with TrkB, the receptor for the neurotrophin BDNF (Li
et al., 1999). BDNF evokes a nonselective cationic current in neurons, IBDNF. IBDNF requires
extracellular Ca2+, but how BDNF regulates Ca2+ is not fully understood, since voltage
dependent calcium channels are not essential so another channel by default must be
responsible for the calcium influx. An antibody for a portion of TRPC3 was able to abolish I-
BDNF in pontine neurons (Li et al., 1999). Subsequently a study using siRNA against TRPC3
was able to support this finding, showing a similar result of a block on IBDNF (Amaral and
Pozzo-Miller, 2007a). A known TRP channel blocker, SKF-96365, is also able to block IBDNF
(Amaral and Pozzo-Miller, 2007a;Li et al., 2005) adding further weight to the supposition
that the calcium influx evoked by BDNF is carried through TRPC3 channels. This calcium
influx through TRPC3 induces dendritic spine formation (Amaral and Pozzo-Miller, 2007b)
and growth cone turning in neurons (Li et al., 2005). BDNF is proposed to increase Ca2+
influx through TRPC3 via two mechanisms, firstly as a store operated channel by activating
PLCγ leading to emptying of intracellular stores (Li et al., 2005), secondly by rapid vesicular
insertion of TRPC3 channels into the plasma membrane by a PI3 kinase dependent
mechanism (Amaral and Pozzo-Miller, 2007b). In addition to being involved in neuronal
growth, TRPC3 may also be involved in CNS development. TRPC3 protein expression in the
brain peaks during a narrow time window immediately before and after birth (Li et al., 1999),
and TRPC3 in tandem with TRPC1 are essential for differentiation of hippocampal cells in
vitro (Wu et al., 2004).
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1.4.6 Targeted gene deletion by homologous recombination in
embryonic stem cells
Homologous recombination provides a mechanism to introduce exogenous portions of DNA
to create a knock-in transgene. The desired alteration is introduced into a cloned DNA
sequence, which then recombines with the targeted sequence within the genome to transfer
this alteration (Smithies et al., 1985). In mammalian cells DNA generally integrates at
random sites, making it difficult to target a specific gene. However, pluripotent embryonic
stem cells (ES cells) can undergo homologous recombination in vitro when electroporated
with DNA. ES cells can then be microinjected into a blastocyst and resume normal
embryonic development. In the resulting chimeric mice, the ES cells contribute to the germ
line as well as to the somatic tissues, enabling this system to be used as a way to generate
transgenic animals.
1.4.7 Cre/loxP system
The production of knockout mouse lines is invaluable in elucidating gene function in
mammalian tissues but global knockouts can lead to embryonic lethality in mice, obscuring
the role of that gene in a target tissue or in the adult. Site-specific recombinases allow control
of the targeted null mutation both spatially and temporally, avoiding lethality and also
allowing investigation of just one tissue without the complications from knockout in other
organs. The Cre recombinase of phage P1 catalyzes site-specific excision in mammalian cells
and requires no other protein factors, making it an ideal tool for generating a conditional
knockout (Sauer and Henderson, 1988).
The Cre-loxP system consists of the Cyclization Recombination protein (Cre) and its short
DNA recognition sequence called loxP:
ATAACTTCGTATAATGTATGCTATACGAAGTTAT
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The site-specific recombinase Cre will excise a sequence flanked by loxP sites that are placed
in the same direction (Figure 1.5) or invert a sequence flanked by loxP in opposite directions.
The Cre gene or the loxP sites are inserted into the genome using homologous recombination.
Two lines of mouse are required, one with the expression of Cre limited to the tissue of
interest, and one with the gene of interest flanked by loxP sites. When these two mouse lines
are crossed the flanked sequence will be recombined and removed, but only in tissues that
express Cre. The expression of the gene in other tissues will be normal.
1.4.8 Flp/FRT system
The Flp-FRT system also consists of a site specific recombinase and target sequences
(Dymecki, 1996). Flp recombinase originates from the yeast Saccharomyces cerevisiae and
the FRT target sites are similar to loxP sites but with the following sequence;
GAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC
Figure 1.5 The Cre/loxP system
Cre recombinase excises the target sequence flanked by loxP sites (red triangles). The excised sequence
is degraded.
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1.5 Aims
The aim of this thesis is to investigate the role of TRPC channels in sensory pathways,
including the somatosensory and auditory/vestibular systems using tissue-specific and global
knockout animals.
 Firstly, I looked at the effect of deletion of TRPC3 in DRG neurons on acute and
inflammatory pain thresholds. I used Cre recombinase under the control of two
different promoters to elucidate TRPC3’s roles in nociceptors and non-nociceptors.
 Secondly, I investigated the changes in gene expression within the DRGs of
TRPC3fl/fl:Nav1.8Cre mice using microarray technology.
 Next we examined the effect of global deletion of both TRPC3 and TRPC6 on touch,
pain and auditory response thresholds.
 Lastly, I generated a construct to enable tissue-specific knockout of TRPC4 using
Cre/loxP technology.
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2 Materials and Methods
2.1 Molecular Biology
2.1.1 Gel electrophoresis
Agarose gel electrophoresis was used to separate DNA bands by size. 0.7-1 % agarose gels,
depending on the size of the fragments, were prepared by dissolving agarose (Sigma, UK) in
TAE 1X buffer (40mM Tris-acetate, 1mM EDTA). After cooling, ethidium bromide (EtBr)
was added (0.5µg/ml) and then set into a gel tray. 1-3ul of 6X loading buffer was added to
each sample before loading into the wells, alongside an appropriate molecular weight marker.
A power pack supplying 80-120 volts was used to separate the bands which were then
visualised using UV, UVP Biodoc-ItTM Systems, and a picture printed from a thermal printer.
2.1.2 Polymerase Chain Reaction (PCR)
Fragments of DNA were amplified for subcloning using PCR. Phusion High Fidelity PCR kit
(Finnzymes) and Extended Long Template kit (Roche) were used for cloning purposes and
Taq polymerase for genoytyping. The typical PCR protocol was as follows.
Phusion High Fidelity
10 ng template DNA
4.0µl 5x HF buffer (includes MgCl2)
0.4µl dNTP (10mM)
1.0µl of each primer (10µM)
0.2µl DNA polymerase
ddH2O up to 20µl
The PCR cycles were carried out using the DNA Engine DYAD. The PCR conditions were
denaturation at 98ºC for 30 seconds, 20-30 cycles of 8 seconds at 98ºC, 20 seconds at 60-
65ºC to anneal primers to the single strands and 2-3 minutes at 72ºC for extension of the
DNA. Finally 10 minutes at 72ºC for further extension and then the reaction was cooled to
4ºC.
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Extended Long Template
10 ng template DNA
5.0µl Buffer 1, 2 or 3 depending on size of product (includes MgCl2)
1.0µl dNTP (10mM)
2.0µl of each primer (10µM)
0.75µl DNA polymerase
ddH2O up to 50µl
The PCR cycles were carried out using DNA Engine DYAD. The PCR conditions were
denaturation at 94ºC for 2 minutes, 10 cycles of 10 seconds at 94ºC, 30 seconds at 50-60ºC to
anneal primers to the single strands and 5 minutes at 68ºC for extension of the DNA. A
second set of PCR conditions with higher annealing temperatures was then used, 20 cycles of
15 seconds at 94ºC, 30 seconds at 60-65ºC to anneal primers to the single strands and 5- 6
minutes at 68ºC. Finally 10 minutes at 68ºC for further extension and then the reaction was
cooled to 4ºC.
2.1.3 Gel extraction
After separation by agarose gel electrophoresis DNA fragments of the required size were
excised from the gel and the QIAgen gel extraction kit was used to extract and purify the
DNA.
2.1.4 DNA Digestions
Restriction enzyme digests of DNA were performed using the appropriate restriction
enzymes and according to manufacturer’s instructions. Restriction enzymes were obtained
from New England Biolabs. Typically 3µg of DNA was digested for approximately 1 hour at
37ºC; the enzyme deactivated at 65ºC for 20 minutes followed by separation on an agarose
gel.
2.1.5 Ligation of fragments into vectors
The vector was first cut using the appropriate restriction enzymes as previously described
then treated with shrimp alkaline phosphatase, SAP, (30 minutes at 37⁰C and then
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deactivated at 65ºC for 15 minutes) to prevent re-ligation of an empty vector. The desired
insert was cut with the same restriction enzymes to produce ‘sticky’ ends. Ligation was
carried out using, where possible, a 1:3 ratio of vector to insert. The concentration of DNA
was estimated by visualisation on an agarose gel or the nanodrop. 1µl of buffer and 1µl of T4
Ligase (Roche) was added and the volume adjusted to 10µl using purified water. The reaction
was incubated at 16ºC overnight before transformation into bacterial cells took place.
2.1.6 Transformation
Transformation was carried out using DH5α heat activated competent cells, TOP10 
competent cells or TSS competent cells.
TSS competent cells
DNA was added to 100µl of TSS cells and incubated on ice for 15 minutes. 900µl of pre-
warmed SOC media was added and the samples were shaken at 37ºC for 1 hour. The cells
were plated onto an LB+Amp agar plate with dilution and Xgal if necessary and incubated at
37ºC overnight.
TOP10 competent cells
5µl of DNA was added to 50µl of TOP10 cells and mixed gently before incubating on ice for
30 minutes. The cells were then heat shocked at 42ºC without shaking for exactly 30 seconds
and then put back on ice for 2 minutes. 250µl of pre-warmed SOC media was added and the
samples were shaken at 37ºC for 1 hour. The cells were plated onto an LB+Amp agar plate
with dilution and Xgal if necessary and incubated at 37ºC overnight.
DH5α heat activated competent cells 
5µl of DNA was added to 50µl of DH5α cells and mixed gently before incubating on ice for 
30 minutes. The cells were then heat shocked at 42ºC without shaking for exactly 20 seconds
and then put back on ice for 2 minutes. 950µl of pre-warmed SOC media was added and the
samples were shaken at 37ºC for 1 hour. The cells were plated onto an LB+Amp agar plate
with dilution and Xgal if necessary and incubated at 37ºC overnight.
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2.1.7 Preparation of DNA
2.1.7.1 Mini-prep using QIAkit
From a Petri dish a single colony was inoculated in 2 ml of LB/Amp at 37ºC in a shaking
incubator overnight. 600µl of media was spun down at 8,000RPM for 30 seconds. The
supernatant was discarded and the pellet resuspended in 250µl P1 buffer, 250µl P2 buffer and
350µl N3 buffer. The mixture was spun at 13,000RPM for 10 minutes and the supernatant put
into a QIAprep spin column which was then spun for 30-60 seconds and the flow-through
discarded. The pellet was washed with PB buffer and PE buffer, and then the DNA was
eluted in 30-60µl elution buffer.
2.1.7.2 Mini-prep using Solutions I, II, III
From a Petri dish a single colony was inoculated in 2 ml of LB/Amp at 37ºC in a shaking
incubator overnight. 1.5ml of media was spun down at 8,000RPM for 30 seconds. The
supernatant was discarded and the pellet resuspended in 100µl chilled Solution I (50nM
glucose, 20mM Tris-HCl, pH 8.0, 10 mM EDTA, pH 8.0). Lysozyme was added (2.5mg/ml)
and tubes were incubated on ice for 5 minutes. 200µl freshly prepared Solution II (0.2M
NaOH, 1% SDS) and 150µl Solution III (3M Potassium acetate, pH 4.8) were added, mixing
at each stage. The mixture was spun at 14,000RPM for 6 minutes and the supernatant put into
a clean 1.5ml eppendorf with 1ml of ethanol and spun for a further 6 minutes. The
supernatant was discarded and the pellet was air-dried. The pellet was then washed with 70%
ethanol before being resuspended in 20µl elution buffer.
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2.1.8 Sequencing
Sequencing was carried out using BigDye3.1 kit. A single sequence reaction containing 1.5µl
BigDye Mix, 2.5µl BigDye buffer, 1µl 3.2µM primer, 2µl DNA and purified water up to
10µl was mixed. The sequencing reaction was carried out using the following cycle:
96ºC for 30 seconds
50ºC for 15 seconds
60ºC for 4 minutes
25 cycles and kept at 4ºC until purification.
Purification was performed by adding 2µl of 3M sodium acetate (pH 5.2) and 50 µl of 100%
ethanol and incubated on ice for 10 minutes. The mix was then spun at 13,000RPM for 15
minutes and the supernatant discarded. The pellet was washed with 100µl of 70% room
temperature ethanol and spun for 5 minutes at 13,000 rpm. The ethanol was carefully
removed and the pellets air-dried on the bench. The sequencing reaction was performed at
UCL sequencing facility (Stuart Martin).
2.1.9 Southern Hybridization
2.1.9.1 DNA separation and Blotting
Around 50ug of DNA from transfected ES cells was digested with at least 50 U of the
appropriate restriction enzyme in a 50ul reaction volume. Digestion reactions were incubated
at the appropriate temperature, usually 37⁰C, overnight. The digestion products were
separated by electrophoresis in a 0.6% agarose gel for approximately 4 hours. The gel was
exposed to UV light for 1 minute to nick the DNA and then denatured in a denaturing
solution (1.5M NaCl and 0.5M NaOH) for 45 - 90 minutes with agitation and subsequently
incubated with agitation in neutralising solution (1.5M NaCl, 0.5M Tris pH 7.0) for 45 – 90
minutes. The DNA was transferred to a nylon membrane (Hybond-N+) overnight by capillary
action using 10x SSPE (1.5M NaCl, 100mM NaH2PO4-H2O, 10mM EDTA, pH 7.4) as the
transfer buffer. DNA was fixed to the nylon membrane using the auto crosslink settting of the
UV stratalinker which delivered 1200mJ.
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2.1.9.2 Pre-Hybridization
Southern blot membranes were placed in hybridisation tubes (Hybaid) and incubated in
hybridisation solution (Dextran sulphate, NaCl, SDS) at 65 C with rotation for at least 1 hour.
2.1.9.3 Oligoprobe labeling and Hybridisation
Labelled dsDNA probes were obtained by PCR amplification of genomic DNA followed by
gel electrophoresis separation of the DNA fragment. The probes were between 300-500bp.
The desired band was excised and melted in the minimum amount of water and stored at -20
C. The DNA fragment was labelled with alpha-32 P dATP (3000Ci/mMol, GE healthcare)
using the Prime-it II random priming kit (Stratagen) according to the manufacturer’s
protocol. Briefly, 12ul of dissolved probe was added to 5ul of random 9-mer primers and
heated at 95⁰C for 5 minutes and 37⁰C for 5 minutes. 5ul of buffer and 2.5ul of P32 was added
followed by 0.5ul of Klenow enzyme followed by a 30 minute-1 hour incubation at 37⁰C.
The labelled DNA was purified from the non-incorporated nucleotides using the QIAquick
nucleotide removal kit (Qiagen) according to the manufacturer’s protocol.
The labelled dsDNA probe was mixed with 1mg of sheared salmon sperm DNA and
denatured by incubating at 95⁰C for 5 minutes and placed on ice for 2 minutes before being
added to the hybridisation tubes containing the membrane and hybridisation solution and
incubated at 65⁰C with rotation overnight.
2.1.9.4 Membrane washing and imaging
The membranes were washed with 2xSSPE +0.1% SDS for 15-30 minutes at 65⁰C and an
optional wash of 0.2xSSPE +0.1%SDS for 1-5 minutes at 65⁰C and exposed to X-ray film
(Amersham) for 1-7 days at -80⁰C.
2.1.10 Genotyping
Mice of at least 3 weeks of age were marked using an ear puncher and the tissue samples
were then used for genotyping.
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2.1.10.1 DNA extraction
Each sample was incubated with 30µl PCR lysis buffer at 55⁰C for 1 hour followed by 95⁰C
for 5 minutes to inactivate the Proteinase K. The samples were vortexed briefly and spun for
1 minute. The supernatant was removed and stored at -20⁰C.
PCR lysis buffer: 3.6ml 10X GB, 0.72ml 25% TritonX-100, 0.36ml b-mecaptoethamol,
31.32ml H2O. 1µl of 19.7mg/ml Proteinase K (Roche) was added to 475µl of PCR lysis
buffer before use.
2.1.10.2 PCR Protocol
The following conditions for the PCR reactions were used
Components uL Final Conc.
H2O 17.7
10x PCR Buffer 2.5 1x
25 mM MgCl2 1.5 1.5 mM
10 mM dNTPs 0.5 0.2 mM
10 µM Primer1 1.0 0.4 µM
10 µM Primer2 1.0 0.4 µM
DNA 0.5 1.0 ug/25 µl
Taq 0.3 1.5 U/25 µl
Volume 25
Table 2.1 : PCR reaction quantities for genotyping
A typical PCR cycle was as follows:
Denaturation at 95ºC for 2 min
Denaturation at 94 ºC for 30 seconds
Annealing at 58 ºC for 30 seconds
Extension of the product at 72 ºC for 1 min
Steps 2-4 repeated 35 times
Additional extension step at 72 ºC for 10 min
PCR product kept at 4 ºC
The primers used to genotype each mouse strain are shown in Table 2.2.
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Gene Primer name Sequence WT KO
TRPC3 TRPC3 F GCTATGATTAATAGCTCATACCAAGAGATC
300 none
TRPC3 R GGTGGAGGTAACACAGACCTAAGCC
TRPC3 F2 GAATCCACCTGCTTACAACCATGTG
800 300
TRPC3 R GGTGGAGGTAACACAGACCTAAGCC
TRPC6 E7F CAGATCATCTCTGAAGGTCTTTATGC
234 none
E7R TGTGAATGCTTCATTCTGTTTTGCGCC
IFF ACGAGACTAGTGAGACGTGCTACTTCC
none 339
PgkR GGGTTTAATGTCTGTATCACTAAAGCCTCC
Cre –ve Cre +ve
Nav1.8 Cre Sns13S TGTAGATGGACTGCAGAGGATGGA 461
Cre 5a AAATGTTGCTGGATAGTTTTTACTGCC
Adv Cre Avil/003F CCCTGTTCACTGTGAGTAGG
480
Avil/002B AGTATCTGGTAGGTGCTTCCAG
Avil/003F CCCTGTTCACTGTGAGTAGG
none 180
Avil/001B GCGATCCCTGAACATGTCCATC
Table 2.2 : Genotyping primers
2.1.11 RNA Extraction
Mice were culled according to Home Office procedures and the DRG removed quickly on
ice. DRGs were microdissected to remove the axons and placed into RNAlater. The RNA
was extracted using QIAgen RNeasy mini kit within 48 hours. Briefly, 1 ml of Buffer RLT
(with 2-mercaptoethanol) was added to the tissue samples. The tissue was homogenized using
a glass homogenizer cleaned with distilled water, Ambion RNAzap® and
diethylpyrocarbonate treated water followed by a single wash with Buffer RLT. The tissue
was kept on ice throughout the homogenization process and tissue was homogenized for no
longer than 2 minutes. The tissue samples were passed through a QIAshredder column
(Qiagen, UK) and spun for 2 minutes at 13,000 rpm. The supernatant was transferred to a
clean RNAase free tube and 1 volume of 70% ethanol was added and mixed. This mixture
was passed through a RNaeasy column and spun briefly at 13,000 rpm. The column was
washed with buffer RW1 once and RPE once. Finally the RNA was eluted with RNAase free
water. RNA concentration was checked using nanodrop and quality was checked by agarose
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gel electrophoresis, looking for two distinctive bands representing ribosomal RNA 28s and
18s subunits with a 1.5:1 ratio. RNA was stored at -80ºC
2.1.12 cDNA synthesis
cDNA was made using a Bio-Rad iscript cDNA synthesis kit according to manufacturer’s
instructions. Briefly, the following components were mixed and incubated for 60 minutes at
42⁰C and 5 minutes at 85⁰C. The cDNA was stored at -20⁰C.
Components Amount
5 x iScript select reaction mix (containing
dNTPs, MgCl2 and stabilizers
4µl
Oligo(dT)20 2 µl
RNA sample 1µg
iScript reverse transcriptase 1 µl
Nuclease-free water Variable
Total 20µl
Table 2.3 Reverse transcription reagents for cDNA synthesis
2.1.13 Reverse transcription Polymerase Chain Reaction
Confirmation of knockout of TRPC3 was performed using RT-PCR to check for a change in
size of mRNA for the TRPC3 gene. A typical PCR cycle was performed as outlined above in
Section 2.1.10.2 with the following primers (Table 2.4).
Gene Primer name Sequence WT KO
TRPC3 TRPC3F3 GGGCCAAAGTAAATCCTGCT
630bp 432bp
TRPC3R3 GGCTGGAGATATCCTGCTTG
Table 2.4 Primers for RT-PCR of TRPC3
2.1.14 Quantitative PCR
DRGs from 2 TRPC3fl/fl, 2 TRPC3fl/fl:Nav1.8Cre and 2 TRPC3-/- mice were excised and
the RNA extracted as described above. The RNA was reverse transcribed into first strand
cDNA and used for the qPCR. Reactions were performed in triplicate in 50 µl volume using
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Bio-Rad iQ SYBR Green Supermix. Reaction mixtures were run using an Eppendorf
RealPlex PCR machine, a typical programme was:-
Denaturation at 95ºC for 2 min
Denaturation at 95 ºC for 15 seconds
Annealing at 60 ºC for 15 seconds
Extension of the product at 72 ºC for seconds
Steps 2-4 repeated 40 times
Followed by a melt curve to check for one specific product.
Primer efficiency was measured using serial dilutions of cDNA and the efficiency, E, was
calculated using the gradient of a graph of log [template] against Ct values. Efficiency is
given by the formula E = 10(-1/gradient) – 1. Only primers with efficiencies of 90-110% were
used for RNA quantification. The Pfaffl method (Pfaffl, 2001) was used for the relative
quantification of cDNA levels. GAPDH was used as a reference gene.
Primer name Sequence
TRPC3 TRPC3S AGCCGAGCCCCTGGAAAGACAC
TRPC3AS CCGATGGCGAGGAATGGAAGAC
GAPDH GAPDHS TGCGACTTCAACAGCAACTC
GAPDHAS CTTGCTCAGTGTCCTTGCTG
Table 2.5 qPCR primers
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2.2 Behavioural phenotyping
Animals were tested between 6-8 weeks of age between 8am and 6pm. The investigator was
unaware of the genotype of the animals at the time of testing. Animals were used for one test
only unless the stimulus was considered innocuous, for example rotarod and von Frey tests
were performed on the same animsls.
2.2.1 Rotarod
Mice were placed on a rod rotating at a constant 5 revolutions per minute (rpm) for 2
minutes. The speed of rotation was increased from 5 rpm to 40 rpm over 3 minutes and the
time the mouse was able to remain on the rod from the beginning of acceleration was
recorded. If the mouse made two full rotations this was considered a fall. Each mouse had
three trials and the average was taken.
2.2.2 Mechanical sensitivity
Two methods of mechanical testing were employed to mimic innocuous, or light touch, and
noxious, painful, mechanical stimuli.
2.2.2.1 von Frey monofilaments
Calibrated nylon filaments are used to deliver a graded mechanical force to the plantar
surface of the hind paw to assess mechanical response threshold to an innocuous stimuli. The
filament is applied perpendicular onto the paw’s plantar surface until the filament slightly
buckles and a constant force is thereafter applied for 3 seconds. A positive response is
recorded if the mouse flinches, lifts or licks the paw whilst the stimulus is being applied, or if
these responses occur immediately after withdrawal.
The up-down method described by Chaplan et al. was used to calculate the 50% withdrawal
threshold with the minimum application of filaments to minimise discomfort of the animal
and false positive results (Chaplan et al., 1994). Briefly, a filament expected to give a
positive withdrawal response 50% of the time is applied to the paw, if a response is recorded
this is followed by application of a weaker strength. Alternatively, if no response to that
filament occurs a stronger filament is applied. This is repeated until 6 responses are recorded.
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The pattern of responses, together with the force of the last hair applied, is used to calculate
algorithmically the 50% threshold as described in Chaplan et al 1994.
Mice were acclimatised in the apparatus for at least 90 minutes before testing. Mechanical
sensitivity was tested using Ugo Basile automatic von Frey. The force at which the hindpaw
was withdrawn was recorded. Each paw was tested 6 times with an interval of at least 2
minutes between each test. Mechanical sensitivity was tested on two non-consecutive days
and the average taken.
2.2.2.2 Randall Selitto apparatus
The Randall Selitto apparatus applies an increasing mechanical pressure from a blunt probe
to the tail of the mouse until a withdrawal response is observed. Withdrawal responses
include vocalisation, writhing and flinching of the tail. The increasing pressure applied from
a 3mm2 blunt probe activates high threshold mechanoreceptors in the C-fibres as a response
to a noxious insult (Hogan, 2002;Takesue et al., 1969).
The mouse was restrained in a Perspex tube and allowed to acclimatise for 5 minutes until
settled. The tail was then placed on the apparatus and gradually increasing force was applied
using the Ugo Basile analgesy meter the force at which the mouse moved the tail or struggled
was recorded. Three trials were performed, each on different parts of the tail that were close
together, and the average taken.
2.2.3 Thermal sensitivity
2.2.3.1 Hargreaves’ apparatus
A radiant heat source is applied to the hind paw through a glass plate (Hargreaves et al.,
1988). The latency in seconds until the mouse responds to the heat, usually in the form of
paw withdrawal, is recorded. The fast paw withdrawal is due to a spinal reflex.
Mice were acclimatised in the apparatus for at least 90 minutes before testing. The
withdrawal latency to heat stimulation was tested by using a device of Hargreaves et al.
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(1988) purchased from Ugo Basile (Comerio, Italy). The time until the animals reacted with
withdrawal to the stimulation by a radiant heat source was determined automatically. Each
testing period consisted of a maximum of three presentations for the each hind paw. Thermal
sensitivity was tested on two non-consecutive days and the average taken.
2.2.3.2 Hot plate
The hot plate measures supra-spinal responses to temperatures between 45 – 55 ⁰C. The
mouse is placed on a hot plate at a constant temperature and the latency to a pain response,
such as licking, biting or flinching, is recorded (Jensen and Yaksh, 1984). In contrast to the
Hargreaves’ test, where a heat ramp is applied only to the paw, the hot plate exposes the
whole mouse to a constant temperature.
Each animal was acclimatised for 5 minutes with the apparatus switched off and the plate at
ambient temperature. For testing the plate was heated to the appropriate temperature and the
mouse was placed on the plate and observed. The latency to the first pain behaviour,
licking/biting/shaking of the hind paw or jumping, was recorded and the mouse removed
immediately after this first behaviour. Three temperatures, 45ºC, 50ºC and 55ºC, were tested
on three consecutive days.
2.2.4 Cold plate
Each animal was acclimatised for 5 minutes with the apparatus switched off and the plate at
ambient temperature. The plate was cooled to 0ºC and the mouse was placed on the cold plate
for 5 minutes. The latency to first pain response, licking/biting/shaking of the hind paw or
jumping, was recorded and also the number of pain responses, licking, shaking, jumping, was
counted over the 5 minutes.
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2.2.5 Inflammatory pain models
2.2.5.1 CFA
Injection of complete Freund’s adjuvant (CFA) into the hind paw has been used as a reliable
model of persistant inflammatory hyperalgesia for several decades (Larson et al., 1986).
Thermal and mechanical hyperalgesia develops approximately 24 hours after injection and
remains for up to 2 weeks. Hyperalgesia is linked to TNF α and cytokine release in the 
periphery (Cunha et al., 1992), yet central changes in the dorsal horn of the spinal cord
including increased expression of NMDA receptors, 5-HT receptors and increased PKC
activity can also contribute (Igwe and Chronwall, 2001;Xu and Huang, 2002;Yang et al.,
2009)
Prior to injections the baseline mechanical and thermal thresholds of each animal was
measured on two days using the Hargreaves and von Frey apparatus. Mice received 20-30µl
of CFA (Sigma) into the plantar surface of the left hindpaw. After the injection mice were
tested at day 1, 3, 7 and 10. Oedema was also measured using a Mitutoyo Pocket Thickness
Gage (Toolmix, UK).
2.2.5.2 Formalin
The formalin test allows assessment of continuous moderate pain, lasting around 1 hour in
the absence of evoked stimuli. Typically 1-5% formalin is injected subcutaneously into the
hind paw and the mice exhibits flinching, licking and shaking behaviours in two distinct
phases; the first phase starts immediately after injection and last for approximately 5 minutes
and this phase is due to direct chemical stimulation of C fibres, acting through the TRPA1
receptor (McNamara et al., 2007). The second phase starts approximately 15-20 minutes after
injection and lasts for 20-40 minutes. This phase involves central changes within the spinal
cord and inflammatory molecules (Coderre et al., 1990).
Animals were acclimatised individually in an observation chamber for 1 hour, until
exploratory activity had ceased. 20µl of 5% formalin (40% formaldehyde) in saline was
injected subcutaneously into the plantar region of the left hindpaw. The time spent engaging
in nocifensive behaviour (licking, biting or shaking the injected paw) was recorded in 5
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minute bins over a 1 hour period. The first phase (acute) is defined as 0-10 minutes after
injection and the second phase (inflammatory) 10-60 minutes after injection.
2.2.5.3 Carrageenan induced mechanical hyperalgesia
The injection of carrageenan into the hind paw was originally developed as a model of
inflammation for the screening of anti-inflammatory drugs (Crunkhorn and Meacock, 1971).
Carrageenan causes oedema, which develops over 6 hours (Crunkhorn and Meacock, 1971),
accompanied by mechanical and thermal hyperalgesia. Inflammatory hyperalgesia is
dependent on TNFα activation of cytokine cascades (Cunha et al., 1992) increased COX-2
expression in inflamed tissues and the spinal cord (Hay and de Belleroche, 1997).
Prior to injections, the baseline mechanical thresholds of each animal were measured on two
days using the von Frey apparatus. 20µl of 2% Carrageenan dissolved in saline was injected
into the plantar region of the left hindpaw as described previously. Mechanical withdrawal
thresholds were measured 3 hours after injection.
2.2.5.4 Prostaglandin E2 induced mechanical hyperalgesia
Prostaglandin E2 is synthesised from arachidonic acid by COX-2 and PGE synthase
enzymes. Incidentally, this pathway is the major site of action for NSAIDs which are known
to be effective against inflammatory pain in humans and animals. Intraplantar administration
of PGE2 causes a short lasting mechanical hyperalgesia (Taiwo et al., 1987) by acting
directly on primary afferent nociceptors to sensitise them (Southall and Vasko, 2000)
Prior to injection the baseline mechanical thresholds of each animal was measured on two
days using the von Frey apparatus. 100ng of PGE2 dissolved in 2.5µl saline was injected
intradermally into the plantar region of the left hindpaw. Mechanical withdrawal thresholds
were measured 3 hours after administration of PGE2.
2.2.5.5 Bradykinin induced pain behaviour
Bradykinin is a major inflammatory mediator that produces severe spontaneous pain and
mechanical and thermal hyperalgesia (Couture et al., 2001). Hyperalgesia is caused by
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sensitisation of sensory ion channels such as TRPV1(Chuang et al., 2001) and TRPA1(Wang
et al., 2008) and the acute pain that is directly induced by BK is mediated via Gq/11 protein
coupled receptors, PLC and release of calcium from intracellular stores (Liu et al., 2010).
Animals were acclimatised individually in an observation chamber for 30 minutes, until
exploratory activity had ceased. 10nmol of BK in a 10µl volume of saline was injected
subcutaneously into the plantar region of the left hindpaw. The time spent engaging in
nocifensive behaviour (licking, biting or shaking the injected paw) was recorded over a 30
minute period.
2.2.6 Neuropathic pain models
2.2.6.1 Chung/SNL model
The hyperalgesia, allodynia and tonic pain associated with peripheral neuropathies are due to
changes in primary afferent neurons (Campbell et al., 1992). Damaged primary afferents may
experience changes in excitability, phenotype and/or develop ectopic activity (Noguchi et al.,
1995) moreover, in addition to injured afferents, uninjured afferents can also be affected by
these changes. The spinal nerve ligation, SNL, model for peripheral neuropathy in animals
was developed by Kim and Chung and allows study of the injured and uninjured afferents
(Ho Kim and Mo Chung, 1992). This model involves the complete ligation of either the left
L5 or both L5 and L6 spinal nerves under anaesthesia. In my studies on neuropathic pain, only
L5was ligated. Spinal nerve ligation results in a long-lasting thermal hyperalgesia and
mechanical allodynia on the affected hind paw. The model was developed in rats but also
produces the same hyperalgesia and allodynia in mice (Honore et al., 2000).
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Baseline measurements of mechanical thresholds were performed two days before surgery.
Animals were anaesthetised using isofluorane. A midline incision was made in the skin of the
back. The L5 transverse process was removed and the left L5 spinal nerve cut. Mechanical
thresholds and weight bearing analysis was then performed up to 25 days after surgery.
2.2.7 Vestibular and hearing tests
2.2.8 Preyer reflex test
A custom built click-box (MRC Institute of Hearing Research) was held 30cm above the
mouse and a calibrated 20kHz toneburst at an intensity of 90dB SPL was delivered. The
presence or absence of an ear flick response (Preyer reflex) was recorded. If the animal
responded well a score of 1.0 was given, it the animal did not respond at all a score of 0.0
was given. The Preyer reflex test was performed once on any given day to prevent
habituation to the noise.
2.2.9 Air righting
The mouse was dropped onto a soft surface from a height of 30cm. A contact landing on all
four paws was given a score of 1.0, a landing on its side or back was given a score of 0.0. The
trial was repeated 5 times.
Figure 2.1 : Spinal nerve ligation (SNL) and modified spinal nerve ligation models.
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2.2.10 Reaching response
The mouse was held in the air by the tail 5cm away from a horizontal surface for 5 seconds. It
the mouse reached out with its forelimbs towards the platform it received a score of 1.0. If the
mouse curled towards its belly it received a score of 0.0. If the mouse curled only slightly it
received a score of 0.5.
2.2.11 Swim test
A deep container was filled with at least 4 inches of 24-26⁰C water and the mouse carefully
lowered into the water. The mouse was observed for a maximum of 1 minute and its
swimming ability assessed. The swimming was scored as 3 = Swims, mouse body is
elongated and tail propels in a flagella-like motion, head and back above water; 2.5 = ears
under water, irregular swimming, which includes vertical swimming, swimming in a circle,
swimming on side, swimming in an unbalanced manner; 2 = eyes at water level; 1 = Nose
only above water; 0.5 = head under water; 0 = Underwater tumbling, mouse is unable to
maintain a balanced body position and continuously tumbles. After 1 minute, or if a mouse
displayed underwater tumbling, the mouse was rescued and placed under a heat lamp to dry.
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3 Generation and phenotyping of TRPC3 Knockout mice
3.1 Introduction
3.1.1 TRPC3 channels in sensory neurons
As non-selective cation channels, the TRPCs have an important role in neurons as their
activation and subsequent influx of cations may be sufficient to induce depolarization or
neurotransmitter release, as well as the Ca2+ dependent intracellular signalling required for
growth and development. Microarray analysis of DRGs from a mouse line with complete
ablation of the nociceptor population shows a dramatic down regulation of TRPC3
(Abrahamsen et al., 2008). TRPC3 has also been shown to co localise in neurons with
TRPV1, an indicator of nociceptive neurons (Elg et al., 2007). TRP channels are the
landmarks of our sensory systems, responding to temperature, touch, pheromones and
chemical stimuli so it is understandable that TRP channels are overrepresented in sensory
neurons, however the sensory stimulus that TRPC3 responds to is not known.
TRPC3 is also expressed in the central nervous system and in smooth muscle. In order to
look at the role of TRPC3 in the somatosensory system only we generated a conditional
knockout using Nav1.8Cre to look at the role of TRPC3 in the nociception and Advillin Cre
to look at the role of TRPC3 in all sensory neurons.
3.1.2 Nav1.8 Cre
A “knock-in” mouse strain has been generated by expressing Cre recombinase under the
control of the Nav1.8 promotor (Stirling et al., 2005). The coding sequence for Nav1.8 was
replaced by the gene for Cre but all regulatory elements controlling spatial and temporal
expression patterns were retained. Since Nav1.8 is expressed in a subset of sensory neurons,
primarily nociceptors (Akopian et al., 1996) , this is a very useful tool for investigating gene
function in peripheral nociceptors. The expression pattern of Cre in the knock-ins was
examined using ROSA26 reporter mice and found to match that of Nav1.8 exactly.
Expression of Cre began at embryonic day 14 in small diameter, unmyelinated neurons of
DRG, trigeminal and nodose ganglia. Expression was also shown in a limited number of large
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myelinated DRG neurons. CNS and non-neuronal cells were shown to have no Cre
expression (Figure 3.1). Nav1.8 Cre heterozygotes, expressing one functional copy of the
Nav1.8 channel, were found to have no deficits in sodium channel expression, motor function,
acute pain thresholds nor inflammatory or neuropathic pain.
This makes the Nav1.8 Cre mouse line a suitable tool for nociceptor specific deletion.
Figure 3.1 Expression of Nav1.8Cre in DRG and brain
Expression of Nav1.8Cre in mouse DRG (a) and brain (b) shown by crossing with ROSA26-lacZ
reporter mice and staining with X-gal. (Stirling et al., 2005). Blue cells represent expression of
Nav1.8Cre (scale = 50µm)
a. b.
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3.1.3 Advillin Cre
Advillin is an actin binding protein involved in the organisation of the cytoskeleton which has
been shown to be exclusively expressed in the DRG and TG from embryonic day12.5 with no
expression in the brain or spinal cord. (Marks et al., 1998;Shibata et al., 2004;Ravenall et al.,
2002) Hasegawa et al also showed that Advillin is expressed in postmitotic sensory neurons
and not in progenitor cells further proving the selective expression of Advillin in only DRG
and TG sensory neurons (Hasegawa et al., 2007). Wang et al generated a knock-in mouse
line which expressed Cre under the control of the Advillin promoter enabling gene deletion in
all sensory neurons without affecting other tissues, see Figure 3.2, (Zhou et al., 2010).
Advillin Cre heterozygotes, expressing one functional copy of Advillin, were found to have
no deficits in neuronal function, motor function, acute pain thresholds or inflammatory pain
(Minnet 2010, unpublished data)
This makes the Advillin Cre mouse line a suitable tool for sensory neuron specific
deletion.
Figure 3.2 Expression of Advillin Cre in DRG and brain
Expression of AdvCre in mouse DRG (a) and brain (b) shown by crossing with ROSA26-lacZ
reporter mice and staining with X-gal. Blue cells represent expression of Advillin Cre
(scale = 100µm).
a. b.
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3.2 TRPC3fl/fl:Nav1.8Cre Phenotyping results
3.2.1 Targeting construct design
The design and manufacture of the floxed TRPC3 construct was performed by Birnbaumer et
al (Hartmann et al., 2008). The design and manufacture of the Nav1.8-cre mouse was
performed by Mohammed Nassar (Stirling et al., 2005). The intron-exon organisation of the
Mus musculus TRPC3 gene and a diagram of the expected disruption of the gene is shown in
Figure 3.3 along with the lengths of amplicons that will be used for genotyping.
Figure 3.3 Intron-exon organization of Mus musculus TRPC3 gene
A. Diagram of intron-exon organization, triangles denote loxP sites, *, stop codon, boxes and lines represent exons and
introns respectively, F (5’ GCTATGATTAATAGCTCATACCAAGAGATC), F2
(5’GAATCCACCTGCTTACAACCATGTG), R (5’GGTGGAGGTAACACAGACCTAAGCC), primers. B. Migration of
amplicons from wildtype (WT), floxed TRPC3 (fl/fl) and knockout after cre recombinase (KO) using primers indicated.
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We chose to delete the TRPC3 gene using the Cre/loxP system. This system allows the
deletion of a loxP flanked gene to be restricted to tissues expressing the Cre recombinase
enzyme. This system has a number of advantages; firstly it allows the study of deletion of
TRPC3 in the tissue of interest without affecting any role TRPC3 may play in development
or other systems. Secondly it allows the generation of test and littermate control mice within
a single litter without any unusable genotypes.
The Cre/loxP system is usually used to delete a portion of a gene rather than the whole gene
which reduces the size of the targeting construct and also eliminates any possible reduction in
efficiency of the Cre recombinase over large distances. Exon 7 of the TRPC3 gene was
floxed. The resultant gene would encode a shorter protein of 606 amino acids lacking the C-
terminal part downstream of the pore region (depicted in Figure 3.4). The deletion of exon 7
also induces a frame shift in the remaining exons, further reducing the chance of a functional
protein being made. The deletion of exon 7 avoids any possibility of disrupting the promoter
region of TRPC3, deletion of which is post-natally lethal (Rodriguez-Santiago et al., 2007).
a. b.
Figure 3.4 Illustration of the possible truncated protein encoded by TRPC3fl/fl mouse after
deletion by Cre recombinase
a. After deletion the TRPC3 gene could encode a shorter protein comprising of the N terminus, three
ankyrin repeats (purple boxes) and four transmembrane segments (blue cylinders). b. The full protein
contains an N terminus, three ankyrin repeats, six transmembrane segments, a pore loop and C terminus.
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3.2.2 Breeding strategy
The chimeras were crossed with C57BL/6 mice. This was followed by crossing to FLPe
deleter mice to excise the positive selection cassette, neo resistance. These mice were then
crossed to mice expressing Cre under the control of the Nav1.8 promotor. Finally,
homozygous floxed mice and homozygous floxed mice heterozygous for Cre were crossed to
generate conditional-null mutants and floxed littermate controls for analysis. This ensured an
identical genetic background for conditional-null and control animals. Genotyping was
performed on ear tissue as described in materials and methods.
3.2.3 Confirmation of TRPC3 knockout
The knockout of TRPC3 was confirmed with PCR of genomic DNA (see 8.1.1 ) and also
reverse transcription PCR and quantitative RT-PCR of RNA. RT-PCR showed that TRPC3
RNA from the TRPC3-/- produced a smaller band, confirming excision of exon 7.
Quantitative PCR showed a decrease of TRPC3 RNA in TRPC3fl/fl:Nav1.8Cre mice and a
more substantial decrease of RNA in the TRPC3-/- mouse created by crossing the TRPC3fl/fl
mouse with Cre deleter (see 5.2.1 for more details).
Figure 3.5 Confirmation of TRPC3 knockout at RNA level
a. RT-PCR of wildtype and TRPC3-/- cDNA showed ~200bp difference in band size, confirming the deletion
of exon 7. b. Quantitative PCR showed a reduction in cDNA for both TRPC3fl/fl:Nav1.8Cre (0.7±0.05) and
TRPC3-/- (0.2±0.05) animals. Expressed as a ratio knockout vs wildtype calculated using the Pfaffl method
±SEM.
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3.2.4 TRPC3 fl/fl:Nav1.8Cre mice show no deficits in response to
noxious cold
Behavioural responses to noxious cold were assessed using the cold plate set to 0ºC for 5
minutes. A pain behaviour was classified as a flinching, licking or shaking of the hind paw.
The TRPC3 fl/fl:Nav1.8Cre animals were just as cold sensitive as control animals, with
17.9±1.23 behaviours in 5 minutes compared to 17.8±1.0 behaviours (Figure 3.6).
Figure 3.6 Acute cold pain behaviour in TRPC3 fl/fl:Nav1.8Cre and control (TRPC3 fl/fl) animals.
Noxious cold stimulation using cold plate at 0ºC. No significant difference seen between TRPC3 fl/fl
littermate control (orange, n=5) and TRPC3 fl/fl:Nav1.8Cre (red, n=8) animals. All results shown as mean
±SEM.
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3.2.5 TRPC3 fl/fl:Nav1.8Cre mice have attenuated inflammatory pain in
some models
3.2.5.1 Carrageenan induced mechanical hyperalgesia
Mechanical responses were recorded from mice injected with carrageenan compared to
baseline recordings made prior to the injections. The control mice developed a clear
mechanical hyperalgesia, the 50% threshold dropping from 0.5±0.03g to 0.1±0.03g at 3 hours
after carrageenan injection. The TRPC3 fl/fl:Nav1.8Cre mice developed a less severe
mechanical hyperalgesia the threshold dropping from 0.6±0.08g to 0.3±0.03 g. (Figure 3.7)
An unpaired t-test showed that there was a significant difference between the mechanical
thresholds of TRPC3 fl/fl:Nav1.8Cre mice and the control mice post-carrageenan injection (p
= 0.0195) confirming the result of the formalin test that TRPC3 is involved in inflammatory
pain.
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Figure 3.7 Carrageenan induced mechanical hyperalgesia in TRPC3 fl/fl:Nav1.8Cre and control
(TRPC3fl/fl) animals.
Behaviour following injection of 20µl of 2% carrageenan. The 50% mechanical threshold was recorded using
von Frey hairs on two days prior to injection and three hours post injection. TRPC3 fl/fl:Nav1.8Cre mice
(orange, n = 4) have significantly attenuated mechanical hyperalgesia compared to littermate controls (red, n
= 3). All results shown as mean ±SEM.
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3.2.5.2 Complete Freund’s adjuvant induced mechanical and thermal
hyperalgesia
Mechanical (von Frey) and thermal (Hargreaves’) thresholds were measured from 3 TRPC3
fl/fl:Nav1.8Cre mice and 6 control mice following induction of inflammation by
administration of 20µl of CFA and compared to baseline measurements. The same mice were
used for both mechanical and thermal measurements on days 1, 3, 7 and 10 post injections.
There was no difference between the mechanical hyperalgesia developed after CFA injection
between the TRPC3 fl/fl:Nav1.8Cre mice and the control mice at any of the time points
measured (Figure 3.8a). Thermal hyperalgesia also developed in the TRPC3 fl/fl:Nav1.8Cre
mice to the same extent as the control mice, although the TRPC3 fl/fl:Nav1.8Cre mice did
appear to recover quicker. At day 7 there was a significant difference between the thermal
hyperalgesia experienced by the control mice, 5.9±0.94 seconds, compared to the TRPC3
fl/fl:Nav1.8Cre mice, 10.4±0.32 seconds, (p <0.01) (Figure 3.8b).
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Figure 3.8 Complete Freunds' Adjuvant induced hyperalgesia in TRPC3 fl/fl:Nav1.8Cre and control
(TRPC3fl/fl) animals.
Mechanical and thermal thresholds following injection of 20µl CFA. a. The 50% mechanical threshold was
recorded using von Frey hairs prior to injection and on days 1, 3, 7 and 10 following injection. There is no
significant difference between TRPC3 fl/fl:Nav1.8Cre mice (red, n = 3) and littermate controls (orange, n =
6). b. Paw withdrawal latency to a radiant heat source (Hargreaves’) was measured prior to injection and on
days 1, 3, 7 and 10 following injection. There was a significant difference between the thermal hyperalgesia
between TRPC3 fl/fl:Nav1.8Cre mice (n = 3) and littermate controls (n = 6) on day 7 (p < 0.01, two-way
ANOVA). All results shown as mean ±SEM.
**
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3.2.5.3 Prostaglandin E2 induced mechanical hyperalgesia
Mechanical thresholds were measured from 5 TRPC3 fl/fl:Nav1.8Cre mice and 5 control
mice 3 hours after administration of 100ng of PGE2 and compared to baseline measurements
made on two non consecutive days previously. Both control and TRPC3 fl/fl:Nav1.8Cre
mice developed mechanical hyperalgesia with thresholds dropping to 0.05±0.004 grams and
0.1±0.052 grams respectively (Figure 3.9).
Figure 3.9: PGE2 induced mechanical hyperalgesia in TRPC3 fl/fl:Nav1.8Cre and control
(TRPC3fl/fl) animals.
Mechanical and thermal thresholds following injection of 100ng PGE2. There is no significant difference
between TRPC3 fl/fl:Nav1.8Cre l mice (red, n = 5) and littermate controls (orange, n = 5). The 50%
mechanical threshold was recorded using von Frey hairs prior to injection and 3 hours following
injection.
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3.2.5.4 Bradykinin induced pain behaviour
Behavioural responses from 7 TRPC3 fl/fl:Nav1.8Cre mice and 5 control mice were
recorded for 30 minutes following administration of 10nmol of bradykinin in 10µl saline
intraplantar into the left hind paw. TRPC3 fl/fl:Nav1.8Cre mice displayed 19±3.5 seconds of
pain behaviours compared to 49±3.0 seconds for the littermate controls.
Figure 3.10: Behaviour following injection of 10nmol bradykinin.
TRPC3 fl/fl:Nav1.8Cre mice (red, n=4) had significantly attenuated pain behaviours (unpaired t-test, p =
0.0017) compared to littermate controls (orange, n = 3) following injection of bradykinin. All results shown
as mean±SEM.
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3.3 TRPC3 fl/-:AdvCre Phenotyping results
3.3.1 Breeding strategy
The breeding strategy was as previously described for the TRPC3 fl/fl:Nav1.8Cre mouse
line, chimeras bred with C57BL/6 and the F1 crossed with FLPe deleter mice. But the
homozygous floxed heterozygous Cre mice in the final breeding cross were required to be
male as advillin Cre expression in female mice can be “leaky” and germ line cell
transmission does not occur in all animals.
3.3.2 Confirmation of tissue specific knockout
The knockout of TRPC3 was confirmed with PCR using primers that flank exon 7 (Table
1.2). This enabled identification of a floxed exon 7 as an increase of 100bp of the PCR
product and also the identification of a deleted exon 7 which would produce a smaller PCR
product of 300bp.
Primer Sequence WT fl/fl Cre
TRPC3 F2 GAATCCACCTGCTTACAACCATGTG
800bp 900bp 300bp
TRPC3 R GGTGGAGGTAACACAGACCTAAGCC
TRPC3 F GCTATGATTAATAGCTCATACCAAGAGATC 300bp 400bp none
Table 3.1 PCR primers for confirmation of knockout of TRPC3
Tissue was collected from the ears, tail and DRG of TRPC3fl/fl mice and TRPC3 fl/-:AdvCre
mice and the DNA extracted. PCRs using primers TRPC3F2 x TRPC3R and TRPC3F x
TRPC3R were performed and the results shown in Figure 3.11. The PCR product showed the
floxed band to be present in all tissues of the TRPC3fl/fl animals and also in the ear and tail of
the TRPC3 fl/-:AdvCre mice. A strong knockout band of 300bp was present in the DNA from
the DRG of the TRPC3 fl/-:AdvCre mouse along with a faint band at 900bp indicating the
presence of the floxed TRPC3 gene in the small amount of non-neuronal cells within the
DRG. However, the knockout band was also present in all of the other tissues, along with the
floxed TRPC3 band. This indicates that all of the mice were global heterozygotes for the
TRPC3 gene and the Advillin Cre had acted to excise the one remaining copy of TRPC3 in
66
the DRG cells only. This was also confirmed by using a primer within exon 7 (TRPC3F)
which gave a band in all tissues of the TRPC3fl/fl mouse proving that there is one copy of the
TRPC3 gene in all tissues that do not express Cre. The TRPC3 fl/-:AdvCre mouse gave a
faint band in the DRG, from non-neuronal cells, and a strong band in the ear and tail (Figure
3.11b). The TRPC3fl/- mice which did not have the Advillin Cre gene were used as littermate
controls for all behavioural experiments.
3.3.3
Figure 3.11 Confirmation of tissue specific knockout of TRPC3 in DRG neurons
a. PCR of ear, tail and DRG DNA from a AdvCre+ and AdvCre- mouse using primers TRPC3F2 and
TRPC3R. b. PCR of same ear, tail and DRG DNA using primers TRPC3F and TRPC3R
900bp
300bp
400bp
a.
b.
DRG EAR TAIL DRG EAR TAIL
DRG EAR TAIL DRG EAR TAIL
AdvCre+ AdvCre-
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TRPC3 fl/-:AdvCre mice show no deficits in motor coordination
Motor coordination was judged using an accelerating rotarod. There was no difference in the
motor ability of the TRPC3 conditional null mice (160±19 seconds) compared with control
animals (138±34 seconds) (Figure 3.12).
Figure 3.12 Motor coordination of TRPC3 fl/-:AdvCre and control animals.
There was no difference in motor coordination between TRPC3fl/- littermate control (orange, n=4) and
TRPC3 fl/-:AdvCre (green, n=7) animals. All results shown as mean ±SEM.
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3.3.4 TRPC3 fl/-:AdvCre mice do not show behavioural deficits in
mechanosensation
Behavioural responses to mechanical stimulus were measured using von Frey hairs and the
Randall Selitto test. No difference in withdrawal threshold to von Frey hairs was observed
between TRPC3 fl/-:AdvCre, 0.4±0.04g, and control animals, 0.4±0.03g (Figure 3.13a). The
Randall Selitto test showed there was also no difference in behavioural responses to noxious
blunt stimulation of the tail between TRPC3 fl/-:AdvCre mice, 116±11g, and control animals,
128±4.4g (Figure 3.13b).
Figure 3.13 Acute mechanical pain behaviour in TRPC3 fl/-:AdvCre and control animals
a. Response to mechanical stimulation with von Frey hairs was not significantly different between TRPC3fl/-
littermate control (orange, n=4) and TRPC3 conditional null (green, n=7) animals. b. Response to blunt
mechanical stimulation of the tail in the Randall Selitto test was not significantly different between
TRPC3fl/- littermate control (orange, n=3) and TRPC3 fl/-:AdvCre (green, n=4) animals. All results shown
as mean ±SEM.
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3.3.5 TRPC3 fl/-:AdvCre mice do not show behavioural deficits in
noxious thermosensation
Behavioural responses to noxious thermal stimuli were measured using the Hargreaves’
apparatus and the hot plate test. Paw withdrawal latency in Hargreaves’ test was not altered in
the TRPC3 fl/-:AdvCre mice, 8±1 second, compared to control animals, 8 ±0.9 seconds
(Figure 3.14a). There was also no difference in latency of behavioural responses on the hot
plate at 45ºC, 50ºC or 55ºC (Figure 3.14b).
Figure 3.14 Acute thermal pain behaviour in TRPC3 fl/-:AdvCre and control animals.
a. Noxious thermal stimulation using Hargreaves’ apparatus. No significant difference was observed between
TRPC3fl/- littermate control (orange, n=4) and TRPC3 fl/-:AdvCre (green, n=7) animals. b. Response to
noxious thermal stimulation using the hot plate test was not significantly different between TRPC3fl/-
littermate control (orange, n=6) and TRPC3 fl/-:AdvCre (green, n=5) animals at 45ºC, 50ºC or 55ºC. All
results shown as mean ±SEM.
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3.3.6 TRPC3 fl/-:AdvCre mice show no deficits in cold sensing
Behavioural responses to noxious cold were assessed using the cold plate set to 0ºC for 5
minutes. A pain behaviour was classified as a flinching, licking or shaking of the hind paw.
The TRPC3 fl/-:AdvCre animals had the same number of pain behaviours in 5 minutes 14
±2.7 as control animals, 14±1.3. Innocuous cold sensation was also assessed in the TRPC3
fl/-:AdvCre animals using acetone evaporation, again there was found to be no difference
between the time spent licking, flinching or biting, 4±0.74, compared to the control animals,
4±0.50 seconds.
Figure 3.15 Acute cold pain behaviour in TRPC3 fl/-:AdvCre and control animals.
a. Noxious cold stimulation using cold plate at 0ºC. No significant difference seen between TRPC3fl/-
littermate control (orange, n=6) and TRPC3 fl/-:AdvCre (green, n=5) animals. b. Innocuous cold
stimulation from evaporation of acetone. No significant difference seen between TRPC3fl/-littermate
control (orange, n=9) and TRPC3 fl/-:AdvCre (green, n=10) animals. All results shown as mean ±SEM.
71
3.3.7 TRPC3 fl/-:AdvCre mice display reduced inflammatory pain
behaviour
3.3.7.1 Formalin test
Behavioural responses from 4 TRPC3 conditional null mice and 3 control mice in the two
distinct phases were recorded. In the first phase, 0-10 minutes, the TRPC3 fl/-:AdvCre mice
displayed 135±18 seconds of pain behaviour compared with 172±16 seconds for the control
mice. There was no significant difference between the two groups. In contrast the TRPC3 fl/-
:AdvCre mice showed attenuated pain behaviours in the second phase, from 10-60 minutes,
displaying just 275±14 seconds compared with 450±62 seconds for the control mice. This
was shown to be significant using an unpaired 2-tailed t-test (p = 0.0243). (Figure 3.16)
Figure 3.16b shows the time course of the formalin response and demonstrates that the
TRPC3 fl/-:AdvCre mice displayed reduced pain behaviours at nearly every 5 minute interval
within the second, inflammatory, phase with significant differences at 10-15 and 25-30
minutes found using a 2-way ANOVA.
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Figure 3.16 Formalin induced pain behaviours in TRPC3 fl/-:AdvCre and control mice
Behaviour following injection of 20µl of 5% formalin. a. Time spent licking/flinching/biting the hind paw
was recorded in 5 minute sections. No significant reduction in pain behaviours was seen in Phase I (0-10
minutes) however in Phase II (10-60 minutes) TRPC3 fl/-:AdvCre mice (green, n=4) have significantly
attenuated pain behaviours compared to littermate controls (orange, n=3). b. Time course of the formalin test.
A traditional biphasic response was observed with the attenuated pain behaviour of TRPC3 fl/-:AdvCre mice
apparent in the second phase. All results shown as mean ±SEM.
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3.3.7.2 Carrageenan induced mechanical hyperalgesia.
Mechanical responses were recorded from mice injected with carrageenan compared to
baseline recordings made prior to the injections. The control mice developed a clear
mechanical hyperalgesia, the 50% threshold dropping from 0.5±0.04g to 0.07±0.01g at 3
hours after carrageenan injection. The TRPC3 fl/-:AdvCre mice developed a less severe
mechanical hyperalgesia the threshold dropping from 0.5±0.01g to 0.2±0.04 g. (Figure 3.7)
An unpaired t-test showed that there was a significant difference between the mechanical
thresholds of TRPC3 fl/-:AdvCre mice and the control mice post-carrageenan injection (p =
0.0127) confirming the result of the formalin test that TRPC3 is involved in inflammatory
pain.
Figure 3.17 Carrageenan induced mechanical hyperalgesia in TRPC3 fl/-:AdvCre and control
animals.
Behaviour following injection of 20µl of 2% carrageenan. The 50% mechanical threshold was recorded using
von Frey hairs on two days prior to injection and three hours post injection. TRPC3 fl/-:AdvCre mice (green,
n =5 ) have significantly attenuated mechanical hyperalgesia (unpaired t-test, p = 0.0127) compared to
littermate controls (orange, n =6 ). All results shown as mean ±SEM.
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3.3.7.3 Complete Freund’s adjuvant induced thermal and mechanical
hyperalgesia.
Mechanical (von Frey) and thermal (Hargreaves’) thresholds were measured from 7 TRPC3
TRPC3 fl/-:AdvCre mice and 3 control mice following induction of inflammation by
administration of 20µl of CFA and compared to baseline measurements. The same mice were
used for both mechanical and thermal measurements on days 1, 3, 5, 7 and 10 post injections.
Both control and TRPC3 fl/-:AdvCre mice developed mechanical hyperalgesia from day 1
post injection of CFA, on day 5 it appeared that the TRPC3 fl/-:AdvCre mice had attenuated
mechanical hyperalgesia but this difference was not found to be significant (Figure 3.18a).
Thermal hyperalgesia developed in both the TRPC3 fl/-:AdvCre mice and the control mice
with no significant difference (Figure 3.18b).
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Figure 3.18 Complete Freunds' Adjuvant induced hyperalgesia in TRPC3 fl/-:AdvCre and control
animals.
Mechanical and thermal thresholds following injection of 20µl CFA. There is no significant difference
between TRPC3 fl/-:AdvCre mice (green, n = 7) and littermate controls (orange, n = 4). a. The 50%
mechanical threshold was recorded using von Frey hairs prior to injection and on days 1, 3, 7 and 10
following injection. b. Paw withdrawal latency to a radiant heat source (Hargreaves’) was measured prior to
injection and on days 1, 3, 7 and 10 following injection. All results shown as mean±SEM.
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3.3.7.4 Prostaglandin E2 induced mechanical hyperalgesia.
Mechanical thresholds were measured from 5 TRPC3 fl/-:AdvCre mice and 3 control mice 3
hours after administration of 100ng of PGE2 and compared to baseline measurements made
on two non consecutive days previously. Both control and TRPC3 fl/-:AdvCre mice
developed mechanical hyperalgesia with no significant difference, with 50% thresholds both
dropping to 0.14g (Figure 3.19).
Figure 3.19 PGE2 induced mechanical hyperalgesia in TRPC3 fl/-:AdvCre and animals.
Mechanical and thermal thresholds following injection of 100ng PGE2. There is no significant difference
between TRPC3 fl/-:AdvCre mice (green, n = 5) and littermate controls (orange, n = 3). The 50% mechanical
threshold was recorded using von Frey hairs prior to injection and 3 hours following injection. All results
shown as mean±SEM.
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3.3.7.5 Bradykinin induced pain behaviour
Behavioural responses from 5 TRPC3 fl/-:AdvCre mice and 4 control mice were recorded for
30 minutes following administration of 10nmol of bradykinin in 10µl saline intraplantar into
the left hind paw. TRPC3 fl/-:AdvCre mice displayed 20±9 seconds of pain behaviours
compared to 54±5 seconds for the littermate controls.
Figure 3.20 Bradykinin induced pain behaviours in TRPC3 fl/-:AdvCre and control animals
Behavior following injection of 10nmol bradykinin. TRPC3 fl/-:AdvCre mice (green, n=5) had significantly
attenuated pain behaviours (unpaired t-test, p=0.016) compared to littermate controls (orange, n=4). All
results shown as mean±SEM.
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3.4 Discussion
3.4.1 TRPC3 conditional null mice develop normally.
Before any experiments were performed the fitness of the TRPC3fl/fl:Nav1.8Cre and
TRPC3fl/-:AdvCre mice strains were assessed. There were no differences in weight gain,
motor function, fertility or general behaviour. The size of litters produced was within
expected range and the ratio of male/female progeny was close to 1:1. The Cre+ and Cre-
progeny ratio was also close to 1:1 as expected.
3.4.2 Advillin Cre can produce a heterozygous global deletion
sporadically
The TRPC3fl/fl:AdvCre mice were found to have a heterozygous global deletion that was
also present in TRPC3fl/fl mice. During the breeding strategy the presence of floxed TRPC3,
wildtype TRPC3 and advillin Cre gene were checked in order to set up the next round of
breeding. The Advillin Cre gene had been shown to be “leaky” in females so only male
carriers of advillin Cre were used for breeding. The stages of the breeding and the expected
genotypes of progeny are shown in Table 3.2.
Female Male
Genotypes of progeny
TRPC3 Cre TRPC3 Cre
F1 fl/fl +/+ +/+ Cre/+ fl/+,
cre/+
fl/+,
+/+
F2 fl/+ +/+ fl/+ Cre/+ fl/fl,
cre/+
fl/fl,
+/+
+/+,
cre/+
+/+,
+/+
fl/+,
cre/+
fl/+,
+/+
F3 fl/fl +/+ fl/fl Cre/+ fl/fl,
cre/+
fl/fl,
+/+
Table 3.2 Resulting genotypes from TRPC3fl/fl:AdvCre breeding strategy.
The genotypes of each mouse were checked at each generation. To look for the fl/fl mouse
primers TRPC3F and TRPC3R were used to produce a single band at 400bp that we presume
represents the amplification of two copies of the floxed exon7 of TRPC3. A non-floxed
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TRPC3 gene would give a PCR product of 300bp, these primers were chosen as the size and
separation of the bands is clear and easily identifiable. The non-quantitative nature of
traditional PCR means that using these primers it is not possible to conclusively prove the
presence of two copies of the floxed gene. Some of the progeny from the F2 breeding pairs
may have had spontaneous expression of Advillin Cre leading to a deletion of both copies of
TRPC3 that would produce a heterozygous zygote. This would lead to a proportion of
TRPC3 fl/- mice in the progeny which would still give a single PCR product of 400bp. In the
future it would be possible to identify the erroneous knockout of TRPC3 using primers
TRPC3F2 and TRPC3R for genotyping alongside TRPC3F and TRPC3R.
The loss of one copy of TRPC3 does not affect the pain thresholds or development of
inflammatory pain as throughout all of the behavioural studies the control mice used,
TRPC3fl/-, were found to have comparable results to the TRPC3fl/fl mice from the
Nav1.8Cre strain and also to wildtype mice from other studies conducted in the lab (see
Figure 3.8 and Figure 3.18 for baseline mechanical and thermal thresholds). For this reason it
was decided not to repeat the behavioural experiments using littermate floxed TRPC3 mice to
reduce the number of animals used unnecessarily.
3.4.3 TRPC3 is not involved in acute mechanical sensation.
Mechanosensation was tested using three different methods, von Frey hairs, automated von
Frey and Randall Selitto. Automated von Frey and von Frey hairs test for thresholds to
dynamic light touch and Randall Selitto tests the threshold for noxious mechanical pressure.
Previous studies showed that Nav1.8 neurons are essential for noxious mechanical pressure
sensation but not required for light touch sensation (Abrahamsen et al., 2008). The
TRPC3fl/fl:Nav1.8Cre showed no deficit in light touch sensation but also no deficit in
noxious mechanical pressure proving TRPC3 is not a high threshold mechanosensor in
Nav1.8 neurons.
The TRPC3fl/-:AdvCre mouse had a knockout of TRPC3 in all DRG neurons, including the
subset that must be responsible for transducing light touch signals. This knockout also had no
effect on the animal’s ability to sense light touch.
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When investigating the contribution of TRPC6 to the myogenic response Dietrich et al found
that instead of a reduced response the knockout actually had an increased sensitivity (Dietrich
et al., 2005). Upregulation of TRPC3, which has constitutive activity, was found to be
responsible for this erroneous result. TRPC6 is also shown to be mechanically sensitive and
could be acting in conjunction with TRPC3 in DRG neurons as it is also expressed in these
cells. The knockout of TRPC3 at an early time point, from embryonic day 12-14, could lead
to an upregulation of TRPC6 either at a protein level or increased availability or activity at
the membrane.
3.4.4 TRPC3 is not involved in acute noxious heat sensation
Thermosensation was tested using two different models, the Hot plate and the Hargreaves’
apparatus. The thermal stimulation provided by the hot plate test causes voluntary behaviour
requiring supraspinal responses. There was no difference in the response to the hotplate test
between the control mice and either the TRPC3fl/fl:Nav1.8Cre knockout or the TRPC3fl/-
:AdvCre knockout. The Hargreaves’ apparatus provokes a reflex withdrawal in response to a
radiant heat. There was no difference found between withdrawal reflex time between control
mice and the TRPC3fl/fl:Nav1.8Cre or the TRPC3fl/-:AdvCre.
Previous use of Nav1.8 Cre to knock out Nav1.7 or BDNF in the nociceptors has produced a
significant thermal deficit in either the Hargreaves’ or the hotplate test (Nassar et al.,
2004;Zhao et al., 2006) suggesting that this subset of neurons and proteins are important for
thermal sensation. However, complete ablation of the Nav1.8 expressing neurons produced
only a small thermal deficit (Abrahamsen et al., 2008) casting doubt on their involvement.
Subsets of fibres have been identified with different response thresholds and conduction
velocity (Treede et al., 1995). It is possible that complete ablation of one population of
noxious heat responsive fibres led to compensation from another subset.
Members of the transient receptor protein superfamily have been reported as the mammalian
heat sensors, all of these heat sensors are within the TRPV family. TRPV1 was the first TRP
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to be proposed as a heat sensor, being activated at ~45⁰C in vitro (Caterina et al., 1997).
TRPV1 is found in a subset of peptidergic and IB4+ DRG neurons, the lack of response to
capsaicin both in vitro and in vivo in the DTA-CRE mouse showed that this subset is almost
completely overlapping with Nav1.8 expressing neurons (Abrahamsen et al., 2008). TRPV1
was proposed to be the moderate heat sensor, a theory confirmed by data from the knockout
mouse showing increased thermal thresholds to the hotplate and tail immersion test (Caterina
et al., 2000). However, heat sensing was not completely abolished and further studies on the
TRPV1-/- mouse failed to find a difference in acute thermal sensation, although inflammatory
thermal hyperalgesia was affected (Davis et al., 2000).
As the Nav1.8-expressing neurons have been shown not to be solely responsible for
transducing noxious heat we used advillin cre to produce a conditional knockout in all DRG
neurons allowing us to fully investigate the involvement of TRPC3 in heat sensing. Neither
the hot plate or the Hargreaves’ apparatus showed any differences between the control and
TRPC3fl/-:AdvCre mice proving that TRPC3 has no involvement in acute heat sensing. This
was not surprising as TRPC channels are not closely related to the TRPV family and have not
been shown to be activated by heat in vitro or in vivo.
3.4.5 TRPC3 is not involved in sensing of noxious or innocuous cold
Response to noxious cold was tested using a cold plate at 0⁰ C, well below the 10⁰ C
threshold for cold pain previously described in rats (Allchorne et al., 2005), to ensure a
noxious stimulus. There was no difference in the number of pain behaviours observed in the
TRPC3fl/fl:Nav1.8Cre or TRPC3fl/-:AdvCre mouse compared to control animals.
Nav1.8 is essential for noxious cold sensation (Zimmermann et al., 2007) suggesting that the
cold sensor is expressed within the Nav1.8 + neurons; this was confirmed by the DTA mouse
which is resistant to the noxious cold experienced on the cold plate (Abrahamsen et al.,
2008). TRPM8 has been suggested as the cold sensor but is not co-localised with Nav1.8 and
is thought to be responsible for sensing of innocuous cold (Jordt et al., 2004;Dhaka et al.,
2007). Another ion channel must be responsible for noxious cold sensation.
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As noxious cold is sensed by the Nav1.8+ neurons if TRPC3 was important for noxious cold
sensation the TRPC3fl/fl:Nav1.8Cre mouse would be resistant to noxious cold, Figure 3.6
shows this is not the case. The TRPC3fl/-:AdvCre mouse also shows no resistance to noxious
cold confirming this result. Innocuous cold is thought to be transmitted by TRPM8
expressing neurons, which are Nav1.8-ve. The sensitivity of TRPC3fl/-:AdvCre mice to
innocuous cold was tested using the acetone test and showed no difference between wildtype
and knockout mice, Figure 3.15. This confirms that TRPC3 is not involved in noxious or
innocuous cold sensation.
3.4.6 TRPC3 has an important role in inflammatory pain
Inflammatory pain requires the peripheral and/or central sensitization of DRG neurons. The
release of inflammatory mediators linked to this sensitization requires ion channels and
receptors expressed at the termini of the primary sensory neurons.
Both the nociceptor-specific and pan-DRG knockout of TRPC3 showed reduced
inflammatory pain in the formalin and carrageenan tests, and the pan-DRG TRPC3 knockout
had an attenutated phenotype in the bradykinin test. It is not possible to directly compare the
phenotype of TRPC3fl/-:AdvCre mice with the phenotype observed previously in the
TRPC3fl/fl:Nav1.8Cre mice as the formalin test is highly sensitive to external environmental
factors (Rosland, 1991) and also subjectivity of the experimenter. However, as shown in
Figure 3.16, pain behaviours are not completely abolished in the inflammatory phase,
suggesting that additional deletion of TRPC3 from the large diameter neurons has no further
effect on the attenuated inflammatory phenotype. This fact, together with previous work
showing the importance of the Nav1.8+ve neurons in inflammatory pain, suggests that the
role of TRPC3 in inflammatory pain is mainly within the small-medium nociceptors.
The first phase of formalin induced pain behaviours was unaffected by the knockout of
TRPC3, this was expected as this phase is known to be directly mediated through TRPA1
(McNamara et al., 2007). The second phase of formalin is mediated through a variety of
inflammatory mediators causing peripheral and central sensitisation by enhancing excitability
of neurons. NMDA receptors are fundamental for the central sensitisation, excitatory amino
acids released from peripheral neurons act on post-synaptic NMDA receptors in the dorsal
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horn leading to calcium entry and an increase in intracellular signalling cascades (Coderre
and Melzack, 1992). Phosphorylation of NMDA receptors increases calcium entry and
correlates with the second phase of formalin (Zhao et al., 2006). This synaptic plasticity is
regulated by presynaptic molecules such as BDNF and Ephrin-B2 that are increased in
inflammatory pain states (Zhao et al., 2010;Zhao et al., 2006).
Many inflammatory mediators signal through GPCRs, which are found on both peripheral
and central neurons. Phospholipase C is downstream of a number of GPCRs and is essential
for the second phase of formalin, PLC inhibitors can block the second phase without
affecting the first phase (Coderre, 1992) . PLC is part of a second messenger cascade that
also involves arachidonic acid, PGE2 and PKC. PKC inhibitors and COX-2 inhibitors,
preventing the formation of PGE2, are able to attenuate the pain behaviours in the second
phase of formalin but not abolish them (Coderre and Yashpal, 1994) .
TRPC3 can be activated by PLC, via the production of DAG, which leads to an influx of
cations which increases excitability, releases secondary mediators and phosphorylates other
channels. To investigate whether the attenuated inflammatory phenotype seen in the TRPC3
fl/fl:Nav1.8Cre mice is specifically linked to PLC signalling we looked at the induction of
inflammatory pain directly through two different G proteins. There are three main G-protein-
mediated signalling pathways, mediated by four subclasses of G-proteins, Gs, Gi/o, Gq/11,
G12/13. Most GPCRs are capable of activating more than one subtype of G protein but show
a strong preference for one over another. BK receptors are Gq protein coupled receptors and
cause activation of PLC. PGE2 acts through four EP receptors, EP1 coupled to Gq, EP2 and
4are Gs protein coupled receptors causing the activation of adenylate cyclase and EP3 is
coupled to Gi causing inhibition of cAMP. The TRPC3 fl/fl:Nav1.8Cre mice had attenuated
inflammatory pain in the BK model but not with PGE2 suggesting that it’s involvement in
inflammatory pain is restricted to the Gq/11 signalling pathways.
TRPC3 fl/fl:Nav1.8Cre mice also have reduced carrageenan induced mechanical
hyperalgesia. In a similar way to formalin, carrageenen leads to the production of many
inflammatory mediators which act to sensitise the peripheral neurons, reducing the threshold
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and increasing the excitability. An important molecule for inflammatory hyperalgesia is
TNFα which initiates a cascade of pro-inflammatory cytokines, antisera to TNFα is able to 
abolish carrageenan induced thermal and mechanical hyperalgesia (Cunha et al., 1992).
Recently the association of TRPC3 with cytokines has been investigated in human monocytes
and found to be positively correlated with TNFα and IL1 (Thilo et al., 2008). Furthermore,
TNFα has been shown to increase mRNA and protein levels of TRPC3 in human airway 
smooth muscle cells (HASMCs) (White et al., 2006). The increased levels of TRPC3 are
thought to be responsible for the TNFα induced increase in intracellular Ca2+ levels which 
control a number of cellular responses in HASMCs including contractility. A similar
upregulation of TRPC3, and resulting rise in intracellular Ca2+, in neurons as a response to
pro-inflammatory cytokines could trigger intracellular signalling pathways leading to
sensitisation.
As the knockout of TRPC3 did not produce a complete abolition of pain behaviours in any of
these inflammatory models there are obviously other inflammatory mediator pathways that
are still intact, which may explain the lack of phenotype in the CFA model. TRPC3
fl/fl:Nav1.8Cre mice showed no attenuation of mechanical or thermal hyperalgesia from day
1 to day 10 after CFA injection. The other inflammatory models studied were of a shorter
duration so it is possible that TRPC3 is involved in the early stages of hyperalgesia initiation.
However, another explanation may be functional differences between the models. Whereas
carrageenan and formalin provoke an innate immune response the CFA model produces an
adaptive immune response which includes T-cell activation. This would lead to a different
profile of inflammatory mediators being released, activating different pathways which may
eclipse the deficient PLC pathway outlined above.
In conclusion, TRPC3 plays a role in the PLC signalling pathway downstream of Gq/11
coupled receptors acting to sensitise peripheral nociceptors in acute inflammatory pain
conditions. TRPC3 may be coupled to a specific GPCR, i.e. BK, or to a range of GPCRs of
the Gq/11 subtype. Further investigations with different inflammatory mediators and G
protein inhibitors could help to find this out. TRPC3 expression may also be increased by
TNFα, or downstream cytokines, increasing intracellular Ca2+.
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Test Modality TRPC3fl/fl:
Nav1.8Cre
TRPC3fl/-:
AdvCre
Von Frey hairs Light touch No phenotype No phenotype
Automatic von
Frey
Touch
No phenotype No phenotype
Randall Selitto Noxious pressure No phenotype No phenotype
Hot plate Noxious thermal No phenotype No phenotype
Hargreaves Noxious thermal No phenotype No phenotype
Cold plate Noxious cold No phenotype No phenotype
Acetone Innocuous Cold N/A No phenotype
Formalin Spontaneous acute pain behaviours No phenotype No phenotype
Spontaneous inflammatory pain
behaviours
Attenuated Attenuated
Carrageenan Mechanical hyperalgesia
(inflammation)
Attenuated Attenuated
CFA Thermal (inflammation) No phenotype No phenotype
Mechanical (inflammation) No phenotype No phenotype
PGE2 Mechanical hyperalgesia
(inflammation)
No phenotype No phenotype
Bradykinin Spontaneous inflammatory pain
behaviours
Attenuated Attenuated
Table 3.3 Summary of phenotypes in TRPC3 fl/fl:Nav1.8Cre and TRPC3 fl/-:AdvCre mice
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4 Effects of nociceptor TRPC3 deletion on gene
expression
4.1 Introduction
The deletion of a gene, such as TRPC3 does not just have an effect on the single protein. The
complex molecular pathways and networks within a cell can all be affected by the deficit
especially when the gene is knocked out early on in development. Redundancy within a large
family such as the TRP channel superfamily can lead to upregulation of similar channels to
compensate for the deficit (Selli et al., 2008). TRPC3, 6 and 7 are highly homologous,
furthermore it has been shown that in the global knockout of TRPC6 there was an
upregulation of TRPC3 (Dietrich et al., 2005).
The TRPC3fl/fl:Nav1.8Cre mouse line have attenuated inflammatory hyperalgesia in the
formalin, bradykinin and carrageenan tests. The inflammatory hyperalgesia, which develops
rapidly in these models, is linked to the release of cytokines and activation of signalling
cascades sensitising the nociceptors. Although TRPC3 may be activated directly by
inflammatory mediators, such as substance P (Ben-Mabrouk and Tryba, 2010), it is also
possible that the deletion of TRPC3 may have a secondary effect on the expression of
proteins which are involved in the generation of inflammatory hyperalgesia.
DNA microarrays allow the investigation of thousands of genes simultaneously allowing us
to gain a complex and integrated view of the molecular events taking place within a cell.
Microarrays can be used to look at the differences in gene expression between a wildtype and
knockout mouse by determining the amount of mRNA present. Affymetrix uses the
photolithographic method to synthesise oligonucleotides representing the entire mouse
genome in situ directly onto a silica slide. Labelled cRNA, made from cDNA synthesised
from mRNA, obtained from samples with different conditions, in this case wildtype and
knockout, are hybridised to the chip. The labelled cDNA fragments hybridise with their
corresponding oligonucleotides and the resulting fluorescent readout shows the abundance of
each specific nucleotide sequence present in each sample. A comparison can be made
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between the wildtype and knockout samples and a list of up- or downregulated genes can be
generated. The resulting transcriptional profile is very informative and can show adjustments
of the cell to protein functional disruption. As well as providing a list of individual genes
which are up or down regulated further analysis can look at pathways and biological gene
networks allowing detection of small, but consistent, changes in expression of a group of
genes with a related function. This can lead to elucidation of biological aspects and trends
that would be hidden in a gene-by-gene analysis. A microarray cannot detect any difference
in the translation of mRNA into functional protein, a Western blot would need to be used for
this purpose.
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4.2 Results
4.2.1 Microarray analysis
Around 7,500 genes were found to be significantly dysregulated (p < 0.05) between the
TRPC3 fl/fl:Nav1.8Cre and control mice. Gene ontology enrichment analysis using Partek
software grouped the genes according to the gene product properties. The most biologically
relevant groups are displayed in Table 4.1. Pathway analysis using DAVID mapped the genes
onto known pathways to determine which pathways were overrepresented in the dysregulated
gene list.
Function Enrichment score
% of genes in group
that are present
G –protein coupled receptor activity 77.44 10.15
G-protein couple receptor protein signalling
pathway
63.68 11.75
Ribonucleotide binding 20.90 34.26
Protein kinase activity (MAPK, PI3K) 19.03 40.87
Protein binding (Cytokines) 18.83 29.78
Table 4.1 Gene ontology enrichment analysis
The dysregulated genes grouped by gene properties and functions are displayed in
alphabetical order in Table 4.2 to Table 4.4. Genes are listed in alphabetical order: shaded
lines are downregulated and unshaded lines are upregulated genes in the TRPC3
fl/fl:Nav1.8Cre mice.
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G-Protein Receptor Signalling Proteins
Gene
Symbol
Gene Name Fold-change p-value
Adora2b adenosine A2b receptor -1.39862 0.0498
Adora3 adenosine A3 receptor -1.28955 0.02182
Adra1b adrenergic receptor, alpha 1b -1.35294 0.02711
Adrb3 adrenergic receptor, beta 3 -1.3506 0.03755
Bai1 brain-specific angiogenesis inhibitor 1; similar to brain-specific
angiogenesis inhibitor 1
1.51744 0.04948
C3ar1 complement component 3a receptor 1 1.26338 0.03156
Calcr calcitonin receptor 1.83535 0.02937
Cckbr cholecystokinin B receptor -1.68023 0.02282
Ccr6 chemokine (C-C motif) receptor 6 -1.33221 0.04759
Ccrl2 chemokine (C-C motif) receptor-like 2 -1.60451 0.00955
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo
homolog, Drosophila)
-1.60572 0.04362
Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo
homolog, Drosophila)
-1.53368 0.03087
Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo
homolog, Drosophila)
-1.50139 0.03334
Cmklr1 chemokine-like receptor 1 -1.47397 0.03241
Cnr2 cannabinoid receptor 2 (macrophage) -1.63407 0.04627
Cxcr6 chemokine (C-X-C motif) receptor 6 -1.51509 0.01187
Drd2 dopamine receptor 2 1.27574 0.0452
Drd5 dopamine receptor 5 1.24028 0.02296
Ednrb endothelin receptor type B 1.5803 0.00971
Eltd1 EGF, latrophilin seven transmembrane domain containing 1 1.43492 0.0378
Emr4 EGF-like module containing, mucin-like, hormone receptor-
like sequence 4
1.86491 0.0302
F2r coagulation factor II (thrombin) receptor 1.20442 0.02004
Fshr follicle stimulating hormone receptor -1.59003 0.03584
Fzd4 frizzled homolog 4 (Drosophila) 3.11054 0.02144
Galr2 galanin receptor 2 1.52444 0.03829
Ghrhr growth hormone releasing hormone receptor -2.27873 0.02827
Glp1r glucagon-like peptide 1 receptor; similar to glucagon-like 2.445 0.02257
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peptide-1 receptor
Gpbar1 G protein-coupled bile acid receptor 1 -1.1183 0.02552
Gpr1 G protein-coupled receptor 1 1.21718 0.01611
Gpr112 G protein-coupled receptor 112 -1.21938 0.01166
Gpr123 G protein-coupled receptor 123 -1.23449 0.03623
Gpr132 G protein-coupled receptor 132 2.29839 0.0145
Gpr139 G protein-coupled receptor 139 1.18112 0.0049
Gpr156 G protein-coupled receptor 156 1.4024 0.03699
Gpr56 G protein-coupled receptor 56 1.50256 0.04203
Gpr64 G protein-coupled receptor 64 1.5002 0.00309
Gpr84 G protein-coupled receptor 84 -1.2254 0.01348
Gpr98 G protein-coupled receptor 98 2.16921 0.04429
Gprc5b G protein-coupled receptor, family C, group 5, member B -1.22433 0.03126
Gprc5c G protein-coupled receptor, family C, group 5, member C;
similar to G protein-coupled receptor, family C, group 5,
member C
1.76189 0.02467
Grm5 glutamate receptor, metabotropic 5 -1.72125 0.03304
Grm7 glutamate receptor, metabotropic 7 1.31024 0.04433
Gucy2g guanylate cyclase 2g 1.29511 0.04955
Hcrtr1 similar to Hypocretin (orexin) receptor 1; hypocretin (orexin)
receptor 1
-2.0562 0.03784
Lgr4 leucine-rich repeat-containing G protein-coupled receptor 4 1.312 0.02199
Lgr6 leucine-rich repeat-containing G protein-coupled receptor 6 -1.77361 0.03154
Lhcgr luteinizing hormone/choriogonadotropin receptor 1.48492 0.04447
Lpar1 lysophosphatidic acid receptor 1 -1.29522 0.03467
Lpar6 purinergic receptor P2Y, G-protein coupled, 5 1.40968 0.00661
Lphn3 latrophilin 3 -2.94302 0.0232
Ltb4r1 leukotriene B4 receptor 1 -1.554 0.00575
Mc3r melanocortin 3 receptor 1.84627 0.01805
Mrgpra4 predicted gene 5734; predicted gene 5733; MAS-related
GPR, member A4; MAS-related GPR, member A8; predicted
gene 9717
1.39821 0.00267
Mrgprg MAS-related GPR, member G -1.37152 0.00463
Mtnr1a melatonin receptor 1A 1.3149 0.04505
Nmur2 neuromedin U receptor 2 -1.27556 0.0351
Npy6r neuropeptide Y receptor Y6 -1.07549 0.01538
Olfr1002 olfactory receptor 1002 -1.0669 0.01168
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Olfr1039 olfactory receptor 1039 -1.17109 0.02747
Olfr1082 olfactory receptor 1082 -1.14074 0.03594
Olfr112 olfactory receptor 112 -1.45858 0.03297
Olfr1135 olfactory receptor 1135 1.03294 0.01789
Olfr1138 olfactory receptor 1138 -1.10808 0.03582
Olfr1140 olfactory receptor 1140 1.78285 0.0026
Olfr1151 olfactory receptor 1151 1.09939 0.02736
Olfr119 olfactory receptor 119 -1.47475 0.02202
Olfr1199 olfactory receptor 1199 1.07442 0.04212
Olfr1200 olfactory receptor 1200 1.20037 0.03061
Olfr1203 olfactory receptor 1203 1.12851 0.03731
Olfr1252 olfactory receptor 1252 -1.28163 0.00755
Olfr1256 olfactory receptor 1256 1.07715 0.03025
Olfr1264 olfactory receptor 1264 -1.16247 0.00902
Olfr128 olfactory receptor 128 1.16926 0.02222
Olfr1289 olfactory receptor 1289 -1.08937 0.04964
Olfr1294 olfactory receptor 1294 -1.13056 0.04198
Olfr1295 olfactory receptor 1295 -1.49532 0.03737
Olfr1298 olfactory receptor 1298 -1.51931 0.00911
Olfr1321 olfactory receptor 1321 -1.25539 0.03042
Olfr1349 olfactory receptor 1349 -1.04691 0.02528
Olfr1357 olfactory receptor 1357 -1.05694 0.01939
Olfr1387 olfactory receptor 1387 1.19039 0.03126
Olfr1395 olfactory receptor 1395 -1.16074 0.04742
Olfr1404 olfactory receptor 1404 -1.07483 0.00218
Olfr142 olfactory receptor 142 -1.07319 0.03702
Olfr1420 olfactory receptor 1420 -1.30721 0.00742
Olfr1426 olfactory receptor 1426 1.11218 0.03386
Olfr1499 olfactory receptor 1499 -1.13539 0.02131
Olfr1501 olfactory receptor 1501 1.21514 0.02869
Olfr1506 olfactory receptor 1274; olfactory receptor 1506; predicted
gene 13766
-1.07363 0.04916
Olfr1510 olfactory receptor 1510 1.17054 0.03715
Olfr191 olfactory receptor 191 1.1055 0.00639
Olfr205 olfactory receptor 205 -1.08197 0.02819
Olfr208 similar to olfactory receptor 208; olfactory receptor 209;
olfactory receptor 208; olfactory receptor 207
-1.11276 0.04891
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Olfr24 olfactory receptor 24 -1.25452 0.00915
Olfr272 olfactory receptor 272 1.1604 0.0332
Olfr283 olfactory receptor 283 -1.61662 0.04072
Olfr351 olfactory receptor 351 -1.13665 0.02628
Olfr402 olfactory receptor 402 -1.22236 0.03355
Olfr419 olfactory receptor 419 -1.10526 0.02873
Olfr421 olfactory receptor 421 -1.58137 0.04336
Olfr456 olfactory receptor 456 -1.08026 0.03008
Olfr461 olfactory receptor 461 -1.10063 0.02684
Olfr513 olfactory receptor 513 -1.04814 0.03732
Olfr514 olfactory receptor 514 -1.14504 0.01493
Olfr544 olfactory receptor 544 -1.14698 0.02092
Olfr56 olfactory receptor 56 -1.35927 0.03464
Olfr582 olfactory receptor 582 -1.17023 0.00814
Olfr59 olfactory receptor 59 -1.28268 0.02644
Olfr61 olfactory receptor 61 -1.12722 0.03203
Olfr655 olfactory receptor 655 -1.08031 0.01581
Olfr659 olfactory receptor 659 1.14756 0.03777
Olfr669 olfactory receptor 669 1.0987 0.04151
Olfr676 olfactory receptor 676 1.14361 0.03054
Olfr683 olfactory receptor 683 -1.10152 0.02605
Olfr689 olfactory receptor 689 1.05886 0.02492
Olfr70 olfactory receptor 70 1.4977 0.02179
Olfr706 olfactory receptor 706 -1.10886 0.03437
Olfr714 olfactory receptor 714 -1.32792 0.02346
Olfr731 olfactory receptor 731 1.13099 0.0133
Olfr74 olfactory receptor 74 -1.11298 0.04499
Olfr748 olfactory receptor 748 1.20363 0.0347
Olfr76 olfactory receptor 76 -1.1374 0.00042
Olfr761 olfactory receptor 761 1.13 0.04204
Olfr776 olfactory receptor 1518; olfactory receptor 776; olfactory
receptor 774
-1.09671 0.00152
Olfr782 olfactory receptor 782 1.12587 0.03962
Olfr813 olfactory receptor 813 -1.08656 0.03615
Olfr818 olfactory receptor 818 1.11669 0.031
Olfr829 olfactory receptor 829 -1.17185 0.02352
Olfr859 olfactory receptor 857; olfactory receptor 859; olfactory 1.34349 0.01911
93
receptor 58
Olfr926 olfactory receptor 926 -1.2012 0.02845
Olfr935 olfactory receptor 935 -1.09106 0.04787
Olfr99 olfactory receptor 99 1.13175 0.00502
Opn1mw opsin 1 (cone pigments), medium-wave-sensitive (color
blindness, deutan)
1.60474 0.03302
Opn1sw opsin 1 (cone pigments), short-wave-sensitive (color
blindness, tritan)
1.40117 0.02584
Opn5 opsin 5 1.40368 0.03455
Oprl1 opioid receptor-like 1 1.58561 0.00772
Oprm1 opioid receptor, mu 1 -2.64743 0.04067
Prlhr prolactin releasing hormone receptor -1.51821 0.03085
Ptger1 prostaglandin E receptor 1 (subtype EP1) -1.67613 0.0176
Ptger2 prostaglandin E receptor 2 (subtype EP2) 1.39571 0.00916
Ptger3 prostaglandin E receptor 3 (subtype EP3) 1.66151 0.00401
Pth1r parathyroid hormone 1 receptor 1.46914 0.04052
Pth2r parathyroid hormone 2 receptor 1.42525 0.0106
Rxfp1 relaxin/insulin-like family peptide receptor 1 2.76272 0.0457
Sstr3 somatostatin receptor 3 -1.29761 0.01776
Sucnr1 succinate receptor 1 1.26105 0.01758
Tas1r2 taste receptor, type 1, member 2 -2.22575 0.03892
Trhr2 thyrotropin releasing hormone receptor 2 1.48953 0.00624
Tshr thyroid stimulating hormone receptor -1.16878 0.01205
Vipr1 vasoactive intestinal peptide receptor 1 1.65673 0.02443
Vipr2 vasoactive intestinal peptide receptor 2 1.22358 0.00731
Table 4.2 G-protein receptor signaling proteins dysregulated in TRPC3 fl/fl:Nav1.8Cre mice
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PI3K Signalling Pathway
Gene
Symbol
Gene Name
Fold-
change
p-value
Cds2 CDP-diacylglycerol synthase (phosphatidate
cytidylyltransferase) 2
-1.14669 0.013879
Dgki diacylglycerol kinase, iota -1.35829 0.047392
Itpr1 inositol 1,4,5-triphosphate receptor 1 -2.62009 0.013892
Itpr2 inositol 1,4,5-triphosphate receptor 2 -2.00108 0.032144
Itpr3 inositol 1,4,5-triphosphate receptor 3 1.29266 0.022612
Inpp4a inositol polyphosphate-4-phosphatase, type I -1.26067 0.049702
Inpp5a inositol polyphosphate-5-phosphatase A -1.12735 0.019539
Inpp5d inositol polyphosphate-5-phosphatase D -1.8362 0.025926
Inpp5e inositol polyphosphate-5-phosphatase E -1.34082 0.033357
Inpp5f inositol polyphosphate-5-phosphatase F -1.27 0.003589
Pik3r3 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide
3 (p55)
1.18656 0.031314
Pik3cd phosphatidylinositol 3-kinase catalytic delta polypeptide;
RIKEN cDNA 2610208K16 gene
-1.5837 0.015683
Pik3c2a phosphatidylinositol 3-kinase, C2 domain containing, alpha
polypeptide
1.53673 0.012696
Pik3c2g phosphatidylinositol 3-kinase, C2 domain containing, gamma
polypeptide
-1.8824 0.025506
Pik3cb phosphatidylinositol 3-kinase, catalytic, beta polypeptide 1.38045 0.002054
Pik3r1 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide
1 (p85 alpha)
-1.17062 0.001974
Pip5k1b phosphatidylinositol-4-phosphate 5-kinase, type 1 beta; 1.41511 0.022619
Pip5k1c phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma -1.22606 0.043822
Pik3ap1 phosphoinositide-3-kinase adaptor protein 1 -1.74252 0.016098
Pik3ip1 phosphoinositide-3-kinase interacting protein 1 1.2579 0.018488
Pik3cg phosphoinositide-3-kinase, catalytic, gamma polypeptide -2.72543 0.042276
Pik3c2b phosphoinositide-3-kinase, class 2, beta polypeptide -1.59959 0.026033
Pik3r6 phosphoinositide-3-kinase, regulatory subunit 6 1.64621 0.015919
Plcb4 phospholipase C, beta 4 -1.45394 0.034925
Plcd1 phospholipase C, delta 1 -1.55796 0.029271
Plcg2 phospholipase C, gamma 2 1.42275 0.009242
Plcz1 phospholipase C, zeta 1 -2.53562 0.036422
Table 4.3 PI3K signaling proteins dysregulated in TRPC3 fl/fl:Nav1.8Cre mice
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MAPK Signalling Pathway
Gene
Symbol
Gene Name
Fold-
change
p-value
Cacna1a calcium channel, voltage-dependent, P/Q type, alpha 1A
subunit
-3.01242 0.2999
Cacna1b calcium channel, voltage-dependent, N type, alpha 1B
subunit
-1.29064 0.033873
Cacna1c calcium channel, voltage-dependent, L type, alpha 1C
subunit
2.27069 0.048964
Cacna1d calcium channel, voltage-dependent, L type, alpha 1D
subunit
2.27069 0.048964
Cacna1e calcium channel, voltage-dependent, R type, alpha 1E
subunit
-1.30304 0.044397
Cacna1f calcium channel, voltage-dependent, alpha 1F subunit -2.19039 0.010133
Cacna1g calcium channel, voltage-dependent, T type, alpha 1G
subunit
-1.32601 0.038265
Cacna1h calcium channel, voltage-dependent, T type, alpha 1H
subunit
-1.19875 0.007808
Cacna1i calcium channel, voltage-dependent, alpha 1I subunit -1.70664 0.029454
Cacna1s calcium channel, voltage-dependent, L type, alpha 1S
subunit
2.38838 0.023724
Cacna2d2 calcium channel, voltage-dependent, alpha 2/delta subunit
2; similar to Cacna2d2 protein
1.99894 0.047296
Cacna2d4 calcium channel, voltage-dependent, alpha 2/delta subunit 4 -3.38467 0.007552
Cacnb3 calcium channel, voltage-dependent, beta 3 subunit -1.38103 0.02486
Dusp10 dual specificity phosphatase 10 1.95411 0.042402
Fas Fas (TNF receptor superfamily member 6) -1.93293 0.014972
Fgf18 fibroblast growth factor 18 -1.2977 0.025489
Fgf6 fibroblast growth factor 6 -1.81101 0.021649
Fgf9 fibroblast growth factor 9 -1.57222 0.014944
Fgfr1 fibroblast growth factor receptor 1 -1.47564 0.04324
Fgfr3 fibroblast growth factor receptor 3 -1.32813 0.017987
Fgfr4 fibroblast growth factor receptor 4 -2.05918 0.005423
Flna filamin, alpha 2.30043 0.04151
Flnb filamin, beta -2.59033 0.042665
Flnc filamin C, gamma 1.49663 0.020983
Hspa8 similar to heat shock protein 8; heat shock protein 8 2.15725 0.046987
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Il1a interleukin 1 alpha -1.68167 0.037311
Il1b interleukin 1 beta -1.45757 0.010813
Il1r1 interleukin 1 receptor, type I 1.41169 0.04951
Jmjd7,
Pla2g4b
phospholipase A2, group IVB (cytosolic); jumonji domain
containing 7
-1.79936 0.001136
Map2k5 mitogen-activated protein kinase kinase 5 1.32356 0.042167
Map2k6 mitogen-activated protein kinase kinase 6 -1.68971 0.038545
Map3k10 mitogen-activated protein kinase kinase kinase 10 -1.24805 0.027814
Map3k14 mitogen-activated protein kinase kinase kinase 14 -3.35982 0.000949
Map3k15 mitogen-activated protein kinase kinase kinase 15 -3.21509 0.044432
Map3k2 mitogen-activated protein kinase kinase kinase 2 1.10891 0.0081
Map3k5 mitogen-activated protein kinase kinase kinase 5 -1.29092 0.031118
Map3k6 mitogen-activated protein kinase kinase kinase 6 -2.61658 0.049409
Map4k2 mitogen-activated protein kinase kinase kinase kinase 2 -1.41688 0.024496
Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 -1.33711 0.035203
Map4k5 mitogen-activated protein kinase kinase kinase kinase 5 1.20557 0.014635
Mapk1 mitogen-activated protein kinase 1 1.07803 0.014384
Mapk12 mitogen-activated protein kinase 12 2.47187 0.009211
Mapk14 mitogen-activated protein kinase 14 -1.38381 0.030209
Mapk4 mitogen-activated protein kinase 4 1.66141 0.002742
Mapk8ip1 mitogen-activated protein kinase 8 interacting protein 1 2.16785 0.032464
Mapkap1 mitogen-activated protein kinase associated protein 1 -1.16248 0.012883
Mapkapk2 MAP kinase-activated protein kinase 2 1.11854 0.027234
Mapkapk3 mitogen-activated protein kinase-activated protein kinase 3 -1.97475 0.00608
Mapkapk5 MAP kinase-activated protein kinase 5; similar to MK-5 type
2
1.18366 0.022651
Mapkbp1 mitogen-activated protein kinase binding protein 1 -2.91122 0.014916
Mknk1 MAP kinase-interacting serine/threonine kinase 1 -1.34666 0.041772
Ngf nerve growth factor -1.38703 0.041977
Nlk nemo like kinase; similar to nemo-like kinase 1.13698 0.039565
Pla2g12b phospholipase A2, group XIIB -1.69136 0.045898
Pla2g2d phospholipase A2, group IID -1.41167 0.005237
Pla2g4a phospholipase A2, group IVA (cytosolic, calcium-dependent) -1.90122 0.009625
Pla2g4e phospholipase A2, group IVE -1.76591 0.020157
Pla2g7 phospholipase A2, group VII 11.1518 0.020251
Pla2r1 phospholipase A2 receptor 1 2.1758 0.002845
Plac1 placental specific protein 1 2.37659 0.000835
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Plag1 pleiomorphic adenoma gene 1 1.46279 0.027824
Rap1b RAS related protein 1b; similar to GTP-binding protein (smg
p21B)
1.05826 0.032762
Rapgef2 Rap guanine nucleotide exchange factor (GEF) 2 1.21705 0.02585
Rasa2 RAS p21 protein activator 2 1.30517 0.043228
Rasgrf1 RAS protein-specific guanine nucleotide-releasing factor 1 1.45261 0.047802
Rasgrp2 RAS, guanyl releasing protein 2 -1.9529 0.021783
Rasgrp4 RAS guanyl releasing protein 4 -1.34799 0.02518
Taok2 TAO kinase 2 -1.14029 0.04993
Taok3 TAO kinase 3 1.16228 0.045618
Traf2 TNF receptor-associated factor 2 -1.8359 0.029042
Traf5 TNF receptor-associated factor 5 1.91994 0.039169
Traf6 TNF receptor-associated factor 6 -1.27159 0.041114
Table 4.4 MAPK signaling pathway proteins dysregulated in TRPC3 fl/fl:Nav1.8Cre mice
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4.3 Discussion
TRPC3 fl/fl:Nav1.8Cre mice have an attenuated inflammatory phenotype which is likely due
to a decrease in sensitisation of peripheral afferents. Sensitisation occurs from enhanced
activity of nociceptor ion channels which leads to a decrease of threshold at which an action
potential is fired. The gene list from the microarray analysis did not show any significant
change in expression of any ion channels themselves so the decreased sensitisation in the
TRPC3 fl/fl:Nav1.8Cre mice may be caused by a downregulation of the molecules leading to
the enhanced activity of ion channels or an upregulation of inhibitory molecules.
Gene ontology (GO) analysis allows identification of functionally related gene groups within
the microarray gene list to enable increased understanding of the biological meaning.
Although the most up and down regulated proteins in the TRPC3 fl/fl:Nav1.8Cre mice were
cytoskeletal proteins and some ATP linked enzymes the GO analysis shows that a large
number of signalling pathways such as GPCRs, MAPK and cytokines are dysregulated which
is more biologically relevant given the attenuated inflammatory phenotype of these animals.
4.3.1 Technical considerations
A microarray compares only the mRNA for known genes, there can be no analysis of novel
transcripts and the amount of message can only give an indication of the amount of protein
made. Trafficking, phosphorylation and other modulations and alternative splicing can also
affect the amount of functional protein but these are not detected in a microarray. Affymetrix
technology does allow some analysis of splice variants but this type of array was not chosen
due to expense and time considerations. To minimise false positives each sample has three
biological replicates but qPCR is also recommended to validate specific targets of biological
importance.
4.3.2 G-protein coupled receptor activity and signalling are dysregulated
in TRPC3fl/fl:Nav1.8Cre mice
The gene ontology group that was most represented in the gene list was GPCR activity and
signalling. TRPC3 is known to be activated downstream of phospholipase C, PLC, which is
activated by GPCRs. GPCRs are a large family of receptors that are ligand activated and
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activate intracellular signalling pathways. Many inflammatory mediators such as BK, PGE2
and complement signal through GPCRs from the Gq/11,Gs, Go/i sub types.
Prostaglandin E receptor subtypes 2 and 3 were identified in the gene list as being up
regulated in the TRPC3 fl/fl:Nav1.8Cre mouse, however subtype 1 was slightly down
regulated (Table 4.2). The PGE2 receptors, EP1-4, signal through three types of GPCR. EP1
couples to Gq, EP2 and 4 to Gs and EP3 to Gi. The TRPC3 fl/fl:Nav1.8Cre mice had no
deficits in PGE2 induced mechanical hyperalgesia (Figure 3.9) and it is possible that
upregulation of the Gs and Gi coupled receptors in the TRPC3 fl/fl:Nav1.8Cre mice is
compensating for the deficit in the Gq pathway discussed previously. Complement
component 3a receptor 1 binds to the C3a and C4a components of the complement system
and is slightly upregulated in the TRPC3 fl/fl:Nav1.8Cre mice (Table 4.2). C3AR1 is a
GPCR coupled to G-alpha 16 or G-alpha o/i (Settmacher et al., 2003), not the Gq pathway
that appears to be affected by the TRPC3 knockout. These compensation mechanisms may, in
part, explain why the TRPC3 fl/fl:Nav1.8Cre mouse line has no attenutated inflammatory
phenotype in CFA induced hyperalgesia. Even though CFA initiates an inflammatory
signalling cascade including Gq proteins and PLC the other pathways that are activated,
including Gs and Gi/o, are up regulated and the neurons are still sensitised to the same extent.
Interestingly, there are also up and down regulations in the metabotropic glutamate receptor
(mGluR) genes. GRM5 is a Group I mGluR and is able to activate PLC (linked to Gq), and is
pro-nociceptive in inflammatory pain states (Sharpe et al., 2002;Zhu et al., 2004). GRM7 is a
Group III mGluR that inhibits cAMP production and is hence anti-nociceptive (Zhang et al.,
2002;Kumar et al., 2010). GRM5 is down-regulated and GRM7 in upregulated in the TRPC3
fl/fl:Nav1.8Cre mice. The mGluR receptors regulate glutamate release in the spinal cord in
both inflammatory and neuropathic pain states, (Kumar et al., 2010), and are also important
in the periphery where mGluR5 mediates inflammatory induced nociceptive behaviour (Lee
et al., 2006).
The dysregulation of the GPCR signalling pathway, and specifically the upregulation of some
Gs and Gi/o protein coupled receptors, substantiates the theory that TRPC3 is downstream of
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Gq protein coupled receptors. As no single GPCR is especially up or down regulated in the
TRPC3 fl/fl:Nav1.8Cre mice it is not clear if TRPC3 is coupled to a specific GPCR or if it is
downstream of a number of different receptors.
4.3.3 MAP Kinase and PI3 Kinase pathways are dysregulated in
TRPC3fl/fl:Nav1.8Cre mice
Pathway analysis using DAVID identified a large number of genes from the
phosphatidylinositol signalling pathway. 27 genes in total were significantly up or down
regulated which represents around 32% of the number of genes known to be involved in this
signalling pathway. Phosphatidylinositol signalling includes both the MAP Kinase and PI3
Kinase pathways which cause phosphorylation of ion channels leading to enhanced
excitability and sensitisation of nociceptors. The MAPK and PI3K pathways are activated
downstream of inflammatory mediators via GPCRs and receptor tyrosine kinases. Reduced
signalling via these pathways would lead to a reduction of sensitisation and associated
hyperalgesia in response to inflammatory mediators.
4.3.4 TRPC channel expression is not upregulated in
TRPC3fl/fl:Nav1.8Cre mice
TRPC3 was not present in the microarray downregulated list, despite gene deletion being
confirmed previously (Figure 8.1). The design of this mouse strain results in the deletion of
exon 7, a partial length mRNA may still be made which would be picked up in the microarray
even though this would not be translated into a functional protein. There would also be full-
length TRPC3 mRNA present from Nav1.8 negative neurons within the DRG and non-
neuronal cells.
TRPC6 was not present in the list of significantly up or down regulated genes in the
TRPC3fl/fl:Nav1.8Cre mouse. However, this does not prove that TRPC6 is not compensating
for the lack of TRPC3. The microarray detects only the change in messenger RNA, not the
levels of functional protein. Although the level of mRNA for TRPC6 does not change it is
possible that the compensation is acting through a different mechanism. TRPC6 is regulated
by an exocytotic mechanism that controls levels of the ion channel within the plasma
membrane. There are also a number of auxillary proteins such as Src Kinase that modulate
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channel activity. An increased level of TRPC6 at the plasma membrane of increased activity
could only be detected by immunohistochemistry, using an antibody to look at the location of
TRPC6 and also to see whether it is phosphorylated.
4.3.5 Further work
The microarray was performed using three biological replicates to minimise false positives
however qPCR was not used to validate the results. The original gene list of significantly up
or down regulated genes contained over 7,500 genes. The most up-regulated and most down-
regulated genes did not appear to have any obvious biological relevance to TRPC3 or the
attenuated inflammatory phenotype. Pathway analysis did show some interesting targets,
however individually each of the genes contained within the pathway lists were not massively
up or down regulated. This doesn’t invalidate the results but means that an extensive list of
genes would need to be investigated with qPCR before any follow up experiments performed.
It would also be interesting to look at the gene expression profile of wildtype and knockout
mice after inflammatory insults such as formalin and carrageenan.
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5 Phenotyping TRPC3-/-:TRPC6-/- mice
5.1 Introduction
TRPC3 and TRPC6 are in the same sub-group of the TRPC family, along with TRPC7. This
gives them a high degree of sequence homology and also similarities in activation, expression
and functional properties. Knockout or knockdown of genes can lead to other, related, genes
compensating for the deficit, concealing the true phenotype. For these reasons we used a
double knockout of TRPC3 and TRPC6 to minimise compensation and redundancy. A global
knockout of both TRPC3 and TRPC6 also allowed us to look at other tissues where
mechanically activated channels are known to be important. Global knockout, including
germline cells, of a gene flanked with loxP sites can be achieved using a Cre-deleter mouse
strain. This Cre-deleter mouse uses human cytomegalovirus promoter to control expression of
Cre which together with a nuclear localization signal and addition of splicing and
polyadenylation signals to increase Cre recombinase efficacy lead to global deletion or the
floxed region (Schwenk et al., 1995).
5.1.1 Mechanotransduction in sensory neurons
The molecular transduction mechanisms mediating the detection of mechanical stimuli in the
somatosensory and auditory/vestibular systems remain undefined. The vast majority of DRG
neurons are mechanosensitive but the sensitivity and pattern of firing varies (Lewin and
Moshourab, 2004), determined by the position of the termini and the complement of voltage
gated ion channels and primary mechanotransducers. DRG neurons respond to mechanical
stimuli, either low threshold, innocuous touch sensation, or high threshold, noxious pressure
sensation. The currents mediated by the mechanosensitive ion channels can be separated by
their decay kinetics, rapidly adapting (RA) currents decline very quickly (<20 ms), slowly
adapting (SA) currents decline in around 100 ms and the third population are intermediately
adapting (IA). SA and IA currents are the major mechanically activated currents in
nociceptors, whereas RA form the majority of the mechanically activated currents in large
mechanosensitive neurons.
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The two types of mechanical stimuli are transduced by distinct populations of neurons which
show different properties. Nociceptors respond to high threshold stimuli and ablation of these
neurons abolishes noxious mechanosensation in vivo without affecting innocuous touch
sensation (Abrahamsen et al., 2008). A subset of TRPV1 negative neurons respond to lower
thresholds but with larger, RA, currents than nociceptors (Drew et al., 2002). The noxious
mechanosensation blocker 1, or NMB-1, also abolishes noxious mechanosensation in vivo by
selectively inhibiting slowly adapting (SA) mechanically active currents (Drew et al., 2007),
suggesting there are also pharmacologically distinct mechanically gated receptors in
mammalian sensory neurons. These data suggests that the RA currents are mainly activated
by light touch and the SA currents by noxious mechanical stimuli.
5.1.2 Mechanotransduction in hair cells
Hearing and balance are dependent on hair cells within the inner ear and vestibule that are
able to detect mechanical stimuli and therefore allow sensitive detection of sound and head
movement. The mechanically sensitive part of the hair cell is its stereociliary bundle,
consisting of 50-100 individual sterocilia. Mechanical stimuli cause a small displacement of
the bundle mediating the opening of mechanically activated channels producing a receptor
potential and subsequent depolaraization of the hair cell. Hearing loss is the most common
form of sensory impairment and is frequently of genetic origin. Only a fraction of the affected
genes have been identified which include cytoskeletal components and transcription factors
but not, as yet, the mechanically activated channel.
Hair cells are arranged along the length of the cochlea and vary in their frequency sensitivity
with highest frequencies found at the base of the cochlea. The kinetics of the mechanically
activated channels also varies with an increase in activation speed and conductance
accompanying higher frequency sensitivity. The mechanically activated channels have high
calcium permeability, linked to their Ca2+ dependent adaptation, and can be blocked by Gd3+,
ruthenium red, and amiloride (Nagata et al., 2005). Mechanically gated ion channels in
various organisms have been identified as TRP channels, additionally the block of
mechanically activated channels in hair cells by Gd3+ and RR make the TRPs obvious
candidates for the hair cell mechanotransducer. Several TRPs have been investigated for
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involvement in hair cell mechanotransduction and subsequently eliminated including TRPV4,
TRPA1 and TRPML3
TRP channels were first implicated in mechanosensation in the ear when a genetic screen in
Drosophila revealed a new ion channel family, “nomp” (Kernan et al., 1994), which were
later shown to have homologues in vertebrates, renamed TRPN, (Sidi et al., 2003) . Zebrafish
TRPN1 mutants showed auditory and vestibular dysfunction but cannot be part of the
transduction channel in all vertebrates as TRPN1 is entirely absent in mammals and birds.
TRPV4 was also identified as a candidate in a genetic screen in C elegans. TRPV4 is
mechanically sensitive (Liedtke et al., 2003) and found in the ear, although mainly in the stria
(Shen et al., 2006) and TRPV4 knockout mice have a late-onset hearing deficit (Tabuchi et
al., 2005). However an osmoregulatory role is more likely due to expression in the stria rather
than hair cells and slow activation that isn’t conducive to transduction. Variant waddler mice
exhibit deafness and circling behaviour along with other deficits such as pigmentation. The
mutant gene was mapped to TRPML3 (Di et al., 2002) and loss of function causes
disorganization of hair cell stereocilia (Cable and Steel, 1998;Di et al., 2002) due to abnormal
organgelle trafficking, likely ruling out TRPML3 as a transduction channel. TRPA1 is
expressed in the sensory epithelium of the mouse utricle and has large numbers of ankyrin
repeats that are attractive as a gating spring, but activators of TRPA1 have no affect on hair
cell transduction and TRPA1 knockout mice have no hearing deficits (Bautista et al.,
2006;Kwan et al., 2006).
TRPC channels have not yet been investigated for hair cell mechanotransduction. As
mentioned previously, TRPC channels are calcium permeable and can be blocked by
gadolinium and ruthenium red and TRPC3 is found in the cochlea, in the hair cells (Tadros et
al., 2010) . TRP channels are known to heteromultimerize, this could produce a number of
mechanically gated channels with different kinetic properties to explain the variation in
mechanically activated channel properties at different locations along the cochlea.
Additionally, the redundancy among the pore-forming subunits in a heteromer could account
for the lack of an ion channel mutation in the human deafness or ENU mice screens.
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Figure 5.1 The ear and cochlea.
(adapted from (Holley, 2000))
a The cochlea. Sound enters the outer ear canal, vibrates the eardrum and is transmitted to the cochlea by
the middle ear bones. b. Inside the cochlea, the organ of Corti sits upon the basilar membrane, which is
covered by the tectorial membrane. Vibration of the basilar membrane leads to lateral displacements of the
mechanosensory bundles on the hair cells (coloured orange). Inner hair cells form a row to one side of two
rows of specialized supporting cells (pillar cells); outer hair cells form three rows on the other side. Inner
hair cells are connected mainly to afferent nerve fibres and so are responsible for sending sensory
information to the brain. Outer hair cells are connected to relatively few afferent fibres and are located
above the most flexible region of the basilar membrane, where they can more easily influence its
mechanical responses. c, The plasma membrane of outer hair cells contains a high density of membrane
proteins embedded within the lipid layer.
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5.1.3 Evidence for a role for TRPC3 and TRPC6 in mechanosensation
When TRPC6 is expressed in HEK293 cells they are able to be activated by mechanically- or
osmotically-induced stretch (Spassova et al., 2006). This stretch-activated current is blocked
by GsMTx-4, a tarantuala toxin known to specifically inhibit mechanosensitive channels, and
is PLC independent (Spassova et al., 2006;Suchyna et al., 2004;Suchyna et al., 2000).
Additionally TRPC6 shares many other biophysical properties of stretch activated channels
including activation by DAG, high divalent cation permeability and blockade by Gd3+
(Setoguchi et al., 1997;Welsh et al., 2000;Inoue et al., 2001).
TRPC3 and TRPC6 are also able to be mechanically activated in vivo. As described earlier
TRPC3 and TRPC6 are highly expressed in vascular smooth muscle where they are
mechanically activated, contributing to the myogenic response. TRPC6 has been implicated
in the mechanosensory complexes found in the kidney as the PHB domain membrane protein
podocin associates with and regulates TRPC6 as part of a complex that also includes Neph1,
Neph2, Nephrin, and CD2AP which may act to sense glomerular pressure (Huber et al.,
2006). All seven TRPC channels are found within the inner ear where they may contribute to
the sensory transduction process (Takumida and Anniko, 2009). The developmental
regulation of TRPC3 coincides with the development of the sensory and neural tissues of the
ear (Phan et al., 2010) .
TRPC3 and TRPC6 are also highly expressed in DRG (Elg et al., 2007) where stretch-
activated channels (SAC) participate in mechanical stimulus detection (McCarter et al.,
1999;Hu and Lewin, 2006). The SAC blocker, GsMTx-4, is able to block inflammatory
induced mechanical hyperalgesia in vivo (Alessandri-Haber et al., 2009). GsMTx-4 blocks
both TRPC1 and TRPC6 but the mechanical hyperalgesia can be attributed to TRPC6 as only
antisense to TRPC6 but not TRPC1-antisense is able to block the hyperalgesia (Alessandri-
Haber et al., 2009). TRPV4 plays a role in mechanical hyperalgesia (Alessandri-Haber et al.,
2006) but does not itself appear to be gated by mechanical stretch (Strotmann et al.,
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2000).TRPV4 is frequently coexpressed with TRPC6 so could be contributing to mechanical
transduction by functional coupling with this SAC.
As well as being expressed in tissues which have physiologically relevant mechanosensitive
functions such as smooth muscle, kidney and the cochlea, TRPC channels also associate with
a number of proteins that have a role in mechanosensation. Caveolae, which are found in
many cell types including endothelial cells, are 50-100nm invaginations that facilitate
interactions between proteins and are involved in endocytosis. Mechanical forces have been
shown to increase translocation of signalling molecules and activation of secondary
messenger pathways specifically at caveolae. TRPC6 in particular translocates to caveolae
where it mediates Ca2+ facilitation (Cayouette et al., 2004).
Both in vitro and in vivo evidence both suggest a role for TRPC3 and TRPC6 as
mechanically sensitive channels but do these channels fit into what is currently known about
the mechanisms of mechanotransduction?
There are two main theories for how mechanically activated channels are opened, namely the
membrane model and the tether model. The membrane model proposes that mechanical force
causes a change in the lipid bilayer inducing exposure and/or conformational change of the
channel resulting in an open state. Chemicals which disrupt the lipid bilayer are able to
activate mechanically sensitive channels supporting this theory. The tether model suggests
that specific proteins are responsible for inducing a conformational change in the channel
allowing it to open. These proteins could be cytoskeletal elements, diffusible messenger
proteins or part of the channel itself. Many putative mechanosensors have elements which
have the right properties to act as a tether, sometimes termed the “gating spring”. These two
mechanisms may however not be mutually exclusive; each could be acting in different tissues
or in response to different mechanical stimuli.
TRPC3 and TRPC6 are both activated by DAG, a small-headed lipid produced from the
breakdown of PIP2 molecules located within the membrane bilayer. The breakdown of PIP2
into a smaller molecule could result in increased membrane stress similar to that produced by
stretch. This mechanism, proposed by Spassova et al, provides a common mechanism of
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action for the stretch activated and receptor operated functions of TRPC3 and TRPC6
(Spassova et al., 2006).
The evidence for the TRPC channels playing a critical role in mechanotransduction does not
necessarily mean that the TRPC channels themselves are the direct sensors of mechanical
stimuli, instead they may be indirectly activated downstream of other molecules. For
example, Gudermann et al showed that membrane stretch activation of TRPC6 in HEK cells
may be due to Gq/11 – coupled receptors acting as mechanosensors, independent of ligand,
and in turn activating TRPC6 (Schnitzler et al., 2008). It appears that many GPCRs are able
to be mechanically activated which are found ubiquitously, yet specialised
mechanotransduction occurs only in certain tissues such as primary afferent neurons and
outer hair cells; if GPCRs are mechanosensors they must undergo some kind of
conformational coupling to infer selectivity.
Translocation of ion channels could confer another mechanism leading to TRP channels’
mechanosensitive properties. Mechanical forces are able to initiate rapid translocation of TRP
channels to the plasma membrane, for example TRPM7, TRPV2 and TRPV4 have been
shown to be translocated to the plasma membrane following mechanical forces applied to
endothelial cells or myocytes (Oancea et al., 2006;Iwata et al., 2003;Loot et al., 2008). A
number of TRPC channels are also translocated to the plasma membrane following
stimulation. TRPC3 interacts with VAMP2, a SNARE protein found in neuronal tissues, to
insert into the plasma membrane in response to carbachol (Singh et al., 2004). TRPC6 is also
inserted into the plasma membrane following GPCR activation (Cayouette et al., 2004).
These translocations could also occur in response to mechanical stimulation as is the case for
other members of the TRP family.
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5.2 Results
5.2.1 Targeting construct design
Flockerzi et al generated the TRPC3-/-:TRPC6-/- global knock out . The intron-exon
organization of the TRPC3 and TRPC6 genes and the expected disruptions caused by the
knockout are shown in Figure 5.2.
Figure 5.2 Generation of TRPC3-/-:TRPC6-/- mouse
A. (Top) Diagram of the intron-exon organisation of the Mus musculus TRPC3 gene. The lengths of the
amplicons, including primers, are depicted. F2 (5’ GAATCCACCTGCTTACAACCATGTG) and R (5’
GGTGGAGGTAACACAGACCTAAGCC), PCR primers, *, stop codon, black triangle denotes loxP site.
(Bottom) Diagram of the expected disruption after excision of exon 7 by the action of Cre recombinase. B. (Top)
Diagram of the intron-exon organisation of the Mus musculus TRPC6 gene. The lengths of the amplicons,
including primers, are depicted. E7F (5’ CAGATCATCTCTGAAGGTCTTTATGC), E7R (5’
TGTGAATGCTTCATTCTGTTTTGCGCC), IFF (5’ ACGAGACTAGTGAGACGTGCTACTTCC) and PgkR
(5’ GGGTTTAATGTCTGTATCACTAAAGCCTCC), PCR primers. (Bottom) Diagram of the TRPC6 gene after
targeted disruption by the PGKNeo cassette. C. Image of the electrophoretic migration in an agarose gel of the
amplicons obtained using the indicated primers
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A floxed TRPC3 mouse, obtained from Birnbaumer as before, was crossed with Cre deleter
as described in (Schwenk et al., 1995). The offspring of homozygous floxed, heterozygous
cre will have a global deletion of TRPC3. A TRPC6 global knockout mouse was generated
using a “knock-in” targeting construct, replacing exon 7 of the TRPC6 gene with a pgk NEOr
cassette to create a non-functional gene. These two mouse lines, TRPC3-null and TRPC6-
null, were crossed to create a double knockout of both TRPC3 and TRPC6 in all tissues.
5.2.2 Breeding strategy
A double knockout was crossed with a C57BL/6 to generate heterozygous null-TRPC3;
heterozygous null-TRPC6 animals. Heterozygotes were then crossed together to create a
number of genotypes, including TRPC3-/-:TRPC6-/-, TRPC3-/-; TRPC6-/- and littermate
wildtype controls.
In order to reduce the number of animals needed a non-littermate control was used where
possible. This was obtained either by crossing a 129 strain with a C57BL/6 to create a strain
with as similar genetic background to the double knockouts as possible or using floxed
TRPC3 mice which also have a mixed 129/C57Bl6 background.
5.2.3 TRPC3-/-:TRPC6-/- mice have normal development and fertility
TRPC3-/-:TRPC6-/- mice developed normally and survived to ages within the normal mortality
range. Litters from the double knockout x double knockout cross were of expected size.
Litters from the heterozygous x heterozygous were also of normal size and weight (Figure
5.3) and the ratios of all genotypes were as expected (1:1:1:1:2:2:2:2:4), illustrated in Table
5.1.
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Observed Expected
TRPC3-/-TRPC6-/- 42 36.625
TRPC3-/-TRPC6-/+ 80 73.25
TRPC3-/+TRPC6-/- 71 73.25
TRPC3-/+TRPC6-/+ 145 146.5
TRPC3-/-TRPC6+/+ 33 36.625
TRPC3+/+TRPC6-/- 38 36.625
TRPC3+/+TRPC6-/+ 74 73.25
TRPC3-/+TRPC6+/+ 71 73.25
TRPC3+/+TRPC6+/+ 32 36.625
Chi squared value 2.567
p = 0.9586 Not statistically significant
Table 5.1 Observed genotypes from double heterozygote x double heterozygote cross
(‘+’ indicates wildtype allele, ‘-‘ indicates knockout allele)
Figure 5.3 Litter sizes and weights of TRPC3-/-:TRPC6-/- mice.
a. Average litter size from 25 C57Bl/6 breeding pairs compare with 25 litters from TRPC3-/+TRPC6-/+
breeding pairs. b. Average weight of 8 week old mice (6 mice in each group). All results expressed as
mean ±SEM.
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5.2.4 TRPC3-/-:TRPC6-/- mice show no deficits in locomotion
Motor coordination was judged using an accelerating rotarod. There was no difference in the
motor ability of the TRPC3-/-:TRPC6-/- mice compared with control animals or TRPC3-/- or
TRPC6-/- animals (Figure 5.4).
Figure 5.4 Motor coordination of TRPC3-/-:TRPC6-/-, TRPC3-/-, TRPC6-/- and wildtype control
animals.
There was no difference in motor coordination between wildtype control (orange, n=6) and TRPC3-/-
:TRPC6-/- (blue, n=5), TRPC6-/- (purple, n=5) and TRPC3-/- (red, n = 6) animals. All results expressed as
mean ±SEM.
113
5.2.5 TRPC3-/-:TRPC6-/- mice do not show behavioural deficits in noxious
mechanosensation
Behavioural responses to noxious mechanical stimuli were measured using the Randall
Selitto test. There was no difference in behavioural responses to noxious blunt stimulation of
the tail between TRPC3-/-:TRPC6-/- and control animals (Figure 5.5). Results expressed as
mean threshold±SEM are as follows, TRPC3-/-:TRPC6-/-, 143.1±3.2g, TRPC3-/-, 147±11,
TRPC6-/-, 136±6, control mice 140±9g.
Figure 5.5 Acute mechanical pain behaviour in TRPC3-/-:TRPC6-/- , TRPC3-/-, TRPC6-/- and
wildtype control animals.
Response to blunt mechanical stimulation of the tail in the Randal Selitto test was not significantly
different between wildtype control animals (orange, n=4) and TRPC3-/-:TRPC6-/- animals (blue, n=9),
TRPC6-/- (purple, n=7) and TRPC3-/- (red, n = 6) animals. All results expressed as mean±SEM.
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5.2.6 TRPC3-/-:TRPC6-/- mice have a behavioural deficit in light touch
sensation.
Behavioural responses to light touch were assessed using von Frey hairs and the up-down
method. TRPC3-/-:TRPC6-/- mice had an increased mechanical threshold (0.6±0.04g)
compared to wildtype controls (0.3±0.03g) which was statistically significant (one-way
ANOVA with post-hoc Bonferroni test, p = 0.01). TRPC3-/- and TRPC6-/- mice did not have
increased mechanical thresholds, 0.04±0.03g and 0.38±0.03g respectively.
Figure 5.6 Light touch sensation in TRPC3-/-:TRPC6-/- and littermate control animals assessed using
von Frey hairs.
Response to mechanical stimulation with von Frey hairs was significantly different between littermate control
(orange, n=5) and TRPC3-/-:TRPC6-/- (blue, n=6) animals (p = 0.01). TRPC6-/- (purple, n=12) and TRPC3-/-
(red, n=6) animals were not significantly different from control animals. All results expressed as mean±SEM.
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5.2.7 TRPC3-/-:TRPC6-/- mice do not show behavioural deficits in noxious
thermosensation
Behavioural responses to noxious thermal stimuli were measured using the Hargreaves’
apparatus and the hot plate test. Paw withdrawal latency in Hargreaves’ test was not altered in
the TRPC3-/-:TRPC6-/-, TRPC6-/- not TRPC3-/- animals compared with littermate control
animals (Figure 5.7a). Results expressed as mean latency±SEM are as follows, TRPC3-/-
:TRPC6-/- mice 8.5±0.8 seconds, TRPC6-/- mice 8±1.2 seconds, TRPC3-/- mice 6.5±0.5
seconds and control mice 9.5±2.8 seconds. There was also no difference in latency of
behavioural responses on the hot plate at 45⁰C, 50⁰C or 55⁰C. TRPC3-/-:TRPC6-/- responding
on average 133±23 seconds compared to 120±30 seconds for floxed TRPC3 controls at 45⁰C,
32±4 seconds compared to 34±6 seconds at 50⁰C and 16±1 seconds compared to 13±1
seconds at 55⁰C (Figure 5.7b).
Figure 5.7 Acute thermal pain behaviour in TRPC3-/-:TRPC6-/- and control animals
a. Noxious thermal stimulation using Hargreaves’ apparatus. No significant difference was observed
between littermate control (orange, n=3) and TRPC3-/-:TRPC6-/- (blue, n=3), TRPC6-/- (purple, n=4), nor
TRPC3-/-- (red, n=4) animals. b. Response to noxious thermal stimulation using the hot plate test was not
significantly different between TRPC3fl/fl control (orange, n=7) and TRPC3-/-:TRPC6-/- (blue, n=8)
animals at 45ºC, 50ºC or 55ºC. All results shown as mean ±SEM.
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5.2.8 TRPC3-/-:TRPC6-/- mice show no deficits in response to noxious
cold
Behavioural responses to noxious cold were assessed using the cold plate set to 0ºC for 5
minutes. There was no significant difference in the behavioural responses in the TRPC3-/-
:TRPC6-/- mice, 13.9±1 behaviours, compared to control TRPC3fl/fl animals, 13±2.3
behaviours, (Figure 5.8).
Figure 5.8 Acute cold pain behaviour in TRPC3-/-:TRPC6-/- and control (TRPC3fl/fl) animals.
Noxious cold stimulation using cold plate at 0ºC. No significant difference seen between TRPC3fl/fl control
(orange, n=5) and TRPC3-/-:TRPC6-/- (blue, n=8) animals. All results expressed as mean±SEM.
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5.2.9 TRPC3-/-:TRPC6-/- mice display reduced inflammatory pain
behaviour
5.2.9.1 Formalin Test
Behavioural responses from 4 TRPC3-/-:TRPC6-/- mice and 4 control mice in the two distinct
phases were recorded. In the first phase, 0-10 minutes, the TRPC3-/-:TRPC6-/- mice displayed
127±13.3 seconds of pain behaviour compared with 128.5±11 seconds for the control mice.
There was no significant difference between the two groups.
In contrast the TRPC3-/-:TRPC6-/- mice showed attenuated pain behaviours in the second
phase, from 10-60 minutes, displaying just 194±22 seconds compared with 564±77 seconds
for the control mice. This was shown to be statistically significant using an unpaired 2-tailed
t-test, p = 0.0035, (Figure 5.9a).
Figure 5.9b shows the time course of the formalin response and demonstrates that the
TRPC3-/-:TRPC6-/- mice displayed reduced pain behaviours at each 5 minute interval within
the second, inflammatory, phase with significant differences found at the time points between
15-35 minutes using a 2-way ANOVA with Bonferroni post test.
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Figure 5.9 Formalin-induced inflammatory pain behaviour in TRPC3-/-:TRPC6-/- and control
(129sv/Bl/6) animals.
Behaviour following injection of 20µl of 5% formalin. a. Time spent licking/flinching/biting the hind paw
was recorded in 5 minute sections. No significant reduction in pain behaviours was seen in Phase I (0-10
minutes) however in Phase II (10-60 minutes) TRPC3-/-:TRPC6-/- mice (blue, n=4) have significantly
attenuated pain behaviours compared to littermate controls (orange, n=4) (p = 0.0035, unpaired t-test). b.
Time course of the formalin test. A traditional biphasic response was observed with the attenuated pain
behaviour of TRPC3-/-:TRPC6-/- mice apparent in the second phase (2-way ANOVA). All results expressed
as mean±SEM.
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5.2.9.2 Carrageenan induced mechanical hyperalgesia
Mechanical responses were recorded from mice injected with carrageenan compared to
baseline recordings made prior to the injections. The control mice developed a clear
mechanical hyperalgesia, the 50% threshold dropping from 0.5±0.03g to 0.1±0.03g at 3 hours
after carrageenan injection. The TRPC3-/-:TRPC6-/- mice had a significantly higher baseline
mechanical threshold, and developed a less severe mechanical hyperalgesia with the
threshold dropping from 0.7±0.04g to 0.4±0.08 g, p < 0.01, (Figure 5.10).
Figure 5.10 Carrageenan induced mechanical hyperalgesia in TRPC3-/-:TRPC6-/- and control
(TRPC3fl/fl) animals.
Behaviour following injection of 20µl of 2% carrageenan. The 50% mechanical threshold was recorded
using von Frey hairs on two days prior to injection and three hours post injection. TRPC3-/-:TRPC6-/-
mice (blue, n = 4) have significantly attenuated mechanical hyperalgesia compared to floxed TRPC3
controls (orange, n = 3). All results expressed as mean±SEM.
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5.2.9.3 Complete Freunds’ Adjuvant induced hyperalgesia
Mechanical (von Frey) and thermal (Hargreaves’) thresholds were measured from 6 TRPC3-/-
:TRPC6-/- mice and 6 control mice following induction of inflammation by administration of
20µl of CFA and compared to baseline measurements. The same mice were used for both
mechanical and thermal measurements on days 1, 3, 5, 7 and 10 post injections. Both control
and TRPC3-/-:TRPC6-/- mice developed mechanical hyperalgesia from day 1 post injection of
CFA, on day 3 the TRPC3-/-:TRPC6-/- mice had significantly attenuated mechanical
hyperalgesia, p < 0.05, 2-way ANOVA (Figure 5.11a). Thermal hyperalgesia developed in
both the TRPC3-/-:TRPC6-/- mice and the control mice with no significant difference at any
timepoint (Figure 5.11b).
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Figure 5.11 Complete Freunds' Adjuvant induced hyperalgesia in TRPC3-/-:TRPC6-/- and control
(TRPC3fl/fl) animals.
Mechanical and thermal thresholds following injection of 20µl CFA. a. The 50% mechanical threshold
was recorded using von Frey hairs prior to injection and on days 1, 3, 7 and 10 following injection. b.
Paw withdrawal latency to a radiant heat source (Hargreaves’) was measured prior to injection and on
days 1, 3, 7 and 10 following injection. No significant difference was seen between TRPC3-/-:TRPC6-/-
(blue, n=6) and control TRPC3fl/fl animals (orange, n=6). All results expressed as mean±SEM.
*
*
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5.2.10 TRPC3-/-:TRPC6-/- mice do not have any deficits in
neuropathic mechanical allodynia
To test the effect of TRPC3 and TRPC6 knockout on neuropathic pain 5 TRPC3-/-:TRPC6-/-
and 5 wildtype mice underwent spinal nerve ligation. Thresholds to von Frey filaments were
recorded before and after surgery. Both TRPC3-/-:TRPC6-/- and wildtype controls developed
mechanical allodynia to the same extent.
Figure 5.12 Mechanical allodynia following spinal nerve ligation in TRPC3-/-:TRPC6-/- and control
(TRPC3fl/fl) animals
Mechanical thresholds before and after SNL surgery. No significant difference was seen between TRPC3-/-
:TRPC6-/- (blue, n = 5) and control (orange, n = 5) animals. All results expressed as mean±SEM.
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5.2.11 TRPC3-/-:TRPC6-/- mice show behavioural signs of vestibular
and auditory dysfunction
A number of tests were used to measure vestibular function, which enables a mouse to
balance and control head movements. The TRPC3-/-:TRPC6-/- mice are able to right
themselves in the air and are also able to swim (Figure 5.15). The TRPC3-/-:TRPC6-/- mice
were slow to begin swimming and alternated between left and right sides, appearing to have
trouble staying afloat, these behaviours were not seen in wildtype animals. The typical
swimming positions of the wildtype and TRPC3-/-:TRPC6-/- animals are shown in (Figure
5.13). However, the scores of the swim test (as described in the methods) were not different
between the TRPC3-/-:TRPC6-/- and the wildtype mice (Figure 5.15).
The TRPC3-/-:TRPC6-/- mice showed an abnormal reaching response in the trunk curl test.
When held 5cm away from a surface the TRPC3-/-:TRPC6-/- curled upwards instead of
reaching forward and down with both forelimbs like the wildtype mice (Figure 5.14 and
Figure 5.15). The TRPC3-/- and TRPC6-/- mice appeared to show a slight trunk curl but this
was not significant (Figure 5.15).
Figure 5.13 : Swimming positions of TRPC3-/-:TRPC6-/- and control mice.
a. A wildtype mouse swimming with an elongated body, using the tail to propel and steer through the water.
b. TRPC3-/-:TRPC6-/- mice are unbalanced and swim irregularly. (Also see video for more information)
a. b.
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The auditory function was tested using a clickbox, the wildtype, TRPC3-/- and TRPC6-/- mice
all displayed a strong Preyer reflex in response to the 20kHz toneburst but the TRPC3-/-
:TRPC6-/- mice did not (Figure 5.15).
Figure 5.14 Reaching responses of wildtype and TRPC3-/-:TRPC6-/- mice
Wildtype mice reach forwards and down when held 5cm away from a surface (a) whereas TRPC3-/-
:TRPC6-/- mice curl upwards towards their tail (b). (example pictures adapted from (Hardisty-Hughes et
al., 2010)
a. b.
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Figure 5.15 Vestibular and auditory testing in TRPC3-/-:TRPC6-/- mice and littermate controls.
a. TRPC3/TRPC6 null mice do not exhibit a Preyer reflex in response to a 20kHz toneburst at 90dSB (Mann-
Whitney test, p <0.0001) . b. TRPC3/TRPC6 null mice show an abnormal reaching response compared to
wildtype littermate controls, TRPC3-/- and TRPC6-/- animals (Mann-Whitney test, p<0.05) c. and d. TRPC3-/-
:TRPC6-/- mice, TRPC3-/- and TRPC6-/- mice are able to swim and have a normal air righting response. All
results expressed as mean ± SEM. TRPC3-/-:TRPC6-/- ; blue, n = 6, TRPC3-/-; red, n = 6, TRPC6-/- ;purple, n
= 10, wildtype; orange, n = 7.
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5.3 Discussion
5.3.1 TRPC3-/-:TRPC6-/- mice develop normally
Before any experiments were performed the fitness of the TRPC3-/-:TRPC6-/- mice strains
were assessed. The size of litters produced with a TRPC3-/-:TRPC6-/- x TRPC3-/-:TRPC6-/-
cross was within expected range and the ratio of male/female progeny was close to 1:1. When
heterozygotes, TRPC3+/-:TRPC6+/- were crossed together the litters were also of an expected
size and with the correct mendelian ratios. There were no differences in weight gain, motor
function, fertility or general behaviour between the various genotypes produced from any of
the breeding crosses.
A gain-of-function mutation in TRPC3 has been attributed to the motor deficit in
moonwalker mice (Becker et al., 2009) and a motor coordination defect was also noted in the
global TRPC3-/- mice (Hartmann et al., 2008). Despite these previous results we found no
deficits in motor ability using the accelerating rotarod test. The primary reason for
performing the rotarod test is to ensure the mice do not have motor defects which would
prevent the withdrawal responses for the pain threshold tests. It was observed that the double
knockout mice had an unusual technique on the rotarod that was different to wildtype mice.
We have not performed more elaborate motor ability tests such as an irregularly spaced
ladder or gait analysis, if we were to do so it is likely that the double knockouts would have a
similar phenotype to that of the TRPC3-/- mice.
5.3.2 TRPC3-/-:TRPC6-/- mice have vestibular and auditory dysfunction
The vestibular apparatus provides information about the location and movement of the head
and body which, along with the visual, proprioceptive and somatosensory systems, enables an
upright position to be maintained. Rodents rely much less on vision than humans so as a
result a vestibular defect can cause severe phenotypes due to inadequate compensation from
the proprioceptive and somatosensory systems. The swim test removes proprioceptive input
from gravity acting on the mouse and also lack of contact with the floor removes
somatosensory input which highlights vestibulopathy. The TRPC3-/-:TRPC6-/- mice displayed
irregular swimming which indicates an element of vestibular dysfunction. The reaching
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response exploits a mouse’s instinct to reach for the ground, a stable, solid surface. In the air,
without the somatosensory inputs, the mouse relies on the vestibular system to determine
which way is up and its relative position. Wildtype mice extended both paws towards the
ground whereas TRPC3-/-:TRPC6-/- mice curled up and twisted their bodies aimlessly.
TRPC3 has been implicated in motor coordination which could be contributing to the
swimming phenotype, however the TRPC3-/-:TRPC6-/- mice moved all four limbs whilst
swimming which indicates this is unlikely.
TRPC3-/-:TRPC6-/- mice have a severe hearing deficit at the high frequency range. The mice
do not exhibit a Preyer reflex in response to a click box, and have an increased threshold to
tones above 32kHz in ABR. The outer hair cells (OHCs) along the corti membrane
responsible for transducing sounds contain mechanosensors. There was no loss of OHCs in
the TRPC3-/-:TRPC6-/- mice to explain the deafness, suggesting the transduction mechanism
has been affected rather than any problems during development. The frequencies transmitted
by the hair cells form a gradient with the lowest frequencies at the apex and highest
frequencies at the basal of the cochlea. Single-cell recordings from apical and basal hair cells
have different conductances (Marcotti et al., 1999) suggesting differences between the
mechanically gated channels. Our work supports this theory as the loss of TRPC3 and
TRPC6 renders the basal hair cells unable to sense mechanical stimulation, however the
apical hair cells function normally.
5.3.3 TRPC3 and TRPC6 are part of the mechanosensory complex
Mechanosensation was tested using two different methods, von Frey hairs and Randall
Selitto, The TRPC3-/-, TRPC6-/- or the TRPC3-/-:TRPC6-/- mice had no deficit in the sensation
of noxious mechanical pressure as tested using Randall Selitto. However, the TRPC3-/-
:TRPC6-/- mice had an increased threshold to innocuous touch tested using von Frey hairs;
the TRPC3-/- and TRPC6-/- mice had normal innocuous touch thresholds.
Sensory neurons can be distinguished by their responses to mechanical pressure, either
classed as high-threshold, low-threshold or non-responsive. The ion channel composition of
these different sub populations of neurons differs, suggesting there are distinct high-threshold
and low-threshold mechanoreceptors. We know that the high threshold mechanoreceptor is
128
predominantly expressed in the small diameter, Nav1.8+ve neurons as the DTA-CRE mouse
had no noxious mechanical pain. The low-threshold mechanoreceptor remains more of a
mystery. A range of sensory neurons respond to innocuous touch, including Aβ-fibres and a 
proportion of small diameter Nav1.8-ve neurons. TRPC3 and TRPC6 are predominantly
expressed in small diameter neurons, where they could be responsible for a proportion of
innocuous touch sensation. As the touch deficit observed in the double knockouts is not
complete, sensory neurons where TRPC3 and TRPC6 are not highly expressed, such as Aβ-
fibres, may contain different mechanosensitive channels.
The total number and proportion of each subpopulation of sensory neuron in the DRG of the
TRPC3/TRPC6 null mice did not differ from the wildtype animals showing that
developmental or neuronal survival cannot explain the decreased sensitivity to touch (Figure
10.4). We looked at the mechanosensitive properties of cultured DRG neurons from the
TRPC3-/-:TRPC6-/- mice compared to TRPC3-/- , TRPC6-/- and wildtype mice (Figure 10.3).
The large neurons had no differences in amplitude or threshold of the mechanically sensitive
current. As discussed previously, TRPC3 and TRPC6 are not largely expressed in these large
neurons so it is unsurprising that the knockout had no effect. However, the mechanically
sensitive currents in the small neurons of the TRPC3-/-:TRPC6-/- mice show differences which
correspond with the behavioural data. The DRG neurons from TRPC3-/-:TRPC6-/- mice had a
larger proportion of non-responders, a 15% increase, and a comparable decrease of RA
currents compared to TRPC3-/-, TRPC6-/- and wildtype DRGs. The total number of
mechanically sensitive neurons was the same for TRPC3-/-, TRPC6-/- and wildtype DRGs but
TRPC3-/- mice showed some change in kinetics. A decrease in the RA currents in TRPC3-/-
appeared to have been compensated by an increase in IA currents.
The motor response to move the hind paw in reaction to the sensing of the von Frey hair is a
spinal reflex. The decrease of neurons able to be activated by mechanical stimulation would
decrease the input into the spinal cord so a larger mechanical stimulus is required to sense the
von Frey hair and elicit a motor reflex response. There is no difference in touch threshold for
the TRPC3-/- mice, therefore the compensation from IA mechanically activated currents
appears sufficient to retain the normal amount of touch sensitivity.
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Heteromultimerization has been shown not only in members of the same TRP subfamily but
also between subfamily groups; for example TRPP2 has been shown to form multimers with
TRPC1 or TRPV4 (Kottgen et al., 2008;Kobori et al., 2009). The large number of subunits
that could participate in a TRP heterotetramer provides countless permutations of cation
channels. The differing biophysical properties of these heterotetramers would confer a range
of mechanically sensitive channels with different thresholds of activation. It would be
expected that some element of redundancy and overlap may occur in this system to preserve
the evolutionary important mechanical sensitivity that is vital for touch, hearing, kidney
function and vasculature.
These results provide evidence that TRPC3 and TRPC6 play a role in mechanotransduction,
but does not prove they are directly gated by mechanical stimuli. TRPC3 and TRPC6 could
be activated indirectly via coupling to mechanosensitive GPCRs which release DAG, similar
to how the angiotensin receptor activates TRPC6 in myocytes (Saleh et al., 2006).
5.3.4 Thermal sensation is not dependent on TRPC3 or TRPC6
Thermosensation was tested using the Hargreaves’ and hot plate apparatus (see page 115).
TRPC3 conditional-null animals showed no deficit in heat sensation and neither TRPC3 nor
TRPC6 have been shown to be thermosensitive in vitro hence this result was expected.
Noxious cold sensation was tested using the cold plate as above. We did not expect to see any
difference in cold sensation as neither TRPC3 conditional null animals showed any deficit
and TRPC6 has also not been suggested to be cold sensitive either in vivo or in vitro.
The presence of normal nociceptive behaviour in response to heat and cold pain indicates the
sensory pathways are intact, for thermosensation at least; this also proves TRPC3-/-:TRPC6-/-
animals have unimpaired motor reflex activity.
5.3.5 TRPC3 and TRPC6 are not involved in neuropathic pain
The mechanisms of neuropathic pain are not fully understood. It is known that the small
Nav1.8 expressing neurons are not required (Abrahamsen et al., 2008), this suggests that Aβ-
fibres are important in neuropathic pain. TRPC3 and TRPC6 are mainly expressed in the
small neurons, shown by immunohistochemistry (Elg et al., 2007), and microarray analysis of
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the DTA-Nav1.8 Cre mouse (Abrahamsen et al., 2008). No differences in mechanical
allodynia after nerve injury were found in the TRPC3-/-:TRPC6-/- mice compared with control
mice suggesting TRPC3 or TRPC6 are not involved. Electrophysiology of cultured DRG
neurons from TRPC3-/-:TRPC6-/- mice show that there is no effect on the large neurons which
are important for mechanical allodynia (Figure 10.4d).
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Test Modality TRPC3-/-:TRPC6-/- TRPC3-/- TRPC6-/-
Von Frey
hairs
Light touch
Attenuated No phenotype No phenotype
Randall
Selitto
Noxious pressure
No phenotype No phenotype No phenotype
Hot plate Noxious thermal No phenotype No phenotype No phenotype
Hargreaves Noxous thermal No phenotype No phenotype No phenotype
Cold plate Noxious cold No phenotype No phenotype No phenotype
Formain Spontaneous acute
pain behaviours
No phenotype N/A N/A
Spontaneous
inflammatory pain
behaviours
Attenuated N/A N/A
Carrageenan Mechanical
hyperalgesia
(inflammation)
Attenuated N/A N/A
CFA Thermal
(inflammation)
No phenotype N/A N/A
Mechanical
(inflammation)
No phenotype N/A N/A
Trunk Curl Vestibular function Attenuated No phenotype No phenotype
Swim test Vestibular function No phenotype No phenotype No phenotype
Click box Hearing function Abolished No phenotype No phenotype
Air righting Vestibular function No phenotype No phenotype No phenotype
SNL Neuropathic pain No phenotype N/A N/A
Table 5.2 Summary of phenotypes of TRPC3-/-:TRPC6-/-, TRPC3-/- and TRPC6-/- mice
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6 Generation of TRPC4 targeting construct
6.1 Introduction
6.1.1 The TRPC4/5 subfamily
TRPC4 and TRPC5 share 65% sequence homology and are also closely related to TRPC1,
and are therefore often placed in the same sub group (Ramsey et al., 2006). TRPC4 and
TRPC5 form ion channels that are mainly permeable to Ca2+ (Philipp et al., 1996;Philipp et
al., 1998). Calcium signalling has been described in a variety of cells and has been attributed
to basic and specific cell functions such as cell growth, differentiation and transmitter release.
TRPC4 is expressed throughout the CNS and is also found in a number of peripheral tissues
including bone (Riccio et al., 2002b). TRPC4 and TRPC5 have overlapping distribution
within the CNS and are able to form heteromeric channels (Strubing et al., 2003). TRPC1 is
also able to form heteromeric channels with TRPC5 (Strubing et al., 2001) although this
interaction has not been shown for TRPC4.
The activation mechanism for the TRPC4/5 family remains controversial. The first
characterization of TRPC4 channels reported that bovine TRPC4 can act as a store operated
channel (SOC) when expressed in HEK cells, demonstrated by thapsigargin mediated store
depletion (Philipp et al., 1996) . A similar methodology was used to characterize mTRPC5 as
a SOC (Philipp et al., 1998). Adding to the evidence for TRPC4 and 5 as SOCs is the
discovery that STIM1 is a sensor of intracellular calcium stores and interacts with a number
of TRPC channels (Worley et al., 2007). Although these studies suggest TRPC4 is vital for
store operated calcium entry, in cell lines at least, it is not known whether TRPC4 is a
channel forming subunit in this complex or an essential constituent. However, both TRPC4
and TRPC5 have also been proposed to be receptor activated channels activated through a
PLC dependent mechanism (Schaefer et al., 2000). The exact mechanism of this activation is
not known, but unlike the TRPC3/6/7 family, neither TRPC4 or 5 can be activated by DAG
(Schaefer et al., 2000).
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There are no specific blockers for the TRPC channels, which makes characterization difficult.
Attempts to clarify activation mechanisms have used genetic manipulation of TRPC genes.
TRPC4-/- mice have almost completely attenuated store-operated calcium currents in
endothelial cells (Freichel et al., 2001) , and in addition, antisense knockdown of TRPC4
reduces store operated currents in adrenal cells (Philipp et al., 2000).
6.1.2 TRPC4 in sensory neurons
TRPC4 is important for endothelial permeability, which studies in TRPC4 knockout mice
have shown, requires TRPC4 dependent intracellular Ca2+ signalling (Tiruppathi et al., 2002),
but its function in other tissues is not known. TRPC4 is found in peripheral afferent fibres,
both peripherin positive and peripherin negative, indicating that TRPC4 is found within
nociceptors and non-nociceptors within the DRG (Buniel et al., 2003).
In neuronal cells both TRPC4 and TRPC5 appear to have a role in growth. A recent report
showed TRPC4 mRNA and protein was significantly increased following nerve injury and is
present in neurite growth cones (Wu et al., 2007) . Inhibiting TRPC4 with shRNA prevents
neurite outgrowth, which can be reversed by over-expressing hTRPC4 (Wu et al., 2007). As
TRPC4 and TRPC5 are closely related and able to form heteromeric channels, the function of
TRPC5 may also give insight into the function of TRPC4. Greka et al. showed that TRPC5
generates instructive intracellular Ca2+ signals in growth cones which control neurite length
and growth cone morphology (Greka et al., 2003). TRPC5 is also upregulated in growth
cones that are under the control of BDNF, with a rapid increase of membrane insertion
(Bezzerides et al., 2004).
Many other TRP channels have sensory functions, and TRPC channels are implicated in a
number of sensory functions including chemosensing in the carotid body (Buniel et al., 2003)
and blood pressure regulation (Sharif-Naeini, 2008). TRPC4 is expressed in sensory neurons,
including small diameter nociceptors, where it possibly plays a role in nociception. As there
are no specific blockers or activators of TRPC4, a conditional knock-out mouse is the ideal
way to investigate the properties of TRPC4 in sensory neurons.
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6.1.3 Strategy for generation of conditional TRPC4 knock-out mice
A TRPC4-/- mouse was produced by Friechel et al in 2001 in order to investigate the role of
TRPC4 in the endothelium (Freichel et al., 2001). The TRPC4-/- mice were found to be
essential for store-operated and agonist-activated Ca2+ entry in endothelial cells (Freichel et
al., 2001;Tiruppathi et al., 2002). Additionally, in TRPC4-/- mice the 5-HT-induced increase
in GABA release from thalamic interneurons is largely reduced (Munsch et al., 2003).
TRPC4 could therefore be contributing to the state-dependent processing of visual
information in the thalamic network. The role of TRPC4 within sensory neurons has not been
investigated, and since TRPC4 is expressed in a variety of tissues within the central nervous
system including the olfactory bulb, septal nuclei, hippocampus, cortex and cerebellum, then
the global knockout could have a number of central nervous system defects that would
complicate any conclusions from in vivo behavioural tests. For this reason we chose to
generate a floxed TRPC4 mouse which could then be crossed with a number of neuronal Cre
lines for further analysis to enable tissue specific gene deletion. Use of the Cre/loxP system
also minimises the potential problems that global deletion poses such as reduced fitness.
We chose to flank exon 4 with loxP sites as this will produce a frameshift upon deletion and
lead to a truncated protein. The targeting construct was designed to contain positive and
negative selection markers and two arms of homology, each approximately 5kbp in length.
The targeting construct was obtained by polymerase chain reaction, or PCR, of BAC clones
from a 129sv database and genomic DNA. The strategy of subcloning steps is shown in full
in Figure 6.1.
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Figure 6.1 Subcloning strategy for generation of targeting construct for TRPC4 gene.
a. The 5’arm and exon 4 will be obtained using PCR and ligated into vectors and
sequenced before insertion into a pre-existing construct (pNell1) containing the loxP sites
and a cassette conferring neomycin resistance. b. The 3’ arm will also be obtained using
PCR and sequenced before insertion into a vector (pTK) containing the thymidine kinase
gene. c. Finally the 5’-loxP-E4-loxP-neoR fragment will be inserted into the TK vector to
obtain the final 17.kb construct (d). Red triangles denote loxP sites in same orientation
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6.2 Results
6.2.1 PCR amplification of homologous fragments
The homologous portions of the construct were obtained by PCR of the appropriate BAC
clones or genomic DNA. The 3’ arm was obtained from BMQ 429J2 using the extended long
template kit. The PCR primers used were:
XhoI 11165 GTTCTCGAGGTTAACTTCAAAACTGAGAGGAGTC
SacII 16056AS TAACCGCGGCTGAGTAGAGTGTCTGGAA
The 4.9kb PCR product was visualised with ethidium bromide on an agarose gel and purified
using the QIAgen gel extraction kit.
Exon 4 was obtained from genomic 129 strain DNA using the high fidelity PCR kit. The PCR
primers used were:
TrpC4-H/K9357 AGCAAGCTTGGTACCGGGCATTTTCTAAATTGCTAATTTAG
TC4-BglII-11165AS CCCAAGCAGATCTCCTGAGATTAGG
The 1.8kb PCR product was visualized with ethidium bromide on an agarose gel and purified
using the QIAgen gel extraction kit.
The 5’ arm was obtained from genomic 129 strain DNA using the high fidelity PCR kit. The
PCR primers used were:
TC4-NotI-4338 ATCGCGGCCGCCATCATGTGCTGTCA
TC4-SpeI-9360AS CCCACTAGTGCCCAACAGACATTCCCA
The 5.0kb PCR product was visualized with ethidium bromide on an agarose gel and purified
using the QIAgen gel extraction kit.
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All of the PCR fragments were transformed into empty vectors to allow amplification of the
product and sequencing to ensure the sequence was correct. The vectors used were floxed,
pNell1 and pTK.
6.2.2 Ligation into vectors containing positive and negative selection
markers
The vector containing exon 4 flanked with loxp sites (flE4) and the vector containing the
positive selection marker, neo resistance, (pNellI) were digested with BglII and HindIII . The
restriction digest products were run on an agarose gel and the appropriate fragments excised
and purified as before. The pNell1 vector was treated with SAP before ligation with flE4 and
transformation into TSS cells. DNA was extracted from the colonies using the QIAgen
miniprep kit and double digested with HindIII and BglII to confirm correct insertion of E4
(Figure 6.2).
The vector containing the 5’arm and pNell1-E4 were digested with NotI and SpeI and the
appropriate fragments excised and purified as before. pNell1 was treated with SAP before
ligation with the 5’ arm and transformation into TSS cells. DNA was extracted from the
colonies as before and singly digested with BamHI and HindIII to confirm correct insertion
of the 5’ arm (Figure 6.3).
Figure 6.2 Restriction enzyme analysis of E4-pNel1 ligation
Double digestion with HindIII and BglII confirms correct
insertion of exon 4 into pNel1 vector. 1.8kb band is floxed exon
4, 6.2kb band is pNel1. Digestion of the empty vector would
give just one band at approximately 6.2kb.
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The purified 3’ arm fragment and the vector containing the negative selection cassette,
thymidine kinase, (pTK) were double digested with XhoI and SacII and the appropriate
fragments excised and purified as before. pTK was treated with SAP before ligation with the
3’ arm and transformation into TOP10 cells. DNA was extracted from the colonies as before
and double digested with BamHI and XhoI to confirm correct insertion of the 3’ arm (Figure
6.4).
The 3’-pTK construct and the 5’-E4-pNel1 construct were both double digested with XhoI
and NotI and the appropriate fragments excised and purified as before. The 3’-pTK construct
was treated with SAP before ligation with 5’-E4-neo construct and transformation into
TOP10 cells. DNA was extracted from the colonies as before digestion with a number of
restriction enzymes confirmed correct insertion of the 5’-E4-neo construct (Figure 6.5)
Figure 6.4 Restriction enzyme analysis of 3'-pTK ligation
Double digestion with BamHI and XhoI confirms correct insertion of 3’ arm into pTK
vector.
Figure 6.3 Restriction enzyme analysis of 5'-E4-pNel1- ligation
Digestion with BamHI or HindIII confirms correct insertion of 5’ arm into E4-pNel1
construct.
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6.2.3 Confirmation of correct sequence
Sequencing primers were designed approximately every 500bp and sequenced using the
BigDye kit at either the UCL sequencing facility or WIBR sequencing service. The sequences
were compared to genomic 129 strain sequence of TRPC4 obtained from the Ensembl
database using BLAST2seq (NCBI).
6.2.4 Embryonic stem cell transfection
The final construct was linearized with NotI and electroporated into 129 derived embryonic
stem cells, ES cells, by Monica Mendelsohn at Columbia University, NYC. ES cells were
selected for neomycin resistance and gangcylovir insensitivity and DNA extracted for
Southern hybridization screening.
Figure 6.5 Restriction enzyme analysis of the final construct, 5'-E4-neo-3'-TK.
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6.2.5 Screening for positive ES cells using Southern hybridization
ES cell DNA was screened for targeted insertion of the flTRPC4 construct by Southern
hybridization. 168 samples were singly digested with KpNI or BSTXI and run on a 0.8%
agarose gel. The digested DNA was transferred to a nitrous cellulose membrane and
hybridised to an external probe specific to either the 3’ or 5’ region which had been
radiolabelled with p32αATP. The strategy for the Southern hybridization screening is 
outlined in Figure 6.6.
Figure 6.6 Strategy for Southern hybridization screening.
Location of probe binding and restriction enzyme sites in the targeted and wildtype TRPC4 gene.
a. Targeted insertion produces a 7.9kb band with KpnI digestion and 5’ probe, and two bands at 9.2kb and
5kb with BstXI digestion and 3’ probe. b. The wildytpe gene produces a 10.7kb band with KpnI digestion
and 5’ probe, and two bands at 7.6kb and 5kb with BstXI digestion and 3’ probe
141
The screen for the 5’ end of the targeting construct found one ES cell positive for correct
insertion. This sample shows two bands, one at 10.7kb and one at 7.9kb (Figure 6.7)
indicating one copy of the wildtype TRPC4 gene and one copy of the flTRPC4 targeted gene.
The screen for the 3’ end of the targeting construct found no ES cells positive for correct
insertion. All of the samples showed two bands at 7.6kb and 5kb indicating copies of the
wildtype TRPC4 gene only (Figure 6.8).
The membranes were stripped and hybridized with an internal probe specific for the neo
resistance cassette. All of the samples showed a positive band for neo but the size of the
fragment was extremely variable (Figure 6.9).
None of the 168 clones were positive for the targeted insertion of the flTRPC4 construct
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Figure 6.7 Southern hybridization analysis using 5' probe and digestion with KpnI
The single recombinant found is indicated by a red circle.
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Figure 6.8 Southern hybridization analysis using 3' probe and digestion with BstXI
The clone positive at the 5’ arm is indicated by a red circle, and is negative for
recombination at the 3’ arm.
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Figure 6.9 Southern hybridization analysis using Neo probe and digestion with BstXI
145
6.3 Discussion
6.3.1 Cloning of the targeting construct was successful
The targeting construct was cloned in 3 separate steps using 129 strain DNA from either
genomic or BAC sources. In order to obtain the greatest degree of homology we initially used
genomic DNA extracted from the same ES cell line which would be used for transfection. It
was possible to amplify the 5’ arm and exon 4 from the genomic DNA, however PCR of the
3’ arm proved problematic. PCR of large fragments from genomic DNA can be difficult due
to variable quality and complexity. However, PCR from Bacterial Artificial Chromosomes,
BACs, is generally easier than from genomic DNA and enables a higher concentration of
amplification fragments to be generated. BACs are plasmids which are modified to contain a
large segment of exogenous DNA which can be transformed into bacteria allowing the DNA
fragment to be amplified. The BAC library used was from an end-sequenced 129 strain which
has previously been shown to produce targeting vectors with up to 35% targeting efficiency
in 129 derived ES cells (Adams et al., 2005). PCR amplification of the 3’ arm from BAC
BMQ429J2 was successful.
6.3.2 Southern hybridization screening was capable of identifying
targeted and wildtype events.
The Southern hybridization produced specific bands at the appropriate size for each probe
with no background or nonspecific binding, proving that the screening method was capable of
detecting recombinants.
6.3.3 Embryonic stem cells did not undergo targeted homologous
recombination.
The Southern screening found that no ES cells had the correct targeted insertion of the
construct. One ES cell appeared to have the 5’ end of the construct inserted, but this cell did
not have a positive result at the 3’ end. This result could be due to partial insertion of the
construct, with the second crossover occurring before the 3’ arm of homology or random
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insertion of the entire construct, including the TK cassette. There are a number of reasons that
could have prevented the targeted insertion:
1. DNA is mutated and not isogenic
Homologous recombination within mammalian cells is rare, occurring in approximately 1 in
106 cells (Reid et al., 1991). Studies of the mechanism of homologous recombination have
identified several factors that affect the frequency of homologous recombination. The extent
of homology between the targeting vector and target locus is extremely important with
isogenic (identical) sequences giving maximum targeting efficiency. For this reason we chose
to make the targeting construct from 129 genomic DNA and a library of BAC clones derived
from 129sv mice (Adams et al., 2005). 129sv mice are commonly used for embryonic stem
cell transfection as they are more reliable at colonizing germline cells in chimeric animals.
The targeting construct was periodically sequenced to screen for spontaneous mutations and
compared to the most up to date 129sv genomic sequence. Non-isogenic targeting has
previously been shown to reduce homologous recombination 15-fold with only 2%
divergence between targeting vector and targeting locus sequences (Zhou et al., 2001). A
small mistake in the sequence database, or the sequencing data from the targeting vector,
would have greatly reduced the number of homologous recombination events. The construct
was resequenced after the failed transfection and no errors were found in the sequence,
therefore non-isogenic sequences were not the cause of the low frequency of homologous
recombination.
2. Homologous recombination occurred in the short floxed arm
Homologous recombination can occur between any isogenic sequences. The correct targeting
event would require two crossovers, one within the 3’ arm of homology and one within the 5’
arm of homology. The targeting construct we designed contained a third, much smaller, area
of homology between the loxP sites. Thomas and Capecchi originally showed an increase in
targeting rate with an increase in targeting arm size (Thomas and Capecchi, 1987) but a study
targeting the β-globin locus found the size of the targeting arm made no difference (Lu et al.,
2003). Therefore, although the region of homology within the floxed region is small a
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crossover could theoretically take place and prevent full insertion of the targeting vector. If
homologous recombination had occurred in the floxed region the band identified by digestion
with KpnI and 5’ probe would be 7.9kb as expected for a targeted insertion as the additional
KpnI site will have been inserted at the end of the 5’ arm. However, the largest band
identified with the 3’ probe and digestion with BstXI would have been approximately 7.6kb,
as expected for a wildtype gene, since the large 9.2kb band observed with targeted insertion
arises from the addition of the Neo cassette and two loxP sites between the two endogenous
BSTXI sites. A crossover in the floxed region would lead to the addition of just one loxP site
which would not lead to a considerable size difference in the digested fragment.
3. TRPC4 has a lower than average recombination frequency
The efficiency of targeted insertion of a vector varies at different chromosomal loci (Hasty et
al., 1994). Changes in chromatin structure along the length of a chromosome can affect DNA
accessibility leading to recombination “hot spots” and “cold spots” (Petes, 2001). If the
TRPC4 gene is within a “cold” spot for recombination this would reduce the chances of
chiasmata forming and reduce the probability of homologous recombination between the
targeting vector and the targeted locus.
6.3.4 Future work
A low homologous recombination frequency would require a large number of ES cells to be
screened in order to find a positive targeted event. We screened just 168 ES cell clones which
should be increased to improve our chances of finding a correct recombinant.
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7 Summary
The work presented in the thesis demonstrates the importance of TRPC channels in sensory
systems. The Cre/loxP system was used to delete TRPC3 exclusively from sensory neurons in
the mouse, allowing the investigation of TRPC3 function without confounding effects from
deletion in other tissues. This mouse line displayed deficits in inflammatory pain, which
could be due to dysregulated inflammatory signalling cascades in the TRPC3 conditional null
animals revealed with microarray analysis.
A global deletion of TRPC3 together with TRPC6 exposed further sensory functions of
TRPC channels. This mouse line displayed deficits in touch sensation and hearing,
implicating TRPC3 and TRPC6 in mechanical sensation. The reduced mechanical sensitivity
was found to be due to a reduction in mechanically sensitive DRG neurons, particularly the
subpopulation characterised by small diameter and rapidly adapting currents. The hearing
deficit was localised to the high frequency ranges between 32-40kHz as assessed by auditory
brainstem responses. This evidence alludes to a range of mechanically sensitive channels,
including TRPC3 and TRPC6, which may form heteromers with different activation
thresholds and properties dependent not only on subunit identity but also modulatory
proteins. Direct recordings from hair cells and sensory neurons could help to determine if
TRPC3 and TRPC6 are themselves mechanically gated or if they are indirectly activated by
other molecules such as GPCRs.
The generation of a floxed TRPC4 construct would allow us to look at the functions of
TRPC4 limited to certain tissues of interest, in light of the functions of TRPC3 and TRPC6
this may include sensory neurons and also the outer hair cells.
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8 Appendix A
8.1 Additional results for Chapter 3 : Generation and phenotyping
of TRPC3 Knockout mice
8.1.1 Confirmation of tissue-specific knockout
The confirmation of tissue-specific knockout was performed by Dr Jing Zhao.
The knockout of TRPC3 was confirmed with PCR using primers that flank exon 7. This
enabled identification of a floxed exon 7 as an increase of 100bp of the PCR product and also
the identification of a deleted exon 7 which would produce a smaller PCR product of 300bp.
Tissue was collected from the tail and DRG of TRPC3fl/fl mice and TRPC3fl/fl:Nav1.8Cre
mice and the DNA extracted. PCRs using primers TRPC3F2 x TRPC3R were performed and
the results shown in Figure 8.1.
8.1.2 TRPC3fl/fl:Nav1.8Cre mice show no deficits in motor coordination
The rotarod test was performed by Dr Cruz Miguel Cendan
Figure 8.1 Confirmation of tissue specific knockout of TRPC3 in DRG neurons.
PCR of tail and DRG DNA from a Nav1.8Cre+ and Nav1.8Cre- mouse using primers TRPC3F2 and
TRPC3R. Floxed TRPC3; 900bp, KO TRPC3; 300bp.
900bp
300bp
DRG TAIL DRG TAIL
Nav1.8Cre+ Nav1.8Cre-
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Motor coordination was judged using an accelerating rotarod. There was no difference in the
motor ability of the TRPC3fl/fl:Nav1.8Cre mice compared with control animals (Figure 8.2).
TRPC3fl/fl:Nav1.8Cre mice were able to carry out normal motor responses such as paw
withdrawal, flinching and shaking in response to the stimuli presented in the other
behavioural tests. Results, expressed as mean time spent on accelerating rotarod ±SEM, were
as follows: TRPC3fl/fl:Nav1.8Cre mice, 218±16 seconds, control animals, 222±16 seconds.
Figure 8.2 Motor coordination of TRPC3fl/fl:Nav1.8Cre and control (TRPC3fl/fl) animals.
There was no difference in motor coordination between TRPC3fl/fl littermate control (orange, n=14) and
TRPC3fl/fl:Nav1.8Cre (red, n=13) animals. All results shown as mean ±SEM.
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8.1.3 TRPC3fl/fl:Nav1.8Cre mice do not show behavioural deficits in
mechanosensation
The Randall Selitto test was performed by Dr Cruz Miguel Cendan
Behavioural responses to mechanical stimulus were measured using von Frey hairs and the
Randall Selitto test. No difference in the 50% withdrawal threshold to von Frey hairs was
observed between TRPC3fl/fl:Nav1.8Cre, 0.45±0.05g, and control animals, 0.47±0.07g
(Figure 8.3a). The Randall Selitto test showed there was also no difference in behavioural
responses to noxious blunt stimulation of the tail between TRPC3fl/fl:Nav1.8Cre mice and
control animals (Figure 8.3b). Results expressed as mean threshold±SEM are as follows,
TRPC3fl/fl:Nav1.8Cre mice, 258±37g, control mice, 287±39g.
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Figure 8.3 Acute mechanical sensation in TRPC3fl/fl:Nav1.8Cre and control (TRPC3fl/fl) animals
a. Response to mechanical stimulation with von Frey hairs was not significantly different between
TRPC3fl/fl littermate control (orange, n=5) and TRPC3fl/fl:Nav1.8Cre (red, n=5) animals. b. Response to
blunt mechanical stimulation of the tail in the Randal Selitto test was not significantly different between
floxed TRPC3 littermate control (orange, n=14) and TRPC3fl/fl:Nav1.8Cre (red, n=14) animals. All results
shown as mean ±SEM.
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8.1.4 TRPC3fl/fl:Nav1.8Cre mice do not show behavioural deficits in
noxious thermosensation
The Hargreaves’ and hot plate tests were performed by Dr Cruz Miguel Cendan
Behavioural responses to noxious thermal stimuli were measured using the Hargreaves’
apparatus and the hot plate test. Paw withdrawal latency in Hargreaves’ test was not altered in
the TRPC3fl/fl:Nav1.8Cre mice compared to control animals (Figure 8.4a). Results expressed
as mean latency±SEM are as follows, TRPC3fl/fl:Nav1.8Cre mice 10±0.6 seconds, control
mice 11.1±0.6 seconds. There was also no difference in latency of behavioural responses on
the hot plate at either 50ºC, TRPC3fl/fl:Nav1.8Cre mice responding on average in
50±2.7seconds compared to 48±4 seconds for control mice, or 55ºC, TRPC3fl/fl:Nav1.8Cre
mice responding on average in 25±1.2 seconds and control mice in 24±1.6 seconds (Figure
8.4b).
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Figure 8.4 Acute thermal pain behaviour in TRPC3fl/fl:Nav1.8Cre and control (TRPC3fl/fl) animals.
a. Noxious thermal stimulation using Hargreaves’ apparatus. No significant difference was observed between
littermate control (orange, n=14) and TRPC3fl/fl:Nav1.8Cre (red, n=14) animals. b. Response to noxious
thermal stimulation using the hot plate test was not significantly different between littermate control (orange,
n=14) and TRPC3fl/fl:Nav1.8Cre (red, n=14) animals at either 50ºC or 55ºC. All results shown as mean
±SEM.
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8.1.5 TRPC3fl/fl:Nav1.8Cre mice display reduced inflammatory pain
behaviour
8.1.5.1 Formalin test
The formalin test was performed by Dr Cruz Miguel Cendan
Behavioural responses from 11 TRPC3fl/fl:Nav1.8Cre mice and 11 control mice in the two
distinct phases were recorded. In the first phase, 0-10 minutes, the TRPC3fl/fl:Nav1.8Cre
mice displayed 62±6 seconds of pain behaviour compared with 72±5 seconds for the control
mice. There was no significant difference between the two groups. In contrast the
TRPC3fl/fl:Nav1.8Cre mice showed attenuated pain behaviours in the second phase, from
10-60 minutes, displaying just 56.5±17 seconds compared with 124±25 seconds for the
control mice. This was shown to be significant using an unpaired 2-tailed t-test (p = 0.0423).
Figure 8.5b shows the time course of the formalin response and demonstrates that the
TRPC3fl/fl:Nav1.8Cre mice displayed reduced pain behaviours at each 5 minute interval
within the second, inflammatory, phase although a significant difference was found only at
15-20 minutes (p < 0.001).
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Figure 8.5 Formalin-induced inflammatory pain behaviour in TRPC3fl/fl:Nav1.8Cre and control
(TRPC3fl/fl) animals.
Behaviour following injection of 20µl of 5% formalin. a. Time spent licking/flinching/biting the hind paw
was recorded in 5 minute sections. No significant reduction in pain behaviours was seen in Phase I (0-10
minutes) however in Phase II (10-60 minutes) TRPC3fl/fl:Nav1.8Cre mice (red, n=11) have significantly
attenuated pain behaviours compared to littermate controls (orange, n=11). b. Time course of the formalin
test. A traditional biphasic response was observed with the attenuated pain behaviour of
TRPC3fl/fl:Nav1.8Cre mice apparent in the second phase. All results shown as mean ±SEM.
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9 Appendix B
9.1 Additional methods for Chapter 4 : Effects of nociceptor
TRPC3 deletion on gene expression
9.1.1 Methods for Microarray
The preparation of the samples and initial microarray data analysis was performed by Priya
Banerjee and Simone Sharma.
The DRGs from three TRPC3fl/fl:Nav1.8Cre and three TRPC3fl/fl (control) mice were
excised and the RNA was extracted as described above. The samples were kept separate to
ensure three biological replicates for each genotype. RNA concentration and quality was
checked using Nanodrop and Agilent Bioanalyser.
NuGen 3’ Applause kit with Encore Biotin Module was used for first and second strand
cDNA synthesis and labeling.
9.1.1.1 First strand synthesis
To each RNA sample of 200ng, 2ul of Buffer A1 (containing a chimeric DNA/RNA chimeric
primer) was added and incubated at 65⁰C for 5 minutes. 3ul of First Strand Master Mix,
containing a reverse transcriptase, was added and the First Strand Synthesis programme was
run for, 4⁰C for 1 minute, 48⁰C for 60 seconds, 70⁰C for 15 seconds, cool to 4⁰C.
9.1.1.2 Second strand synthesis
10ul of Second Strand Master Mix, containing DNA polymerase and DNA primers, was
added to each First Strand reaction tube and the Second Strand Synthesis programme run,
4⁰C for 1 minute, 25⁰C for 10 minutes, 50⁰C for 30 minutes, 70⁰C for 5 minutes, cool to 4⁰C.
9.1.1.3 Single Primer Isothermal Amplification (SPIA)
5ul of SPIA buffer, DNA polymerase, RNase H and SPIA DNA/RNA chimeric primers
master mix were added to each Second Strand reaction and run on the following program,
47⁰C for 90 minutes, 95⁰C for 5 minutes, cool to 4⁰C. The RNase degrades the DNA/RNA
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heteroduplex at the end of the cDNA strand which allows the hybridization of a second SPIA
DNA/RNA chimeric primer. DNA polymerase initiates synthesis at the 3’ end of the primer,
displacing the existing strand and the RNA portion at the 5’ end is again removed by RNase.
This results in rapid accumulation of cDNA with a sequence complementary to the original
mRNA.
SPIA cDNA was purified using QIAGEN’s MinElute Reaction Cleanup Kit. Adding 300ul of
high-salt, binding buffer was added and the sample was applied to the MinElute spin column
where DNA adsorbs to the silica membrane. Flow-through was discarded and the column
washed with buffer PE to remove impurities before eluting with nuclease-free water.
9.1.1.4 Biotin Labelling
7ul of Fragmentation Master Mix (containing fragmentation enzyme and buffer) was added to
25ul of SPIA cDNA and placed into a thermal cycler running the following programme, 37⁰C
for 30 minutes, 95⁰C for 2 minutes, cool to 4⁰C.
1.5ul Biotin Reagent, 1.5ul Labeling enzyme and 15ul Labeling buffer were added to each
fragmented cDNA sample and the following programme run, 37⁰C for 60 minutes, 70⁰C for
10 minutes, cool to 4⁰C.
Sample preparation and the microarray scanning was performed at UCL Genomics centre.
9.1.1.5 Microarray data analysis
Initial microarray data analysis was performed by UCL Genomics which included cluster
analysis to check the biological replicates were similar and ANOVA analysis to determine
which genes were significantly up or down regulated in the knockout animals. Partek
software was used to further analyse the gene list and perform gene ontology enrichment
analysis. Pathway analysis was also performed using the Database for Annotation,
Visualization and Integrated Discovery (DAVID).
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10 Appendix C
10.1 Additional methods and results for Chapter 5 : Phenotyping
TRPC3-/-:TRPC6-/- mice
10.1.1 Patch clamp electrophysiology
Patch clamp electrophysiology is a way of investigating ion channels by recording
electrophysiological characteristics from either small numbers of ion channels in the cell
membrane or from the whole cell. The cell membrane consists of a bilayer of phospholipids
that form a barrier to charged molecules; the flow of ions across the plasma membrane is
facilitated by specialised proteins, ion channels, transporters and pumps. These proteins act to
maintain the differences in osmolarity of the intracellular and extracellular media that many
physiological processes depend on, the distribution of the main ions is shown in Table 10.1.
Ion Intracellular range Extracellular range
Na+ 5-20mM 130-160mM
K+ 130-160mM 4-8mM
Ca2+ 50-1000nM 1.2-4mM
Mg2+ 10-20mM 1-5mM
Cl- 1-60mM 100-140mM
HCO3- 1-3mM 20-30mM
Table 10.1 Intracellular and extracellular distribution of main ions
The membrane potential is the difference in voltage between the interior and exterior of the
cell and the resting membrane potential of a cell is determined by the permeability of the
membrane to ions that produce this electrical potential difference. In most neurons the resting
membrane potential is around -70mV. Each ion will have a characteristic reversal potential
dependent on the concentrations inside and outside and the permeability of the cell membrane
to the particular ion. Diffusion down their electrochemical gradients through ion channels
will move the membrane potential closer to their reversal potential. The resulting resting
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membrane potential would be a weighted average of all the permeable ions reversal
potentials. Ion transporters however can work against the electrochemical gradients. The
particularly important high intracellular potassium and low sodium concentration is
maintained by an Na+/K+ pump, which transports out 3Na+ ions for every 2 K+ ions in at the
cost of one ATP molecule, makes the cytoplasm negatively charged relative to the
extracellular space.
When ion channels open in response to a stimulus, or the extracellular solution, cations flow
down the electrochemical gradient into the cell making the membrane potential more
positive. Voltage gated sodium channels are opened in response to the change in membrane
potential causing a rapid influx of Na+ ions, which depolarizes the membrane leading to an
action potential. Following the action potential K+ channels restore the membrane potential to
the negative resting potential (also see Figure 10.1).
Patch clamp electrophysiology can elucidate the properties of the ion channels responding to
heat, chemical and mechanical stimuli. This transduction occurs at the peripheral terminals of
sensory neurons in vivo but receptors normally found on peripheral terminals are present on
Figure 10.1 Phases of the action potential and inactivation of voltage gated sodium channels
When a defined threshold of depolarization is reached, voltage-gated sodium channels are activated and an action
potential is generated. During an action potential, an IFM-inactivating segment moves to block the channel within
0.5–1 ms. In this inactivated state, the channel cannot be opened. Meanwhile, potassium channels open, acting to
repolarize the membrane. As the membrane repolarizes, the sodium channel gate is closed and inactivating
segment is displaced, returning the sodium channel to a resting closed state adapted from (Raouf et al.,
2010;Lumpkin and Caterina, 2007;Clapham, 2003).
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the cell bodies of cultured sensory neurons allowing these cells to be used as a model for the
study of transduction (Cesare and McNaughton, 1996).
10.1.1.1 Electrophysiological recordings
DRG Culture
Mice were sacrificed by CO2 inhalation followed by cervical dislocation in accordance with
the UK Animals Scientific Procedures Act 1986. All efforts were made to minimize animal
suffering and to reduce the number of animals used. Dorsal root ganglia were removed,
collected in ice-cold medium (Ca2+- and Mg2+-free HBSS supplemented with 5 mM HEPES
and 10 mM Glucose) and subsequently digested in an enzyme mixture containing Ca2+- and
Mg2+-free HBSS, 5 mM HEPES, 10 mM Glucose, Collagenase type XI (5 mg ml−1), 
Dispase (10 mg ml−1) for 1 hour prior to mechanical trituration in Dulbecco's modified 
Eagle's Medium (DMEM) + 10% Heat-inactivated Foetal Bovine Serum (FBS). Cells were
then centrifuged for 5 min at 800 rpm and resuspended in DMEM containing
4.5 g l−1 glucose, 4 mM l-glutamine, 110 mg l−1 sodium pyruvate, 10% FBS, 1% penicillin–
streptomycin (10 000 i.u. ml−1), 1% Glutamax, 125 ng ml−1 nerve growth factor (NGF) and 
50 ng ml−1 Neurotrophin-4 (NT-4) and plated on 35 mm dishes coated with poly-l-lysine 
(0.01 mg ml−1) and laminin (0.02 mg ml−1). Cultures were kept at 37 °C in 5% 
CO2. Neurons were used up to 2 days after plating.
Whole cell perforated patch recordings
Voltage-clamp recordings from cultured DRG neurons were carried out at a holding potential
of -60mV using an Axopatch 200B amplifier (Axon Instruments, Inc). Pipettes were pulled
from borosilicate glass capillaries with a P-97 puller (Sutter Instrument Co.) and exhibited
resistances of 1-3MΩ. Currents were digitized with a Digidata 1322A data acquisition system 
(Axon Instruments Inc.). Data was recorded and stored using Clamps 8.1 (Axon Instruments
Inc.). Currents were low pass-filtered at 2kHz and sampled at 11kHz. Capacity transients
were cancelled, and series resistance was compensated by 80% minimum. Voltages were not
corrected for liquid junction potential. Recordings were performed at room temperature. Off-
line analysis and statistics were performed using Clampfit 9.0 (Graphpad software). Values
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were expressed as means±SEM. The standard pipette solution contained 140mM KCl, 5mM
NaCl, 2mM MgCl2, 5 mM EGTA and 10mM HEPES (pH 7.3). The standard external
solution contained 140mM KCl, 5mM NaCl, 2mM MgCl2, and 10mM HEPES (pH 7.4).
Amphothericin-B was added to the pipette solution to perforate the cell membrane.
Mechanical stimulation of DRG neurons
A heat-polished glass pipette, a tip diameter of ~5-6µm, was used to stimulate the neurons
mechanically at an angle of ~60⁰ to the surface of the culture dish. The probe was connected
to a computer-controlled piezo-electric crystal drive (Burleigh) and positioned such that a
10µm movement did not visibly contact the cell but an 11µm stimulus produced an
observable membrane deflection. A 1µm stimulus was attributed to a probe movement of
11µm stimulation, a 2µm stimulus to a 12µm movement and so on. The probe moved at a
speed of 0.5µm/ms and the stimulus duration was 200ms. The correlation between action
potential properties and DRG neuronal phenotype that exists in adult animals was used to
distinguish between mechanoreceptive (low threshold) neurons and nociceptive (high
threshold) neurons. IB4 staining was used to distinguish between peptidergic and non-
peptidergic IB4+ small neurons.
10.1.2 Auditory Brainstem Response
Mice were anesthetized with ketamine-medetomidine cocktail (50mg ketamine, 0.415mg
medetomidine in 4.1ml saline), 0.01ml/g body weight. Electrodes were placed at the vertex
and the mastoid, with a ground near the tail. TDT System 3 equipment was used to generate
the stimuli and acquire the evoked response. Tone pips were presented through a closed field
speaker at 25 s−1 at each frequency. Pure tone stimuli was generated at 8, 12, 24, 32 and
40KHz. Sound pressure level was varied in 5 dB steps from 10 to 90 relative dB. The data
was converted using Matlab and evoked potential wave forms were visually inspected to
obtain a threshold value.
10.1.3 Fluorescence microscopy
Mice were sacrificed directly after functional testing and cochleae excised from bullae.
Fixative was perfused directly into the cochlea by creating a small opening at the apex of the
cochlea and rupturing the bone between the round and oval window. Cochleae were fixed in
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4% paraformaldehyde for 90 minutes and then decalcified in 4.13% EDTA (pH 7.3). Organ
of Corti strips (1/2 turns) were carefully dissected, categorised into apical or basal, and
incubated in 0.5% Triton X-100 for 20 minutes to permeabilise plasma membranes. Tissue
was then incubated in phalloidin conjugated to rhodamine fluorophore 1μg/ml in PBS with 
0.15% Triton X-100 for 80 minutes at room temperature. Wholemounts were PBS washed x4
and mounted on multispot slides with Vectashield containing DAPI to counterstain nuclei.
Preparations were examined and imaged using a Zeiss Meta confocal laser scanning
microscope. Digital images were exported as TIFF or JPEG files.
10.1.4 Immunohistochemical analysis
To prepare the DRG sections for lectin IB4 (IB4) and calcitonin gene-related peptide (CGRP)
staining, Wild-type control and TRPC3-/-:TRPC6-/- mice were deeply anesthetised with
pentobarbital (140 mg/kg) and transcardially perfused with heparinised saline (0.9% NaCl)
followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB), pH7.4. The lumbar
DRGs were dissected and post-fixed in 4% PFA overnight at 4°C. The tissue was transferred
into 20% sucrose in 0.1 M PB for 24 hours at 4°C and then embedded in O.C.T. compound
(BDH Essex, UK) on dry ice. Cryostat sections (thickness, 11μm) were cut and collected on 
Superfrost plus slides. For Peripherin and Neurofilament 200 (NF200) immunostaining, fresh
unperfused Lumber 4 (L4) DRGs from wild-type control (n = 3) and TRPC3/6 DKO mice (n
= 3) were dissected and embedded in O.C.T. compound. Cryostat sections (thickness, 11μm) 
were serially cut. Every 8th section throughout the L4 DRG was collected. All the slides were
dried over night at room temperature after sectioning. The sections for Peripherin and NF200
staining were fixed with fresh prepared 4% PFA at room temperature for 7 minutes, and then
washed three times for 5 minutes each with 1x PBS containing 0.3% Triton X-100 (PBST).
All the sections for immunostaining were incubated in blocking buffer (PBST containing
10% goat serum, Sigma G9023) at room temperature for 1 hour and then were incubated with
diluted primary antibodies overnight at 4°C. After three times washes for 10 minutes each
with PBST, bound primary antibodies were detected by incubating with diluted secondary
antibodies at room temperature for 2 hours. The slides were washed with PBST for three
times 10 minutes each and then mounted using VECTASHIELD HardSet Mounting Medium
(Vector Labs, H-1400). The staining sections were visualized using a fluorescent Leica
microscope. Images were taken using Hamamatsu Camera and HC Image Live software. The
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same setup of acquisition was used to acquire the pictures of both groups of mice. The
number of DRG neurons was counted as described1. Briefly, the number of peripherin-
positive (green), NF200-positive (red) and double-positive (yellow) neurons were counted
blind in all sections from L4 DRG in each animal. The total number of L4 DRG neurons was
calculated by adding Peripherin-, NF200- and double-positive neuron numbers together.
Mean and SEM of percentages and number of L4 DRG neurons were evaluated for wild-type
and mutant groups. The following primary antibodies were diluted in blocking buffer: rabbit
anti-CGRP (1:4000, Sigma C8198); mouse anti-Peripherin (1:500, Sigma, P5117); rabbit
anti-Neurofilament 200 (1:200, Sigma, UK, N4142). lectin IB4-biotin (1:500, Sigma, L2140)
was diluted in PBS containing 0.1 mM MnCl2, 0.1 mM MgCl2, and 0.1 mM CaCl2. The
following secondary antibodies were diluted in blocking buffer: goat anti-mouse IgG Alexa
fluor 488 (1:1000, Invitrogen, A11017); goat anti-rabbit IgG Alexa fluor 594 (1:1000,
Invitrogen, A11037) and Alexa Fluor 488-conjugated streptavidin (1:200, Invitrogen,
S11223).
10.1.5 TRPC3-/-:TRPC6-/- mice have severe hearing loss
The following work was performed by Professor Jonathan Ashmore amd Dr Ruth Taylor
The TRPC3-/-:TRPC6-/- mice do not show a Preyer reflex response to a 20kHz toneburst at
90dSB delivered by a custom built clickbox (see Supplementary video and Figure 5.15a).
Auditory function was further tested using auditory brainstem responses. The dB threshold at
which a brainstem response was seen in response to pure tone stimuli was assessed by eye.
The TRPC3-/-:TRPC6-/- had a hearing deficit at 32kHz and above compared to age-matched
wildtype controls (Figure 10.2).
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Figure 10.2 Auditory brainstem response TRPC3-/-:TRPC6-/- mice and wildtype controls
TRPC3-/-:TRPC6-/- mice (blue, n=9) had significantly increased thresholds at 32kHz (p<0.01) and 40kHz
(p<0.001) compared to wildtype controls (orange, n=8). Two-way ANOVA with Bonferroni post test.
Results expressed as mean±SEM.
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10.1.6 TRPC3-/--:TRPC6-/- null mice have reduced rapidly adapting
currents in large diameter DRG neurons
The following work was performed by Dr. Francois Rugiero and Dr. John Linley.
Three types of mechanically activated currents are seen in DRG neurons, slowly adapting
(SA), intermediately adapting (IA) and rapidly adapting (RA) (Figure 10.3a), a proportion of
DRG neurons are non responsive to mechanical stimulus. All three types of current were seen
in TRPC3/TRPC6 null, TRPC3-/- and TRPC6-/- mice and the magnitude of currents evoked by
mechanical stimulus did not differ (Figure 10.3c). When looking at the subpopulations of
neurons no difference was found in mechanically evoked currents in the large diameter
neurons (Figure 10.3d). However, in the small diameter neurons there was an increase in the
numbers of non-responsive cells by 15% and a decrease of rapidly adapting current in the
TRPC3/TRPC6 double knockout by a similar amount compared to the wildtype controls
(Figure 10.3b). TRPC3-/- also displayed a decrease of RA currents but an increase of IA
currents meant the overall number of mechanically sensitive neurons remained the same as
wildtype animals.
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Figure 10.3 Mechanosensitive currents in DRG neurons from TRPC3/TRPC6 double knockout,
TRPC3-/-, TRPC6-/- and wildtype controls.
A. Mechanically evoked currents from small diameter mouse DRG neurons normalised to peak were
classified based on kinetic of adaptation; Rapidly adapting (RA) Intermediately adapting (IA), Slowly
adapting (SA). B. Proportion of small diameter mouse DRG neurons expressing each current type from wild
type mice (WT) TRPC3/6 double knockout mice (DKO), TRPC3 single KO mice (C3 KO) and TRPC6
single KO mice (C6 KO). C. Magnitude of currents evoked by a 12 um stimulus in mouse DRG cultures. No
significant difference was found between genotypes (ANOVA, p>0.05). (D) Mechanically evoked currents
from large diameter mouse DRG neurons with action potential widths <1 ms. No significant difference was
seen between genotypes (unpaired t-test, p>0.05, n = 17).
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10.1.7 TRPC3-/-:TRPC6-/- null mice have normal cochlea and DRG
neurons
The following work was performed by Dr Zing Zhao
The sensory neurons of the TRPC3-/-:TRPC6-/- mice were quantified and characterised using
immunohistochemistry. Sections of DRG were stained with anti-peripherin, anti-
neurofilament, anti-IB4 and anti-CGRP; The TRPC3-/-:TRPC6-/- (DKO) mice show the
similar expression pattern of the four markers compared to littermate wild-type control (WT)
mice (Figure 10.4a). The wild-type control and TRPC3-/-:TRPC6-/- mice also have similar
percentage of Peripherin (64.0 ± 1.0%, 64.2 ± 1.0%), NF200 (27.5 ± 1.8%, 26.2 ± 0.7%) and
Peripherin+NF200 (8.5 ± 0.8%, 9.6 ± 0.4%) positive DRG neurons (P > 0.05, Student’s t-
test). TRPC3-/-:TRPC6-/- mice have no deficits in any subpopulations of DRG neurons
(Figure 10.4b-c).
The following work was performed by Dr Ruth Taylor
Cochlea from a wildtype and TRPC3-/-:TRPC6-/- mice were examined with fluorescence
microscopy. There was little evidence of hair cell loss except where the occasional scar
formation, derived from the expansion of supporting cells apices, could be seen in the region
of outer hair cell loss (<0.1% of outer hair cells). Additionally, hair cell loss could be
identified by the absence of nuclei in the apical layer of the tissue. Pillar cells and inner hair
cells were readily recognised with phalloidin labelling and all had normal morphology
(Figure 10.4d).
169
Figure 10.4 No significant neuronal marker changes and neuron losses in DRG, no cell losses in organ of Corti
in TRPC3-/-:TRPC6-/- (DKO) mice.
a, Subpopulation sensory neuron markers IB4 (green, top) and CGRP (red, top), Peripherin (green, bottom) and
Neurofilament 200 (NF200) (red, bottom) were detected in DRG sections by immunohistochemistry. b, The
percentage of Peripherin and NF200 positive DRG neurons was calculated after immunohistochemistry. The positive
cells were counted on every 8th cross section from DRG Lumber 4 (L4). c, The total number of DRG neurons were
calculated on above sections by adding Peripherin positive (+), NF200+ and double-positive neuron numbers together.
There is no significant difference in DRG neuron numbers between WT and TRPC3-/-:TRPC6-/- (1550 ± 93, 1607 ±
72; P > 0.05, Student’s t-test). d, Comparison surface confocal sections of organ of Corti from WT and TRPC3-/-
:TRPC6-/- from same litter. Rhodamine-phalloidin stained shows actin-containing stereocilia (ACT, red) from basal
turn. The three rows of outer hair cells are intact in both cases. The rows of pillar cells show up as strongly labelled
upper band. Mice age is 10.7 weeks. Scale bar = 50 µm.
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